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Previous studies (Francis and Gallagher, 1993) have shown that the ahp promoter of 
Salmonella is activated during macrophage interaction and in response to hydrogen 
peroxide. Subsequent studies (Taylor et al., 1997) reported that the ahp gene when 
tagged with the bioluminescent reporter system Mudlux, became unresponsive to 
hydrogen peroxide in a low osmotic environment, whilst enhanced expression of ahp 
resulted from exposure to a combination of high osmolarity and hydrogen peroxide. 
Thus the Mudlux element appeared to cause ahp to be osmoregulated. In this thesis, 
regulation of wild type and Mudlux-tagged ahp expression was examined by reverse 
transcription and the polymerase chain reaction (RT-PCR). Maximum induction of 
ahpC in MPG203 was seen in LSLB and minimal media, after treatment with both 
hydrogen peroxide and sodium chloride in combination, which is in agreement with 
the luminometer data. However, ahpC in MPG203 was induced to a greater degree 
after treatment with hydrogen peroxide compared with sodium chloride, which is in 
disagreement with the luminometer data. The results from the RT-PCR were 
different for SL 1344, were maximum induction of ahpC in LSLB was recorded after 
treatment with salt, and after treatment with a combination of salt and hydrogen 
peroxide in minimal media. The basis for this aberrant osmoregulation of ahp is still 
not fully resolved, as to whether it is under transcriptional or post-transcriptional 
control. 
Because of its mode of activation, the potential of the ahp promoter as a tool for in 
vivo expression of foreign antigens (Francis et al., 1993; Taylor et al., 1998) was also 
examined. Two other known in vivo expressed promoters, PpagC and PspvA were 
included in the study for comparison. The antigens encoded on the plasmids used for 
immunisation, were gene fragments cloned from listeriolysin (LLO) of Listeria 
monocytogenes and glycoprotein 63 (Gp63) of Leishmania major which contained T 
cell epitopes. GFP, was also used as a control for protein stability and was encoded 
on a plasmid construct and used for immunisations. Salmonella typhimurium strain 
MPG424 was utilised as a vector for immunisation. It contained both a purA and an 
xiv 
aroA mutation, leaving the strain hyper-attenuated. However, the Escherichia co/i 
purA promoter and gene were supplied in trans on plasmids encoding antigens of 
interest, to ensure plasmid maintenance and to moderate attenuation by 
complementation (Nakayama et al. 1988; Curtiss et al. 1990). 
A low level of humoral and cell-mediated immunity against Salmonella GroEL and 
AhpC was recorded after immunisation with some of the plasmid constructs (pTMB7 
and pTMB2). However, no antibody response was detected against the heterologous 
antigens (LLO or Gp63) encoded on the plasmids in any of the experiments. A 
plasmid containing stable GFP under the control of either PahpC or PpagC was 
included in the study as a control for protein stability. However, no significant cell-
mediated immunity or antibody response was recorded against GFP either. Overall, 
these studies indicated that, the combination of the Salmonella lyphimurium strain 
and plasmid constructs were inefficient for immunisation. Greater antibody 
production might well have occurred if a different Salmonella lyphimurium strain 
was utilised as an immunising vector. 
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CHAPTER 1 
The ahp promoter of 
Salmonella enterica sv TYPHIMURIUM: 
regulation and merits for heterologous antigen 
expression in vivo 
1. Introduction 
Salmonellae are motile, gram negative, rod-shaped bacteria, that belong to the family 
Enterobacteriaceae. Strains are mainly differentiated based on their reaction to 
serum and bacteriophage sensitivity. Salmonella has been divided into two species, 
Salmonella bongeri and Salmonella' enterica. (Darwin and Miller 1999). There are 
over 2000 serovars, e.g. Salmonella enterica serovar Typhimurium, Salmonella 
enterica serovar Typhi, but in this thesis they will be referred to by their genus and 
serovar names eg. Salmonella typhimurium and Salmonella typhi (Mc Whorter-
Murlin and Hickman-Brenner, 1994). Salmonella enterica can cause a range of 
disease depending on the serovar and host. Salmonella are considered to cause 
approximately 1.3 billion cases of gastroenteritis per year in the world (Ivanoff et al., 
1994) and the annual incidence of Salmonella infections is estimated to be 0.2% per 
year (Wheeler et al., 1999). A small subset of approximately ten serotypes including 
Salmonella lyphimurium, Salmonella enteriditis and Salmonella heidelberg, account 
for the majority of infections (Darwin and Miller 1999). 
Salmonella serovars such as typhimurium or enteritidis infect a wide range of species 
including poultry, cattle, sheep and pigs. S. abortusovis is a major cause of abortion 
in ewes, and S. typhisuis and S.gallinarum are adapted to swine and poultry, 
respectively. S. dublin is associated mainly cattle, but occasionally infect humans 
(Fang and Fierer, 1991). S. typhimurium is ubiquitous and can infect a wide variety 
of animal hosts, and is a frequent cause of food-borne infections in humans and 
causes a typhoid-like disease in mice. These reservoirs are believed to be a major 
factor in the transmission of Salmonella enterica to humans, by providing a source of 
contaminated food or water (Coynault et al., 1996; Maurice 1994). The widespread 
distribution of Salmonellae in the environment, their increasing prevalence in the 
global food chain, and their virulence and adaptability in the host, result in an 
enormous public health and economic impact. 
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Salmonella enterica is capable of causing enteric fever, bacteremia and enterocolitis, 
depending on the serovar and host (Darwin and Miller 1999). In humans, the 
incubation period for Salmonella infection is anything between 6 hours and 48 hours, 
and followed by headache, abdominal pain, vomiting and diarrhoea. The symptoms 
normally resolve within a week, but Salmonella can still be detected in the faeces for 
approximately 20 weeks in children younger than five years old, for up to eight 
weeks or more in adults (Darwin and Miller 1999). Salmonella typhi only infects 
humans and causes typhoid fever (Finlay and Falkow, 1989). 
According to estimates of the World Health Organisation, 16 million cases of 
typhoid fever occur world-wide annually, with an estimated number of 600,000 
deaths (Hensel 2000). Disease caused by typhoidal and non-typhoidal serovars of 
Salmonella enterica represents a global health problem (Maurice 1994). Moreover, 
the importance of this issue has been increased by the growing problems of multi-
drug resistance in bacteria. A distinct strain of Salmonella typhimurium, known as 
definitive type 104 (DT104), is resistant to ampicillin, chloramphenicol, 
streptomycin, sulfonamides, and tetracyclines. S. typhimurium DT104 is the second 
most prevalent Salmonella strain in the U.K. and resistance to trimethoprim and 
fluoroquinolones are also emerging (Threlfall et al., 1997). It has become a major 
cause of illness in humans and animals in Europe, especially the United Kingdom. 
Infection with S. typhimurium DT104 has been associated with contact with ill farm 
animals and exposure to meat products (Wall et al., 1995). 
Salmonellosis varies from gastroenteritis (commonly known as food poisoning) to 
the more severe typhoid fever, where the bacteria invade into deeper tissues like the 
liver and spleen and replicate (Gulig 1996). However, non-typhoidal cases of 
Salmonella infections can result in systemic infection particularly in the 
immunosuppressed, in the elderly and in pregnant women. Potentially, vaccination 
could alleviate many Salmonella-related diseases in both the developed and 
developing world. Salmonella typhimurium causes systemic disease in mice, and acts 
as an immunological model for human typhoid fever (Lucas and Lee 2000). 
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However, they are of lesser value for studying gastroenteritis as they do not result in 
diarrhoea. 
This introduction is divided into three main sections. The first section reviews the 
immune response of the host to a Salmonella infection. In this section, the immune 
response is further split into the innate and specific immune response to the invading 
bacteria. The second section deals with the biology of Salmonella infection and the 
various factors that help Salmonella survive within the host. The last section of the 
introduction assesses the history of use of Salmonella in immunisation. In this thesis, 
Salmonella is considered as a vehicle for heterologous immunisation. Antigens from 
Listeria monocyto genes and Leishmania major were used as models for heterologous 
immunisation and modes of infection by both these organisms are reviewed, along 
with a review of the chosen antigen from each organism. 
1.1 Infection with Salmonella 
The immune response to microbial infection is complex and varies significantly with 
the organism infecting the host. The host has many levels of defense against an 
invading pathogen. Bacteria must be able tolerate the low pH of the stomach. In the 
intestine they must be able to survive the low oxygen levels, weak acids, enhanced 
osmolarity, intestinal bile salts, pancreatic enzymes and the antimicrobial peptides 
secreted by the epithelial cells of the small intestine (Foster and Spector 1995). 
Invasive Salmonellae are capable of passing through the epithelial barrier of the 
intestine to proliferate in the peyer' s patches and the draining mesenteric lymph 
nodes. In the deeper tissues, Salmonella must be able to avoid and survive the 
oxygen dependent and independent killing mechanisms of professional phagocytes, 
following internalisation. Some oxygen-dependent killing mechanisms involve 
production of superoxide anions, hydrogen peroxide, hypochlorite, hydroxyl radicals 
and nitric oxide that are pumped into the phagosomes. Oxygen-independent killing 
mechanisms include phagosome acidification and exposure to degradative enzymes 
and small bacteriocidal peptides known as defensins (Jones and Falkow 1996). 
Peyers patches form part of the Gut associated lymphoid tissue (GALT) and 
essentially consist of lymphoid follicles. In mice (murine model for Salmonella 
infection) this region contains 5-10% M cells which form tight junctions with 
neighbouring enterocytes. These M cells (membranous epithelial cells) have a 
shrunken cytoplasm that forms a bridge between the intestinal lumen and 
subepithelial space (Finlay and Falkow, 1989). Once this barrier has been breached, 
organisms may enter the reticuloendothelial system and may evade humoral defenses 
by invading macrophages, if they can survive in that environment. It has been 
suggested that M cells sample the gut for antigens, and rapidly transport intestinally 
located antigens to the antigen presenting cells in the basolateral pocket of the M 
cells (Siebers and Finlay, 1996). It seems that Salmonella typhimurium, in a similar 
manner to several other micro-organisms, may target cells and thereby gain entry 
into the epithelial lining (Siebers and Finlay 1996). Ingestion by macrophages may 
also serve as a vehicle for transmitting these bacteria to the lymph nodes, liver and 
spleen and facilitate a systemic infection. Movement of Salmonella species through 
M cells, results in destruction of M cells and subsequent colonisation of the 
subepithelial lymphoid tissue resulting in typhoid-like fever and enteritis (Carter and 
Collins 1974). Recently, CD 18' cells were found to take up non-invasive Salmonella 
in the intestine (Vazquez-Torres et at., 1999). 
After contact with the host membrane, Salmonella induces host cell internalisation. 
Phagocytosis occurs within minutes, and is characterised by local cytoskeletal 
rearrangements and membrane ruffling (Finlay et al., 1991 and Alpuche-Aranda et 
at., 1994). Using murine intestinal loops in cell culture it has been shown that 
Salmonella typhimurium invades M cells almost exclusively within 30 minutes 
(Jones et at., 1994). Invasion results in the loss of epithelial integrity and free access 
of bacteria to the lamina propria independent of traversing M cells occurs. Here the 
bacteria can persist in the reticuloendothelial system and at this time have the 
potential to cause systemic infection (Jones et al., 1994). However 60 minutes after 
infection the M cells start to detach from the epithelial lining and die (Jones et at., 
1994). There has been some controversy over the potential role of M cells in 
Salmonella infection. Non-invasive strains of Salmonella typhimurium could not be 
El 
found associated with M cells within comparable infection times, suggesting a more 
specific role for M cells in the Salmonella infection (Jones et al., 1994). In this 
regard, it should be remembered that Salmonellae have been shown to induce 
endocytosis via interaction with the epidermal growth factor receptor (EGFR) and 
this may have implications as a route of infection. However, it is also of note that 
elimination of the EGFR genes in mice, does not abolish the capacity for 
Salmonellae infection (Bliska et al., 1993). Salmonella typhi uses the cystic fibrosis 
transmembrane conductance regulator (CFTR) to gain entry into epithelial cells (Pier 
et at., 1998). CFTR, has been principally classified as a chloride receptor, but also 
functions as an epithelial cell receptor for internalisation of Salmonella lyphi 
(Gerceker et at., 2000). They found that mouse cells expressing wild-type CFTR 
receptor internalised more Salmonella lyphi than the isogenic cells (delta508) 
expressing the CFTR mutation at residue 508 (deletion of a phenylalanine). In 
heterozygous delta508 Cftr mice, 86% fewer Salmonella lyphi translocated into the 
gasrtointestinal submucosa, compared with wild-type Cftr mice. Moreover, no 
uptake or translocation of Salmonella lyphi, occurred in the homozygous delta508 
Cftr mice. Therefore, lower levels of CFTR in heterozygous, may possibly decrease 
the susceptibility to typhoid fever (Pier et al., 1998). This could also account for the 
increase resistance to typhoid fever in some populations of European ancestry at 
levels of 4-5%, for maintaining the heterozygote advantage A508 CFTR allele 
(Gerceker et al., 2000). Furthermore, it is worth noting that the Cftr genotype had no 
effect on the translocation of Salmonella typhimurium (Pier et al., 1998). 
Many of the properties of Salmonella, including intracellular survival, induction of 
macropinocytosis and formation of the phagosome are controlled by the two-
component regulator phoP/Q (Miller et at., 1989). Salmonella inhibit fusion of 
phagosomes and lysosomes in macrophages to some extent (Isihibashi and Arai., 
1990). Using electron microscopy, 50% of thorium-labelled lysosomes were 
observed not to have fused with phagosomes containing Salmonellae after a period 
of 20 hours (Buchmeier and Heffron,1991). Alpuche-Aranda et al., (1994) proposed 
that no inhibition of fusion occurred, but that Salmonellae were found in a spacious 
phagolysosome similar to macropinosomes. After Salmonella are engulfed by 
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macrophages, the macrophages act as vehicles for widespread dissemination within 
the host and the ability of the Salmonella serovars to survive within and kill 
macrophages leads to an acute systemic infection in mice. In some occasions, 
multiplication of the bacteria may overwhelm the macrophage and cause cell death 
(Schwan et al., 2000). Persistence and growth in the host's macrophage population 
and ability of certain Salmonella serovars to initiate death of infected macrophages 
are likely to contribute to the type and severity of the disease caused by Salmonella 
strains (Schwan et al., 2000). 
1.2 Innate Immunity 
In an immunologically naïve host the primary barriers to bacterial infection are 
antimicrobial factors of the innate immune system, such as phagocytic cells and 
complement. Salmonella are capable of surviving and multiplying within 
macrophages and they can use these cells as a vehicle for transmission to other parts 
of the body such as the liver and spleen (the latter two sites are thought to be the 
main sites for multiplication in the body). In macrophages and polymorphonuclear 
monocytes (PNMs), the oxidative or respiratory burst is one of the primary 
antibacterial functions. These include reactive oxygen intermediates, superoxide, 
peroxide, hydroxyl radicals, hypochlorous acid and nitric oxide (Hasett and Cohen 
1989). Inherent to this process, Salmonella has evolved ways of avoiding killing by 
professional phagocytes thereby allowing their survival and intracellular 
multiplication. This is a co-ordinated event where different sets of genes are switched 
on or off by regulatory systems which are modulated during the course of infection. 
The outcome of infection depends on a number of factors including the size of the 
bacterial inoculum, the virulence of the infecting Salmonella strain, the ability of the 
host to mobilise immune defences to respond to the infection and other less 
characterised factors which may relate to the circumstances associated with specific 
infections (e.g. associated food source, presence of phage etc). 
Since phagocytes have specific cell surface receptors for components of complement, 
the deposition of complement proteins on the surface of bacteria facilitates their 
opsonisation and uptake (Adams and Hamilton 1984; Joiner et al., 1984). 
Complement is predominantly found in the blood under normal circumstances and 
normally not found at the mucosal Surfaces. Therefore, Salmonella that invade 
beyond the mucosal surfaces will come into contact with complement and will have 
to combat the functions of opsonisation and lysis (Gulig,1996). Many bacteria resist 
this activity, due to the presence of a polysaccharide capsule, such as the Vi capsule 
of Salmonella typhi (Gulig, 1996). This capsule masks the surface of the bacterial 
cell and thereby prevents opsonisation. Salmonella typhimurium is not encapsulated 
and relies on the 0 antigen of lipopolysacchande (LPS) on the outer membrane to 
resist complement (Joiner 1988). 
Complement is an important component of innate immunity and plays an important 
role in the host defence against bacteria. The rck locus encodes an outer membrane 
protein (Rck) of 185 amino acids, with a post-cleavage molecular mass of 17.4Kda. 
This protein is homologous to the outer membrane protein PagC (required for the 
survival of Salmonella lyphimurium and virulence in mice) and Ail, which is a 
Yersinia enterocolitica protein (capable of mediating bacterial adherence and 
invasion of epithelial cell lines. Rck most closely resembles PagC (Heffernan et al., 
1992). Rck blocks the formation of the complement membrane attach complex on the 
bacterial surface, and confers complement resistance to serum-sensitive hosts 
(Guiney et al., 1994). 
The role of the classical pathway in complement has been investigated. Mice 
deficient in the first component of the classical pathway (Clq (Clqaj, were infected 
either intravenously (i.v.) or intraperitoneally (i.p.) with Salmonella typhimurium 
12033 (serum resistant strain) and were monitored over a 14-day period. The 
complement deficient mice were more susceptible to infection with Salmonella 
lyphimurium by both routes of inoculation. The Clq-deficient mice started to 
concede to infection, 6 days after inoculation, whereas the wild-type mice survived 
throughout the study. This suggests that the clq- deficient mice are affected in the 
ability to control the growth of the bacteria in the mononuclear phagocytic system. 
This was proved, due to increased bacterial numbers in the liver and spleen of these 
deficient mice. The virulence of Salmonella in vivo, requires the ability to be able to 
survive within macrophages, and clq seems to interfere with the effector 
mechanisms by which the mononuclear phagocytes confront Salmonella (Warren et 
al., 2002). 
Professional phagocytes, mainly mononuclear phagocytes (monocytes and 
macrophages) and polymorphonuclear leucocytes, such as neutrophils are important 
in preventing infection (Adams and Hamilton, 1984). The mononuclear phagocytes 
migrate via the blood as monocytes and enter various tissues including the skin, 
intestine, liver and spleen, where they develop into tissue-resident macrophages. 
Macrophages play an important role in generating specific immunity (Abbas et al., 
1991, 1996). The liver macrophages, known as Kuppfer cells, are a very important 
component of this system (Adams and Hamilton, 1984; Kaufmann, 1993). Wijburgh 
et al., (2000), have shown that macrophages are essential for development of 
infection by virulent Salmonella. They also demonstrated, that macrophages are 
required for the clearance of attenuated bacteria, but are not required for protective 
immunity after immunisation. 
Dendritic cells found just below the epithelium (associated with lymphoid follicles 
close to M cells), are thought to be involved in the capture and presentation of 
antigens in the Peyers patches (Iwaski and Kendall, 2000). Dendritic cells rather than 
macrophages have been shown to internalise Salmonella typhimurium early in 
infection after oral immunisation and after injection into a ligated loop of intestine 
(Hopkins et al., 2000). Niedergang et al. (2000), suggested that dendritic cells play 
an essential role in triggering the immune system, whereas macrophages play a 
central role in the clearance of Salmonella. When mice were inuiiunised orally with 
attenuated Salmonella typhimurium expressing stable green fluorescent protein GFP, 
fluorescent bacteria were found colocalised with CD11c cells, but not with 
macrophages. This suggested that dendritic cells rather than macrophages interact 
with bacteria and play a role in the immune response against genes encoded in the 
vector (Niedergang et al. 2000). 
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1.3 Specific Immunity 
Salmonella enterica is an intracellular pathogen, which can survive within 
macrophages, whereby protection against the action of antibody and complement 
occurs to a certain degree (Finlay and Falkow 1989b). Humans and animals deal with 
Salmonella infections by activating both Humoral and Cell Mediated Immunity 
(CMI) against bacterial proteins and in vivo expressed antigens are thought to be 
important immunological targets for protection 
1.3.1 Humoral responses 
The interaction of relevant cell types results in the production of cytokines that in 
turn enhances the capacity of the phagocytes to kill bacteria or stimulate B cells to 
produce antibody. Thus, during the course of infection there is involvement and 
interaction of a number of cell types, which play a role in the immune response. 
Bacterial lipolysaccharide and peptidoglycan are highly inflammatory and stimulate 
host cells to produce cytokines resulting in fever and shock (Gulig, 1996). Protein 
antigens may stimulate both Humoral and Cell mediated immunity (CMI), whereas 
polysaccharides and lipids generally cannot stimulate cell-mediated immunity well. 
Moreover, different infectious agents or antigens may preferentially stimulate the 
production of antibodies and activate T cells (TO and TH2) to produce distinct sets 
of cytokines, or generate T cytolytic lymphocytes or other effectors of cell mediated 
immunity. The antibody responses to these molecules are T cell independent and 
consist mainly of 1gM. In contrast, proteins can stimulate antibody isotype switching 
and affinity maturation, with subsequent generation of B cell memory. Large 
amounts of polysaccharide or other antigens may even induce tolerance in specific B 
cell lymphocytes and thereby inhibit antibody production (Roitt et al., 1998). 
The importance of the use of antibody in protecting the host against Salmonella 
enterica infection raises interesting issues. Mastroeni et al., (1993), demonstrated 
that T cells were required in addition to antibodies, for protection in the murine 
model. They demonstrated this, by comparing mice that received immune serum and 
immune cells compared to the response of naive mice. They concluded that mice 
receiving immune serum survived 1-2 days more than naïve mice, whereas mice 
receiving both immune serum and immune cells showed a prolonged irregular 
mortality curve with mice dying between 7-16 days. Thus, the immune serum and 
immune cells add to immunity to oral challenge in this experimental model. In 
contrast T cell depleted mice could not control infection when challenged with the 
same virulent strain. Interestingly the Vi polysaccharide vaccine for typhoid fever 
relies solely on humoral immunity (Ivanoff et al., 1994). 
1.3.2 Cell mediated immunity 
The major type of protective immune response against Salmonella is via cell-
mediated immunity. Cell-mediated immunity consists of 2 parts: killing of 
phagocytosed microbes due to macrophage activation by cytokines produced by T 
cells and lysis of infected cells by CD8 cytolytic T lymphocytes (CTL's). Cytolytic 
T cells are characterised by the CD8 cell marker and are a group of T cells capable 
of lysing infected cells, which express bacterial antigens on their surface MHC I 
molecules. Natural Killer (NK) cells are involved in both short-term non-specific 
immunity and specific immunity against Salmonella typhimurium (Gracia Penarrubia 
et al., 1989). NK cells are stimulated to produce IFN-y and macrophages produce IL-
12 to promote the development of Th 1 cells. 
Specific immunity is regulated by T Helper lymphocytes which, identify antigenic 
peptides via the T cell receptor and orchestrate the immune response (Abbas et al., 
1991 and 1996). Antigen is presented to the T cell by Antigen presenting cells 
(APC's), which include monocytes, macrophages, langerhan cells and B cells (Abbas 
et al., 1991 and 1996). It is assumed that the protective effect of live vaccines is 
mainly cell-mediated, and results from macrophage activation by T cells (Collins, 
1974). It has been suggested from work carried out using Listeria monocytogenes 
that the magnitude and the antigen specificity of the memory T cell response is 
proportional to the primary T cell response. Therefore, maximising the initial T 
lymphocyte response during priming, could enhance the development of long term 
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protective immunity (Vijh and Pamer, 1997). There are a number of cell surface 
molecules, which are essential in determining the type of immune response generated 
during infection. These include molecules found on T cells, such as CD4 and CD8, 
and the major histocompatibility molecules I and II (MHCI and MHCII), which are 
found on APC (reviewed in Abbas et al., 1997; Roitt et al., 1998). T cells can only 
identify a processed antigen when it is associated with the products of MHCI or 
MHCII (Abbas et al., 1997) and this ability is restricted only to T cells expressing 
CD8 or CD4 on their surface, respectively. 
CD8 T cells recognise peptides bound to class I MHC molecules and such peptides 
are usually proteins found in the cytosol of APCs, including viral and tumoral 
proteins. The peptide antigens presented by MHC class II molecules are recognised 
by CD4 T cells, thereby stimulating a TO or a TH2 response (Kaufmann, 1993). 
Therefore, the association of antigens with class I or class II MHC molecules, is 
dependent upon whether the antigen is from an exogenous or endogenous source, and 
the trafficking of the antigens through different intracellular compartments (Brodsky 
and Guagliardi, 1991). Host cells expressing endogenous antigens associated with 
class I MHC molecules, are destroyed by CD8 cytolytic T cells (CTL) that 
recognise this complex (Abbas et al., 1997). There is evidence for participation of 
CD8 T cells in immunity to S. typhimurium. CD8 T cells can differentiate into 
cytolytic T cells (CTL), and antigen-specific targeted cell lysis is regarded as one of 
the main tasks of CD8 T cells (Kaufmann, 1988). Since Salmonella lyphimurium is 
a facultative intracellular bacterium, it is possible that lysis of infected cells by CTLs 
would release bacteria from their protective habitat, rendering them accessible for 
activated phagocytes. 
1.3.3 Major Histocompatibility molecules 
T cells can only identify a processed antigen in association with MHC-I and MHC-II. 
MHC-II molecules are delivered via the Golgi apparatus to the phagolysosome where 
the peptides can associate with MHC-II after processing and the complex can be 
transported to the surface of the cell. Uptake of antigens by APC occurs by 
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phagocytosis mediated by receptors including Fc receptors and complement receptors 
(Unanue 1993). Peptide components of bacteria are usually presented in association 
with MHC-II via the endocytic pathway, following engulfment by phagocytes like 
macrophages and degradation into peptides in the phagolysosome (Wick et al., 
1995). T cells require the presence of histocomptability proteins to bind antigen, 
unlike B cells that can bind antigen via their surface immunoglobulins (Schwartz 
1985). The affinity of the MHC molecule for antigenic peptides has been proposed to 
play a major role in immunodominance (Wipke et al., 1993). 
Foreign proteins located in the cytosol or nucleus are degraded and enter the host cell 
MHC-I processing pathway, as part of normal cellular function. These proteins are 
degraded by proteolytic enzymes in the cytoplasm of the host and the resulting 
peptides are transported into the lumen of the endoplasmic reticulum (ER) by 2 ATP-
binding cassette-transporters (TAP 1 and TAP 2). In the ER, MHC class-I proteins 
consisting of a transmembrane heavy chain and a non-covalently associated light 
chain (132-microglobulin) are loaded with the peptides. This trimolecular complex is 
exported through the Golgi and the secretory pathway to the surface of the cell, for 
recognition by CD8T cells (Germain, 1994). 
Peptide fragments, which are presented via the MHC-II system normally, enter the 
process via endocytosis. MHC class II molecules are also assembled in the lumen of 
the ER. The MHC class II proteins are heterodimers made up of two transmembrane 
proteins (a and 13 chains) which become associated with the invariant chain in the 
ER. Peptides are prevented from binding in the ER, due to the binding of the 
invariant-chain peptide region (CLIP) to the MHC class II. This nonamer consisting 
of three heterotrimers ((X303 and the invariant chain trimer) leaves the ER through the 
Golgi apparatus, where the invariant chain diverts the complex towards the 
endosomal pathway. Exogenous antigens degraded into peptides cannot bind to the 
MHC class II molecules until the invariant chain has become dissociated in special 
endosome/lysosome—like compartments (Ghosh et al., 1995). Generally, when 
foreign proteins are expressed in Salmonella typhimurium, the proteins are degraded 
and presented by MHC class II molecules (Brett et al., 1993a). The peptide antigens 
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presented by MHC class II molecules are recognised by CD4 T cells, thereby 
stimulating a TH1 or a TH2 response (Kaufman, 1993). The primary structure of both 
T helper and T cytotoxic epitopes were found to contain a linear pattern containing a 
charged residue or a glycine followed by two hydrophobic residues (Townsend et al., 
1986). The vast majority of T cell epitopes are composed of linear sequence in the 
intact protein, with the minimum size being 8-12 amino acids. The particular epitope 
recognised is dependent on the MHC protein (Rothbard and Taylor, 1988). 
1.3.4 T cell responses to Salmonella 
In BALB/c mice immunity to Salmonella enterica infection, involves a T helper cell 
(TH 1) response. T cells mediate their effect by producing cytokines which modulate 
B cells and macrophages, while also enhancing the activity of other T cells (Nauciel 
et at., 1992). TH1 responses are accompanied by the production of certain cytokines, 
including interlukin-y (INF-y), tumour necrosis factor-3 (TNF-13), interlukin —2 (IL-
2) and interlukin-12 (IL-12). INF-y and IL-12 are thought to be the major cytokines 
promoting Tb! differentiation (Nauciel and Espinasse- Maes 1992; George 1996). 
IFN-y activates macrophages to produce reactive oxygen species and enzymes that 
kill phagocytosed bacteria. IFN-'y also stimulates the production of antibody isotypes 
(e.g. IgG2a) which activate complement and opsonise bacteria by phagocytosis in 
mice (Kaufman, 1993; Romagnani, 1996). 
It is known that both IL-12, and IFN-'y play major roles in suppressing the growth of 
Salmonella enterica in the host (Nauciel and Espinasse- Maes 1992; Mastroeni et at., 
1996). INF-'y is produced in large amounts from the lymphoid cells within the Peyers 
patches in response to Salmonella, indicating that this cytokine has an important role 
in the host response to infection (Ramarathinam et at., 1991). It has been suggested 
that INF-y prevents the outgrowth of TH2 cells, whereas IL-12 has no effect on TH2 
cells (discussed below) (Seder et at., 1993). IL-12 is produced by many cell types, 
especially macrophages (enhancing anti-microbial activity) in response to products 
from microbes and is the principal TH1 inducing cytokine (Mosmann and Sad, 1996). 
The response mediates macrophage activation and a delayed-type hypersensitivity 
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(DTH) reaction, with the main IgG antibody subtype produced being IgG2a (Cher 
and Mosmann, 1987; Romagnani, 1996). DTH is usually associated with the 
development of T cell mediated immunity (Collins, 1974). Since the principal 
function of TH1 cells is to elicit phagocyte-mediated defense against infections, by 
activating macrophages and promoting the production of antibody (IgG2a), they 
could be considered as effectors of phagocyte-dependent responses (Romagnani, 
1996). Responses of the TO type are highly protective and usually cause elimination 
of the organism. However, if this does not occur, the ongoing Thi response results in 
an inflammatory response. 
TH2 type T cell resporjses result in the production of cytokines like IL-4, IL-5, IL-6, 
IL-10 and IL-13 (Brett et al.,1993). IL-4 is the most potent stimulus for TH2 
differentiation and is a major inducer of B cell switching to IgE production 
(Romagnani, 1996). TH2 cells are great helpers for B lymphocytes and stimulate the 
production of high levels of antigen-specific, non-complement fixing IgGi, 1gM and 
IgE responses (Cofmann et al., 1988; Brett et al., 1993). Since some of the cytokines 
produced by TH2 cells promote antibody production from B cells and inhibit several 
macrophage functions, they can be considered as effectors of phagocyte-independent 
responses (Romagnani, 1996). TH2 responses are often associated with 
gastrointestinal nematode infections and are generally considered as the default 
system. 
T cells expressing cytokines of both TO and TH2 cell patterns have been designated 
as ThO cells (Mosmann and Sad, 1996). This mixed cytokine (THO) response is most 
noticeable early after lymphocyte activation and the distinguishable TO or TH2 
states are visible when the antigens are more persistent and not easily eliminated 
(Romagnani, 1996). It is possible that this mixed cytokine response could be induced 
to differentiate further into either a TO or a TH2 response, depending on the 
microenvironment. Induction of a TH2 response, results in the inhibition of further 
TO development and macrophage activation, thereby avoiding or reducing 
inflammation (Ramagnani, 1996). Therefore, in this situation TH2 cells are regulators 
of the immune response. Pascual et al., (1999) demonstrated a biphasic T cell 
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response to mice immunised with Salmonella. The presence of IL-12 was detected in 
the early stages of infection, and therefore such immunisation appears to affect the 
THu TH2 balance in favour of a TH1  response (Hsieh et al., 1993; Seder et al., 1993). 
1.4. Host genetics 
The control of Salmonella typhimurium replication in the spleen and liver depends on 
the macrophage/neutrophil specific protein Nramp 1 (Natural resistance associated 
macrophage protein, whose gene is also called Ity, Bcg, or Lsh). The Ity locus is 
located on chromosome 1 (also known as Nramp) and is believed to be allelic to the 
lsh and bcg loci, which modulate murine susceptibility to Leishmania donovani and 
Mycobacterium bovis BCG respectively. (Vidal et al., 1993). 
Originally the ily gene was believed to affect cytokine production. (Horameche et al., 
1979). However, a conflicting view from a separate study suggested that the ily 
phenotypes were not due to differences in cytokine production (Eckmann et al., 
1996). Comparison of Nramp genes from resistant and susceptible mice, 
demonstrated a single amino acid substitution in the transmembrane portions of the 
protein (Vidal et al. 1993). This difference is believed to alter the insertion and 
stability of NRAMP protein within the phagolysomal membrane, thereby causing 
impairment of function. Therefore, mice that have a defective Nrampl molecule 
(BALB/c or C57BL/6 mice) are susceptible to Salmonella typhimurium infection 
(Vidal et al., 1996). Mice are either Jtys  or they carry the dominant j1R  allele. 
The Ily gene appears to be responsible for much of the difference in Salmonella 
resistance among inbred mouse strains. This gene has a major effect on Salmonella 
pathogenesis during week 1 of infection. By comparing inbred mouse strains, it has 
been suggested that this locus controls the growth of Salmonellae rather than the rate 
of killing (Hormaeche et al. 1990). BALB/c mice (Itys)  are often used to study 
infections with Salmonella typhimurium, since both humoral and cell-mediated 
immunity are required to develop protection. JjyS  mice injected intrapentoneally (i.p) 
with a small number of bacteria, developed sepsis (Benjamin et al., 1990). In 
15 
comparison jjyR  mice can control low numbers of virulent Salmonella syphimurium 
with a moderate non-specific response. The early phase of infection is under the 
control of the Ily gene and regulates the growth of bacteria in the liver and spleen 
(Collins 1974; Mastroeni et al., 1993). Therefore, innately susceptible mice are 
important for the study of cell mediated immunity and in the absence of previous 
exposure, cannot readily control an infection with virulent Salmonella, even with 
very low doses, whereas innately resistant mice can control low doses of virulent 
organisms, even without previous exposure (Collins 1974). 
1.4.1 Salmonella Genetics- Secretion systems 
Polypeptide secretion in gram negative bacteria such as Salmonella enterica requires 
the protein to pass via an inner membrane and outer membrane (reviewed by 
Wandersman, 1996). There are three types of protein secretion systems and all use 
ATP hydrolysis to drive secretion (MacBeth and Lee, 1993; Mecsas and Strauss, 
1996). Type I and type II systems, secrete proteins that are involved in pathogenesis. 
Proteins secreted by the type I system cross directly from the cytoplasm to the cell 
surface, bypassing the general secretory pathway completely. Proteins secreted by 
the Type II system, use the general secretory pathway to reach the periplasm, where 
they make an intermediate stop, and then traverse the outer membrane through 
distinct channel proteins. Type III secretion systems are used by many bacterial 
pathogens to deliver virulence proteins (e.g.toxins) into host cells, that in turn 
interfere with the hosts normal signalling pathways. (Cirillo et al., 1998). 
The highly conserved type III secretion system has been found in many Gram-
negative bacteria that cause disease in humans and plants (Van Gijsegem et al., 1995; 
Galan, 1996; Galan and Sansonetti, 1996). The secretion apparatus is encoded by at 
least 17 different genes. They have a complex composition of at least 20 subunits 
located in the cytoplasm, the inner membrane and outer membrane (Hueck et al., 
1998). Type III secretion systems involve a protein complex that spans the inner and 
outer membrane and mediates secretion directly across both membranes. Type III 
secretion is stimulated when a pathogen comes into close contact with host cells 
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(contact dependent secretion) (Ginocchio et al., 1994). The main function of type III 
secretion systems are to co-ordinately secrete and translocate a set of effector 
proteins into eukaryotic cells (Wallis and Galyov, 2000). 
1.4.2 Salmonella Pathogenicity Islands 
Most virulence genes of Salmonella typhimurium are clustered into distinct 
sequences known as Salmonella Pathogenicity Islands (SPI). Pathogenicity islands 
are chromosomal clusters of virulence genes found in pathogenic organisms, but 
absent or sporadically present in related nonpathogenic species. They are often found 
adjacent to tRNA genes, suggesting transfer into these broadly conserved sites, and 
contain atypical guanine and cytosine content from that of the rest of the 
chromosome (Groisman and Ochman, 2000). There are five known SPI's located 
around the Salmonella typhimurium chromosome. 
SPI-1 is located at 63 minutes (40kb), SPI-2 at 31 minutes (25kb), SPI-3 at 82 
minutes (17kb), SPI-4 at 92 minutes (24kb) and SPI-5 at 23 minutes (7kb). SPI-1 and 
SPI-2 encode type III secretory apparatus that allow the injection of effector proteins 
into the host cell cytoplasm through a specialised syringe. SPI- 1 plays a key role in 
the ability to invade epithelial cells and the inflammatory response, whereas SPI-2 
plays a role in controlling the replication of bacteria in the intracellular 
compartments of phagocytic cells and epithelial cells (Wong et al., 1998; Sirard et 
al., 1999). SPI-3 contains 10 genes organised into 6 transcriptional units and has 
been identified at the seiC tRNA gene locus (Blanc-Potard and Groisman, 1997). 
This includes mgtC'B operon encoding the macrophage survival protein MgtC 
required for virulence in mice and the Mg 2 transporter MgtB, as well as a putative 
transcriptional regulator (SsrB) and proteins of unknown function (Groisman and 
Ochman, 2000). SPI-3 is required for intracellular survival of Salmonella in 
macrophages, by providing products necessary for growth in Mg 2,  limiting 
conditions. SPI-4 is located next to a putative tRNA gene at 92 minutes on the 
Salmonella chromosome map and is believed to be involved in the adaptation of 
Salmonella to the intracellular environment of the macrophage (Wong et al., 1998). 
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SPI-5 maps to the serT tRNA locus and this island encodes proteins such as SopB 
which is also secreted via the SPI-1 apparatus (Sirard et al., 1999). SPI-5 is involved 
in the inflammatory reaction in the intestine for Salmonella dublin and the invasion 
of Salmonella lyphimurium, but it has been suggested that SPI-5 does not play a role 
in systemic disease (Groisman and Ochman 2000). Two of these islands (SPI-1 and 
SPI-2) are discussed in more detail below. 
1.4.2.1. SPI-1 
The majority of the determinants for entry into and invasion of, mammalian cells are 
encoded in SPI- 1 of the Salmonella chromosome at 63 minutes. The majority of 
genes encoded are organised into the mv (invasion), spa (surface presentation of 
pntigen) and prg (PhoP repressed genes) operons. This contains approximately 29 
genes (Galan 1996). The mv locus is required for bacterial internalisation into 
cultured non-phagocytic cells. This region has at least 14 genes in the following 
order- invH, invF, invE, invA, invB, invC, invi, invf, spaO, spaP, spaQ, spaR, spaS. 
This locus is also required for mouse virulence, as strains carrying mutations in mv 
are severely deficient in their ability to enter into cultured epithelial cells (Galan et 
al., 1989). These operons are believed to encode polypeptides, which form the 
structural components of the invasion-protein export system. The organisation of 
genes in SPI- 1 appears to show some degree of conservation in a number of other 
bacterial pathogens, including Shigella species, Yersina species, Pseudomonas 
species and plant pathogens like Erwina amylovora (Galan 1996). 
The invasion machinery encoded by the genes located on SP1-1 are essential for 
invasion of epithelial cells in vitro, and contribute to M cell invasion (Jones et al., 
1994). These genes have several requirements for induction, such as low oxygen, 
high osmolarity and inactive PhoPQ formation. By requiring multiple conditions for 
maximum expression of invasion genes, Salmonella typhimurium may restrict SPI- 1 
invasion gene expression to an unique environment within the host (Bajaj et a!, 
1996). The same signal or a combination of signals may activate one set of genes, 
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while repressing another set. For example, Ph0PQ is thought to activate pag 
expression while also repressing SPI-1 invasion genes. 
The differential regulation of pag and SPI- 1 invasion gene expression in vivo seems 
reasonable, since pag genes are expressed in macrophages while SPI- 1 invasion 
genes are thought to be expressed in the intestine. (Bajaj et al., 1996 and Vescovi et 
al., 1996). This could prevent unnecessary expression of genes that could be 
damaging at a particular location or might represent immunological targets. Since, 
PhoPQ are activated by low cation levels in vitro (discussed later), knowing that pag 
genes are activated in a PhoP-dependent manner, suggests that bacteria are exposed 
to cation limiting conditions in the phagosome. It has been suggested that the cation 
concentration in the intestine is high, so that PhoPQ is inactive and thereby 
expression of invasion genes is possible (Lucas and Lee 2000). 
A number of genes have been identified on SPI- 1 which do not seem to form part of 
the secretory apparatus and are, therefore, believed to be components specifically 
transported by the type III system. These include proteins encoded by the sip locus 
sipABCD (Salmonella invasion protein), the sop locus (Salmonella outer protein) 
which is encoded by sopABCDE and invJ, spoi and sptP genes (Galan, 1996; Wood 
et al., 1996). These Sip proteins appear to be involved in bacterial invasion of 
cultured epithelial cells. Sip and Sop proteins were isolated from culture media after 
growth of Salmonella typhimurium and Salmonella dublin respectively, indicating 
that they had been secreted (Wood et al., 1996). Inactivation of sipB, sipC or sipD 
has a profound effect on the invasion phenotype, whereas inactivation of sipA has 
only a very subtle effect. This coincides with the fact that SipB, SipC and SipD are 
translocaters, whereas SipA is an effector protein. SipA binds actin, thereby aiding 
the internalisation of bacteria into epithelial cell via actin filament rearrangement 
(Zhou et al., 1999). 
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1.4.2.2. SPI-2 
Shea et at. (1996) discovered another 40-kb virulence gene cluster (SPI-2) which is 
located at 31 minutes on the Salmonella chromosome. This locus is conserved among 
all other Salmonella species examined, but is not conserved in a variety of other 
pathogenic bacteria or in Escherichia coli K-12. Salmonella is unique among Gram-
negative pathogens in that it harbours two distinct type III secretion systems, each 
contributing to different stages of the infectious process. To distinguish between the 
two secretion systems, this second type III system secretion system designated 
Spi/Ssa is encoded within the Salmonella pathogenicity island 2 (SPI-2). The SpilSsa 
system is essential for causing systemic disease (Shea et al., 1996). SPI-2 appears to 
enhance bacterial replication, rather than survival within host macrophages. The 
other type III secretion system encoded by the iv/spa invasion locus is known as the 
iv/spa locus which lies within SPI- 1 (Hueck, 1998) (discussed previously in section 
1.4.2.1). 
Genes encoding components of the type III secretion apparatus were designated ssa 
(secretion system apparatus), genes encoding type III substrate proteins and their 
specific chaperones were called sse (secretion ystemeffector) and ssc (secretion 
ystem chaperone) respectively. Genes encoding regulatory proteins of SPI-2 
virulence genes were termed ssrAB (ecretion system regulator) known as the two-
component regulatory system (Hensel 2000). The SsrAB system senses and regulates 
signals, resulting in the induction of SPI-2 gene expression. It has been suggested 
that nutritional starvation might be one of the signals for SPI-2 expression (Hensel, 
2000). Salmonella strains with mutations in ssa or ssr genes, demonstrate defects in 
systemic infection in the host and a reduced accumulation in macrophages. Thus, 
suggests that SsrAB have a central role in virulence gene expression (Deiwick and 
Hensel 1999). SpiC (alternative term SsaB) is a known substrate for the Type III 
secretion system encoded by the SPI-2 system (Hensel 2000). This protein encoded 
within the SPI-2 pathogenicity island might be involved in the inhibition of 
phagosome-lysosome fusion (Groisman and Ochman, 2000). This protein appears to 
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act intracellularly after its delivery into the cytosol through a type III secretion 
system. However, the target of SpiC has not been identified (Uchiya et al., 1999). 
SPI-2 genes were identified as genes specifically induced inside host cells 
(macrophages) using differential fluorescence induction of a random library of 
genomic fragments of Salmonella typhimurium (Valdivia and Falkow, 1997). Pfeiffer 
et al., (1999), found that the intracellular induction of Salmonella typhimurium SPI-2 
genes were not limited to macrophages, but also occurred in infected epithelial cells. 
Bacteria with mutations in SPI-2 virulence genes, were defective in survival and 
intracellular proliferation in host cells (Hensel et al., 1998 and Uchiya et al., 1999). 
SPI-2 and spiC function is required to inhibit maturation of phagosomes containing 
Salmonella into phagolysosomes, (Uchiya et al., 1999). Wild-type Salmonella 
typhimurium were compared with SPI-2 mutants using electron microscopy to reveal 
that phagosomes containing SPI-2 mutants co-localised with NADPH oxidase, 
whereas the opposite was true for wild-type Salmonella. This suggests that SPI-2 is 
required to exclude the NADPH oxidase from Salmonella-containing vacuoles, 
which might allow Salmonella to escape oxidative killing inside infected phagocytes 
(Vazquez-Torres et al., 2000). Virulence studies on the SPI-2 mutants have shown 
them to be highly attenuated in mice, compared with the wild type strain after 
immunisation by the oral, intravenous or intraperitoneal route. They demonstrated 
that SPI-2 plays a critical role in the pathogenesis of systemic infection (Shea et al., 
1996, 1999). Mutant strains with transposons, suggested an absolute requirement for 
functional SsrA (sensor) and SsrB (regulator) for SPI-2 expression. 
1.5. Salmonella vaccines 
The earliest human vaccines used against typhoid fever were heat and phenol 
inactivated cells. However, these vaccines resulted in significant adverse reactions 
(Ivanoff et al., 1994). The acetone-killed whole-cell human typhoid vaccine given 
subcutaneously has been in use for many years. In this case, preservation of the Vi 
capsular antigen made the vaccine more immunogenic and protective than the 
previously used heat-phenol-killed vaccine that lacked the Vi antigen (Tacket and 
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Levine, 1995). However, this acetone-killed whole-cell vaccine did not elicit good 
cell-mediated immunity, had limited protection, low efficacy and excessive 
reactogenicity (Levine et al., 1989). The heat-inactivated phenol-preserved 
inactivated S. typhi vaccine is the most widely available and utilised parenteral 
whole-cell vaccine world-wide. However, the disadvantage of this vaccine is that it 
must be maintained in the cold chain to maintain potency. Nevertheless, the 
lyophilised version retained potency even after 12 weeks of storage at high 
temperatures and was still antigenic after 5 years of storage at 4 °C (Plotkin and 
Orenstein, 1999). 
The later human vaccines moved towards the use of attenuated live bacteria (Collins, 
1974; Ivanoff et al., 1994). Attenuated live bacteria do not produce the disease, but 
persist in the host long enough to stimulate long-term protection and have the ability 
to elicit both an antibody response and cell-mediated immunity. Protection conferred 
in mice by live attenuated S. typhimurium vaccines correlates with high levels of 
anti-lipopolysaccharide (LPS) IgG2a antibodies along with a strong cellular TH 1 type 
response. 
The Ty2la live vaccine (attenuated galE, Vi-negative strain), with undefined 
mutations is a successful commercially available licensed vaccine. When 
administered in three or four oral doses it induces local and systemic humoral and 
cell-mediated immunity, but does not give complete protection against typhoid fever 
(Wahdam et al., 1982; Levine et al., 1987). Hoiseth and Stocker (1981), pioneered 
the use of auxotrophic mutants of Salmonella by transduction of an aroA::TnlO 
lesion from the weakly pathogenic Salmonella typhimurium LT2 into the fully 
virulent Salmonella typhimurium strain SL1344. The latter prototype aroA strains 
that also harboured deletion mutations in purA, were inhibited in their ability to 
proliferate, but remained viable (Stocker, 1991). Two vaccine strains CVD906 and 
CVD908, with mutations in aroC aroD were produced from the wild-type 
Salmonella lyphimurium strain Ty2 and were found to be immunogenic, but 
produced transient bacteremia (Tacket et al., 1992; Stzein et al., 1994). CVD908, 
was the first engineered Salmonella typhi vaccine that proved to be clinically well 
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tolerated and highly immunogenic as a single-dose oral vaccine (Tacket et al., 1992). 
CVD908 triggered strong cell-mediated immune responses, including cytokine 
production (particularly IFN-y) (Sztein et al., 1994). 
Chatfield et al., (1992b), showed that inactivation of htrA, a gene encoding a stress 
protein that functions as a serine protease, attenuates wild-type S. typhimurium in 
mice. Mice immunised orally with S. typhimurium harbouring a deletion mutation in 
htrA were protected against challenge with a lethal dose of wild-type S. typhimurium. 
Recently it has been shown that htrA mutants of S. lyphimurium are more susceptible 
in vitro to oxidative stress than the wild-type, suggesting that the mutants may be less 
able to withstand oxidative killing within macrophages (Tacket et al., 2000). Another 
attenuating mutation was introduced into htrA of CVD908, resulting in strain 
CVD908-htrA that remains well tolerated and highly immunogenic (Tacket et al., 
1997). This could be a single-dose vaccine against typhoid fever, which has the 
potential to be used as a live vector for oral delivery of other vaccine antigens. 
There has been a number of other attenuated vaccines developed for example X3927 
(Salmonella typhi strain Ty2), which had mutations in the cya and crp genes. 
However this strain was not sufficiently attenuated to serve as a live oral vaccine in 
humans as the volunteers developed high temperatures and typhoid-like symptoms 
(Curtiss and Kelly, 1987; Tacket et al., 1992). Two other Salmonella typhi strains 
Ty800 with mutations in phoP phoQ and X4073 (triple mutant strain) with mutations 
in cya crp cdt, have been shown to be safe and immunogenic in humans after given 
orally in single doses. They elicit Salmonella lyphi-specific mucosal and systemic 
antibodies, so are promising vaccines for the future (Tacket et al., 1997; Zhang et al., 
1997). Ty445 with mutations in phoP phoQ, also contains an additional deletion in 
aroA and was overly attenuated and minimally immunogenic (Hohmann et al., 
1996a). 
Most of the research to date has focused on Salmonella typhimurium because of it is 
easy to genetically manipulate and also because it produces a comparable typhoid- 
like disease in susceptible mice. However, it is worth noting that they do not develop 
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gastro-enteritis and lack symptoms of diarrhoea. Attenuated vaccine strains have 
been prepared by inactivating genes encoding various biochemical pathways, global 
regulatory systems, stress proteins, putative virulence properties, other regulatory 
genes. A Salmonella typhimurium strain with mutations in the aroA and purA genes 
has been exploited in this thesis. 
1.6 Aromatic dependent vaccines 
Various strategies have been used to identify genes that can be selectively expressed 
in vivo. Stocker et al., (1977) examined the effects of auxotrophy on virulence. They 
introduced a lesion into one of the genes encoding precursors of the aromatic amino 
acid (aro) pathway, resulting in a Salmonella typhimurium strain (aroA), which was 
dependent on the provision of the essential aromatic compound p- amino benzoic 
acid (pABA). This compound is required for the synthesis of folic acid and 2-3-
dihydroxybenzoic acid in laboratory culture and in turn, these are required for the 
synthesis of aromatic amino acids such as ubquinone and the iron-chelator 
enterobactin. Most bacteria are unable to sequester folic acid from their outside 
environment and therefore they synthesise it from pABA, which is derived from 
chorismate (the final product of the aromatic biosynthetic pathway) (Hoiseth et al., 
1981). A complete block at any step in the pathway should make Salmonella 
lyphimurium auxotrophic for two compounds not available in vertebrate tissues and 
renders the organism attenuated (Hoiseth and Stocker., 1981). 
The discovery that aroA mutants were attenuated in vivo but able to persist in the 
host long enough to produce protective immunity was a major development in terms 
of a rational vaccine design (Hosieth and Stocker, 1981). Aro vaccines of particular 
Salmonella serovars have been shown to be safe and effective for use in chickens, 
sheep and calves (Mukkur et al., 1987; Cooper et al., 1990; Jones et al., 1991). 
Salmonella typhi stains with aro mutations have been evaluated in volunteers. Strain 
CVD908 with mutations in aroC and aroD is highly immunogenic (Hone et al., 
1991). With relevance to this thesis, an aroA strain of Salmonella typhimurium 
SL3261 was used to construct a strain (MPG424), where a purA::TnlO was 
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introduced by transduction, creating a Salmonella typhimurium strain that had two 
attenuating lesions (aroA and purA). 
1.7 Purine-dependent vaccines 
Mutations in pur genes (e.g purA) block the synthesis of adenosine Monophosphate 
(AMP) from inosine monophosphate (IMP) resulting in a requirement for adenine. 
The gene purA encodes adenylosuccinate synthetase, and catalyses the synthesis of 
adenylosuccinate (SAMP) from IMP, the first committed step in AMP biosynthesis. 
Adenylosuccinate synthetase 
IMP + L-Asp+ GTP 	 No SAMP + GDP + P 1 
Mahan et al., (1993, 1995) used a procedure known as IVET (in vivo expression 
technology) to select for genes that were expressed during Salmonella enterica 
infection. As part of their strategy they used a pur mutant of Salmonella typhimurium 
which was unable to grow well in mice because of the auxotrophic requirement for 
purines. Random fragments of wild type Salmonella typhimurium chromosomal 
DNA were ligated upstream of promoterless purA and lacZY genes, situated in 
tandem on a plasmid, and then integrated into the Salmonella typhimurium 
chromosome. When the bacteria were injected into mice, only those bacteria, which 
had developed the capacity for expressing the pur gene, could survive in the mouse. 
The random chromosomal fragments inserted upstream of the promoterless pur gene 
must contain a promoter that is constitutive or is capable of switching on during the 
course of infection. In vivo expressed genes were then identified by extracting the 
bacteria from the spleens of mice and then plating them onto MacConkey lactose 
indicator plates, to screen for Lac colonies, in order to eliminate constitutive 
promoters (Mahan et al., 1993, 1995). 
Pashine et al., (1999), demonstrated that both aroA and purA attenuated strains of 
Salmonella lyphimurium developed the same type of dominant IFN-y T cell response, 
even though they cannot proliferate in vivo. They concluded from their work that 
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invasion into macrophages is necessary for effective generation of Thi-like immune 
responses. However, persistence of Salmonella beyond 48 hours is not required. 
(Pashine et al., 1999). In this thesis, the purA gene was utilised as a means of in vivo 
selection of bacteria that were able to maintain their plasmids. This was achieved by 
using a Salmonella typhimurium strain with a chromosomal purA mutation and 
supplying the purA promoter and gene on a plasmid as a means of in vivo selection. 
For an effective vaccine, activation of both strong cell mediated immunity and 
humoral immunity are preferred (if not required). Attenuated bacteria are thought to 
persist in the body long enough to stimulate protective immunity and so, afford much 
greater protection than that elicited by dead cell vaccines. Live attenuated Salmonella 
strains may persist in the host for several months after the onset of infection (Taylor 
et al., 1998). Salmonella typhimurium purA mutants administered by the i.p. route, 
were found to be highly attenuated in mice (McFarland and Stocker 1987). 
Salmonella enterica strains are ideal vehicles for displaying foreign microbial 
antigens, simultaneously eliciting protection against Salmonella and other pathogens 
(Chatfield et al., .1992c; Gonzalez and Demple., 1994; Verma et al., 1995; 
Chabalagoity et al., 1996). The efficiency of such a system is partially dependent on 
the level of antigen expression and its regulation. 
1.8 Attenuated Salmonella vaccines 
Firstly, successful expression of the antigens and proteins in Salmonella is required, 
followed by delivery of the constructs to the immune system. In the majority of 
cases, immunisation of BALB/c mice intra-pentoneally or orally with live 
Salmonella typhimurium expressing heterologous antigens elicit Thi type T-cell 
responses, while on the contrary immunisation with dead Salmonella typhimurium in 
the presence of adjuvant generates a Th2 response (Yang et al., 1990; Thattle et al., 
1993; George 1996; Xu et al., 1995). 
Before T cells recognise infected cells, the bacterial proteins must be degraded into 
peptides and bind to MHC proteins within the host cell. This peptide-MHC complex 
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is displayed on the host cell surface, where it interacts with a specific T cell receptor 
(TCR). MHC class I molecules bind short peptides between 8 and 11 amino acids 
long, forming hydrogen bonds near the amino and carboxyl- termini. However, on 
the other hand MHC class II molecules bind longer peptides and make hydrogen 
bonds with main-chain residues at many positions along the length of the peptide 
(Madden et at., 1991; Stern et at., 1993). 
The type of antigen display and where the recombinant antigen is expressed can 
influence the immune response. After initial infection, there is a predominance of 
1gM, followed by an isotype switch to IgG after multiple exposures to a particular 
antigen and resulting in an increase in the antibody titre (Weir and Stewart, 1993). 
There is conflicting evidence about whether Thi or Th2 responses result from high 
or low doses of antigen. It is generally suggested that low antigen concentrations and 
low doses induce Thi responses, whereas high doses induce the development of Th2 
responses (Bretscher et al., 1992; Hosken et at., 1995). In one study in which 
BALB/c mice were exposed to repeated low doses of ovalbumin (protein antigen), a 
Th2 response resulted with the production of IgE (Wang et at., 1996). In agreement 
with this observation, in a similar study when HuCiv (peptide antigen derived from 
the sequence of Human IV collagen) was used for immunisation. After immunisation 
with 50.tg, a Thi response developed, whereas when 2tg was used a Th2 response 
resulted (Pfeiffer et at., 1995). In disagreement with these experiments, however, 
BALB/c mice immunised with low levels of parasites resulted in a delayed- type 
hypersensitivity (DTH) response accompanied by protection. However, both DTH 
and protection was gradually lost after increasing the parasite numbers from 102  to 
106  (Bretscher et at., 1992). 
Differences in the T cell response may be a result of the difference in the type of 
antigen used in the immunisation (parasite versus protein). It is possible that at low 
antigen doses, the principal antigen presenting cells (APC) are macrophages or 
dendritic cells if the antigen is a particulate microbe. Both of these cell types produce 
IL-12, which could skew the response towards a Thi response (Bretscher et at., 
1992; Hosken et at., 1995). Also, there may be differences in the number and level of 
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antigenic epitopes that are available to the T cell receptor depending on the initial 
form of the antigen. In the scenario of high antigen concentration, repeated T cell 
stimulation may occur causing an increase in IL-4 production and thereby 
development of a Th2 response (Bretscher et al., 1992; Hosken et al., 1995). In the 
case of parasites, many are naturally glycosylated and this may attribute to high 
uptake at low antigen doses (Sallusto et al., 1995). 
1.8.1 Stable antigen expression 
Both the carrier and the promoter used to drive the antigen expression can affect the 
immune response to an antigen. The T cell pattern can be biased towards a Thi or a 
Th2 depending on the construct (Medina et al. 2000). Throughout this next section, 
a number of different factors are carefully considered in the design of a heterologous 
vaccine when using Salmonella typhimurium as a vector. 
If the antigens are plasmid encoded, both plasmid instability and toxicity of the 
expressed protein in the bacterial host need to be considered. If plasmid number is 
increased, sometimes the immunogenicity of the vaccine is also increased (Molina 
and Parker, 1990; Covone et al. 1998). If a plasmid with a lower copy number is 
selected, this may result in more stable expression of the antigen especially if the 
heterologous antigen is toxic. However, a reduction in the immunogenecity of the 
antigen may result (Coultson et al., 1994; Turner et al., 1993). Another way of 
improving in vivo stability of the plasmid is by incorporating genes essential for the 
survival of the bacteria within the host into the plasmid. 
Aspartate 3-semialdehyde dehydrogenase (ASD), an enzyme common to the 
biosynthetic pathways of several amino acids, and diaminopimelic acid (DAP) have 
been used for plasmid construction vectors. DAP is a component essential for 
peptidoglycan synthesis of the cell wall of Gram negative bacteria, which is not 
present in mammalian cells, and its presence is required to prevent the lysis of 
bacterial cells. A plasmid containing the asd gene and promoter has previously been 
used to complement an asd mutation in a Salmonella strain. Balancing the lethal 
mutation resulted in the maintenance of the cells containing the plasmid containing 
the asd promoter and gene (asd) (Nakayama et al., 1988; Galan et al., 1990). When 
Salmonella carrying the plasmids enters the host and the plasmid that expresses the 
asd gene as well as the antigen is the plasmid that is maintained in vivo. The 
expression of asd is essential for the survival of Salmonella in vivo. After replication 
within the host cell, the other plasmid containing the lacI repressor will segregate 
resulting in constitutive expression of the foreign antigen (j3-galactosidase). This is 
an efficient method of repressing the expression of the antigen in vitro, and 
activation of the expression of the antigen in vivo. However, the downside of this 
particular experiment was production of only systemic antibody but no mucosal 
antibody to -ga1actosidase where immunisation was performed by the oral route. 
The reason for this outcome is unknown. Ervin et al. (1993), used a similar system 
for stabilisation of plasmids expressing toxic products in Salmonella. In this case, the 
foreign antigen was expressed from one plasmid under the trc promoter, and a 
second incompatible plasmid expressed the lacI repressor for repression of antigen 
expression in vitro. 
Heterologous genes can be integrated onto the chromosome to enable stabilisation of 
gene expression (Tzschaschel et al., 1996). This may be achieved by introducing the 
gene via a suicide vector with flanking DNA homologous to the Salmonella 
chromosome, so that the gene is integrated by homologous recombination (Hone et 
al. 1988). However, one possible disadvantage, is the fact that the foreign gene will 
be present as a single copy per bacterial cell, which may result in lower antigen 
expression (Cardenas and Clements., 1993). The gene coding for the C fragment of 
tetanus toxin (TetC) has been integrated into the aroC gene of Salmonella 
typhimurium SL3261 for immunisation of mice, but the amount of TetC produced 
lead to poor immunogenicity (Strugnell et at., 1990). To overcome the problems of 
instability and poor immunogenicity, alternative expression strategies, such as the 
use of in vivo activated promoters, have been investigated (Medina et al., 2000). 
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1.8.2 Vaccines with in vivo inducible promoters 
Previously, a technique called in vivo expression technology (IVET) was used to 
specifically identify genes that were induced in vivo during bacterial infection. These 
in vivo induced (ivi) genes were poorly expressed in laboratory medium, but 
demonstrated increased expression in host cells or cultured macrophages (Mahan et 
al., 1993 and 1995). Mahan and colleagues (1993) used a promoterless lacZ gene 
was fused downstream of a promoterless purA gene. The purA gene was used as a 
marker for in vivo selection, when the cells were grown in medium or animal tissue. 
The need to complement the purA deficiency acts as a positive selection for ivi 
expressed genes. 
A number of other promoters have also been exploited for in vivo expression and 
immunisation. Previous studies have highlighted the potential of the NADH-
dependent nitrite reductase promoter (nirB) for expression of foreign antigens within 
Salmonella and in several cases humoral immunity to such antigens has been shown 
to be produced (Chatfield et al., 1992a; Everest et al., 1995a, Everest et al., 1995b; 
Threlfall et al. 1997). Salmonella typhimurium iXhtrA mutant has a deletion in a serine 
protease gene and the avirulence of this mutant may be due to their inability to mount 
a stress response. The gene htrA encodes a heat-shock protein, and when this gene is 
deleted in Salmonella typhimurium or Salmonella typhi, the resulting mutant is less 
virulent because of an impaired ability to survive and/or replicate within the host 
(Lowe et al., 1999). An example of its use was in the protection against the herpes 
simplex virus after immunisation of mice using a Salmonella typhimurium AhtrA 
strain. This AhtrA mutant expressed a fusion protein of glycoprotein D from the 
herpes virus, to the C fragment of tetanus toxin (Chabalgoity et al., 1996). 
OmpRJEnvZ is a two-component regulatory system that responds to changes in the 
osmotic strength and pH within Salmonella typhimurium. Two Omp-R dependent 
genes include genes ompC and ompF encoding 2 proteins OmpC and OmpF which 
are major outer membrane porins. These proteins are reciprocally regulated, with an 
increase in the level of OmpC in high osmolarity and a repression in the level of 
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OmpF (Dorman et al., 1989). There is a possibility that this system plays a role in the 
survival of the bacterium in the gut, by regulating the expression of outer membrane 
porins like OmpC (Foster and Spector 1995; Garcia et al. 1996). Therefore, 
expression of the ompC promoter would be expected during the early stages of 
disease, such as in the gut due to the high osmotic conditions present here, whereas 
ompF expression would occur outside the host. The ompC promoter has potential to 
be utilised as an in vivo promoter activated under conditions encountered during 
infection. 
In the next section, the in vivo promoters that were used to drive the expression of the 
heterologous antigens on plasmids used in this study are discussed in greater detail. 
The promoters selected for the study carried out in this thesis were pagC, spvA and 
ahpC. 
1.8.3 The PhoPQ two-component regulatory system 
The PhoP-Q system, has been reported by many groups to be important in 
Salmonella pathogenesis (Galan and Curtiss, 1989; Groisman et at., 1989, 2001; 
Miller et at., 1989). The bacterial PhoQ (sensor kinase) and PhoP (transcriptional 
activator) proteins specifically detect the macrophage vacuole environment 
promoting transcription of pag (hoP activated gene) loci. Pho-P activated genes 
have been shown to play important roles in Salmonella pathogenesis. These roles 
include survival within macrophages, virulence in mice, induction of spacious 
phagosome formation, increased resistance to antimicrobial peptides and low pH 
(Miller et at., 1989; Ernst et at., 1999). In the macrophage three to five hours after 
phagocytosis, there is maximal transcriptional activation of pag genes. At this point, 
the acidification of the phagosome is occurring and the pH drops to approximately 
4.9 (Alpuche- Aranda et at., 1992). In contrast the prg (PhoP repressed gene) 
products are required for the induction of membrane ruffling, increased 
macropinocytosis and formation of the spacious phagosome (Alpuche- Aranda et at., 
1994). 
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PhoP/Q was first identified in Salmonella typhimurium and is encoded by the locus 
phoP (Kier et al., 1979). The regulator PhoP is found in the cytoplasm (Kier et al., 
1979) and the sensor PhoQ is located in the inner membrane (Garcia Vescovi et at., 
1996 and Groisman 2001). Initially PhoP/Q was thought to be involved in controlling 
the expression of nonspecific acid phosphate (Kier et at., 1979). However, it is now 
known that the PhoP-PhoQ system responds to the levels of Mg 2 and Ca2 and 
responds to periplasmic levels of cations rather than cytoplasmic levels (Garcia 
Vescovi et at., 1996). It has been proposed that PhoQ responds to both pH and Mg 2 
(Beradson et at., 1998). Mn2 can also repress transcription of PhoP-activated genes, 
but other divalent cations including Ni 2 , Cu2 and Ba2 have no effect (Garcia 
Vescovi et at., 1996). Groisman (2001), suggested that although transcription of 
PhoP-regulated genes can be regulated by other signals, these signals are sensed and 
activated by other systems and affect only a small subset of genes belonging to the 
Pho-PQ regulon. 
PhoQ has two transmembrane domains with a long cytoplasmic C terminal tail 
containing a histidine, which is believed to be the site of autophosphorylation. PhoQ 
also has a periplasmic domain rich in acidic residues which are thought to be 
involved in sensing divalent cations like Mg 2+  and Ca 2+  (Garcia Vescovi et at., 1996 
and Groisman 2001). This periplasmic domain has a stretch of 20 amino acids that 
contain 10 negatively charged amino acids and 4 positively charged residues. This 
anionic region may be involved in the recognition of intracellular signals in the 
phagolysosome (Miller et at., 1989). It has been suggested that binding of divalent 
cations promotes a conformational change in the PhoQ protein, that prevents the 
activation of the PhoP protein, resulting in repression of transcription of the PhoP-
activated genes (Gracia Vescovi et at., 1996). 
In vitro, macrophage-specific pag genes are induced by both low cation 
concentrations and acid pH. However, cation levels, only regulate pag genes that are 
induced in both macrophages and epithelial cells. It has been proposed that 
phagosome acidification is important for activation of PmrA-dependent pag genes in 
macrophages, while the other pags simply require low cation conditions for 
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induction in vivo (Groisman 1998). PmrA-PmrB regulates genes that promote 
resistance to the antimicrobial peptides, polymyxin, protamine and polylysine (Gunn 
and Miller 1996). PmrA and PmrB are similar to members of the OmpR-EnZ family 
of two-component regulators (Roland et al., 1993),It has been shown that pagB, 
another PhoP-activated gene is induced when Salmonella typhimurium is present in 
the macrophage phagosome. This gene forms an operon with pmrAB, where all three 
genes are regulated by PhoP-PhoQ (Alpuche-Aranda et al., 1992). 
The PhoP/Q system controls the expression of several genes required for growth in 
low Mg2 concentrations. These include the mgtA and mgtB genes, which encode 
Mg 2+  transporters in Salmonella. When grown in liquid media with low Mg 2+  
concentration, mutants lacking expression of these genes demonstrated growth 
defects, resulting in elongated cells that were unable to form bacterial colonies. This 
suggests that both transporters are required to maintain the physiological levels of 
Mg 2+  (Soncini et al 1996). Another gene mgtC encodes the MgtC protein, thought to 
localise in the inner membrane. This protein seems to be involved in the survival of 
Salmonella within the macrophage, by ensuring that the correct levels of magnesium 
(Blanc-Potard et al., 1997). 
Growth in millimolar concentrations of Mg 2+  or Ca 2+ represses transcription of phoP 
activated genes, whereas micromolar concentrations of Mg 2+  activates the 
transcription of phoP activated genes (Garcia-Vescovi et al., 1996; Soncini et al., 
1996 and Kato et al., 1999). Activation of pag genes by wild-type PhoPQ occurs 
quickly at cation concentrations below lOOjtM, while pag expression is turned off 
completely when greater than 2mM Ca 2+  is present in the environment (Garcia-
Vescovi et al., 1996). High levels of Mg 2 , promotes the dephosphorylation of the 
phosphate on PhoP by the PhoQ protein (Groisman 2001). 
The PhoP/Q regulatory system regulates the expression of a number of genes 
including pagC, which is important for survival within macrophages and is activated 
in response to low concentrations of Mg 2 (Galan et al., 1989; Garcia Vescovi et al., 
1996; Dunstan et al., 1999). The pagC gene encodes an outer member protein of 188 
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amino acid (PagC), which is essential for the full virulence of Salmonella 
typhimurium in BALB/c mice (Hohmann et at., 1995). A pagC mutant of Salmonella 
typhimurium showed poor survival in BALB/c mice (Pulkkinen and Miller 1991). 
Pag transcription is maximum within acidified macrophage phagosomes, where the 
signal may be the level of acidification (Alpuche-Aranda et at., 1992; Soncini et al., 
1996). Repression of the pagC promoter can be achieved by the addition of high 
concentrations of Mg 2+  to the growth medium, which may be an added advantage for 
growing the cells in vitro (Dunstan et al., 1999). The delay between bacterial 
ingestion and pag expression predicts that a switch between prgR (PhoP-repressed 
gene encoding envelope proteins) to pag transcription, which occurs as the 
Salmonella containing phagosome matures, acidifies and restricts magnesium 
availability. Therefore, the protein encoded by prg may allow survival in the early 
phagosome or in epithelial cells, whereas those encoded by pag may be required later 
(Alpuche- Aranda et at., 1992). 
Hohmann et al. (1995), concluded from their work that a successful antibody 
response was generated against a heterologous antigen Tet C (fragment C of tetanus 
toxin) under the control of the pagC promoter, whereas the constitutive trc promoter 
was not successful. However, in vitro a higher amount of heterologous antigen was 
produced under trc control. This is in agreement with Dunstan et at. (1999), where 
they also got higher expression in activated mouse peritoneal macrophages with the 
pagC (phoP-activated) promoter compared to the katG (catalase) and nirB (NADH-
dependent nitrite reductase) promoters. There was expression of pagC was 10 fold 
greater than katG and 100 fold greater than nirB. The strain with the pagC promoter 
was the only strain to induce a tetanus-toxoid specific antibody. However, the 
bacteria containing the pagC promoter had lost the plasmid from bacteria recovered 
from the peyers patches and mesenteric lymph nodes but not from the spleen over the 
15 day period. Also, in this study, the level of luciferase (cloned from firefly) 
detected in the peyers patches of mice was investigated using constructs with 
luciferase (luc) under the control of the 3 promoters (pagC, katG and nirB). BALB/c 
mice immunised with Salmonella typhimurium expressing luciferase under the 
control of the pagC promoter, produced equivalent to, or lower than background 
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levels of luciferase compared to the mice expressing luciferase from the constitutive 
trc promoter. However, in vitro, all the promoters (pagC, nirB and katG) examined 
in their study appeared to express similar levels of fragment C, compared to the 
constitutive trc promoter analysed by western blotting. It suggests that the total 
amount of heterologous antigen produced from a vaccine strain does not necessarily 
correlate with the ability of the strain to elicit an antibody response to that antigen. 
Bullifent et al., 2000, recorded a high level of IgA antibody against the Fl-antigen of 
Yersinia pestis under the control of the pagC promoter after immunisation with 
Salmonella typhimurium SL326 1 containing this plasmid. However, bacteria 
expressing the Fl antigen from the pagC promoter, showed a reduced ability to 
colonise mysenteric lymph nodes and splenic tissue. The reason for this is not clear. 
A possible explanation is that the high level of expression of the F-i antigen could 
have placed a metabolic load on the bacteria, which could have prevented full 
expression of genes required for host survival. This observation of poor colonisation 
is in disagreement with other studies, but may reflect the fact that different antigens 
were used (Dunstan et al., 1999). Thus, this in vivo activated promoter (pagC) was 
included in the present study, to investigate if sufficient expression of the 
heterologous antigens occurred from the plasmid constructs outlined in chapter 4. 
1.8.4 The Virulence Plasmid 
Most Salmonella serotypes naturally carry virulence plasmids (Gulig, 1990) and the 
virulence in experimentally infected mice is greatly increased when the plasmids are 
present (Gulig et al., 1992). Salmonella carrying these plasmids have been isolated 
from naturally occurring systemic infections in animals and humans. They have 
been often isolated from enteric infections suggesting that these plasmids play an 
important role in the pathogenesis of non-typhoidal Salmonella bacteremia (Fierer et 
al., 1993, Montenegro et al., 1991). 
The virulence of Salmonella strains is highly complex and requires the expression of 
a number of genes and some of these are located on the virulence plasmid. Most 
serovars have plasmids with a highly conserved 8kb region among serovars, known 
as the spy regulon. This is the region mainly responsible for the virulence phenotype 
of the plasmid (Montenegero et al., 1991; Gulig et al., 1992; Libby et al., 1997). In 
mice the virulence plasmid is not required for the translocation of Salmonella 
through the intestinal mucosa, but is necessary for the systemic phase of the disease 
(Heffernan et al., 1992). In cattle, the virulence plasmid is necessary for the 
persistence of Salmonella dublin in systemic sites, but is not required during the 
enteric phase of the infection (Gulig and Doyle, 1993). Gulig and Doyle, (1993) 
showed that these plasmid -encoded genes promote the intracellular growth of 
Salmonella strains. The intracellular environment of phagocytic and non-professional 
phagocytic cells induces the expression of spy genes in vivo. However, in vitro 
studies have not shown any relationship between carriage of the virulence plasmid by 
Salmonella strains and survival within macrophages (Fierer et al., 1993). The spy 
plasmid increased the growth rate of bacteria in the liver, spleen and lymph nodes of 
mice infected orally with Salmonella dublin and Salmonella typhimurium. This led to 
early bacteremia and death before the mice could develop immunity. These studies 
suggests that the plasmid enhances the growth rate of Salmonella within tissues and 
probably inside host cells, since invasive Salmonella are mostly intracellular (Gulig 
and Doyle, 1993, Heffernan et al., 1992). 
The spvA promoter drives the expression of the Salmonella plasmid virulence genes, 
and is located downstream of the spvR gene (Fierer et al., 1993). The spy coding 
region consists of the regulatory gene spvR and the structural genes spvABCD genes, 
which make up a region of 6Kb (Gulig et al., 1992 and Krause et al., 1992). The 
spvABC'D genes form a single operon (Krause et al., 1992). SpvR is located directly 
upstream of spvABCD and is transcribed as a single message in the same orientation. 
The SpvR protein is required for the transcription of spvABCD and binds to the spvA 
promoter upstream from the transcriptional start site (Fang et al., 1991; Krause et at., 
1992). Mutations in the helix-turn-helix motif of SpvR protein prevented spvA 
expression in vivo, thereby showing that spvR is required for the transcription of 
spvA (Krause et at., 1995). Grob and Guiney, (1996), demonstrated using SpvR 
fusion proteins, that SpvR was able to bind to the promoter regions of both spvR and 
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spvA, proving that spvR is involved in both spvR and spvA regulation. However, 
transcription of spvABCD terminates at different sites resulting in mRNA transcripts 
spvA, spvAB, spvABC and spvABCD (Krause et at., 1992). The transcription of the 
spy genes occurs when Salmonella enter stationary phase and under stress conditions 
such as carbon starvation (Fang et at., 1991; Coynault et at., 1992; Krause et al., 
1992; Valone et at., 1993). 
Growth phase regulation of spvABCD is actioned through transcription from the spvA 
promoter, where spvA mRNA increases during stationary phase (Fang et at., 1991; 
Coynault et at., 1992; Krause et al., 1992; Fierer et at., 1993; Krause et at., 1995; 
Chen et at., 1996). Both SpvR and RpoS (Fierer et al. 1993; Chen et al. 1996) control 
the intracellular induction of the spy locus. The gene rpoS encodes the general stress 
sigma factor RpoS or aS  (Korwarz et at., 1994; Chen et at., 1996). RpoS has been 
previously identified as a central regulator of a large number of stress and stationary-
phase genes in Escherichia coti (Hengge-Aronis, 1993b; Loewen and Hengge-
Aronis, 1993). The starvation- induced expression of spy plasmid virulence genes 
closely parallels the pattern of expression of katF regulated genes. Nutrient shortage 
seems to be a critical trigger for the expression of Salmonella virulence genes within 
the phagosome of host macrophages (Fang et at., 1991). Moreover, several of the 
genes that are regulated by KatF, are also required for the resistance of Salmonella to 
starvation and other environmental stresses. These stresses in the phagosome of host 
phagocytic cells include oxidative stress, acid stress and DNA damage. Therefore, 
the spy promoter was included in this study to investigate if sufficient expression of 
the heterologous antigens was achieved from the plasmid constructs outlined in 
chapter 4. 
1.8.5 The ahpC promoter 
Salmonella typhimurium mounts a defensive response to hydrogen peroxide stress 
within macrophages. Francis and Gallagher (1993) identified a hydrogen peroxide 
inducible locus ahpCF (Alkyl hydroperoxide reductase) that was induced upon 
interaction of Salmonella typhimurium cells with macrophages. The ahp locus 
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encodes the heterodimeric enzyme alkyl hydroperoxide reductase, and is induced in 
response to the respiratory burst of macrophages (Francis and Gallagher,1993; Storz 
et al., 1989). It has been shown that after applying hydrogen peroxide to Salmonella 
typhimurium and Escherichia coli there is in increased expression of approximately 
30 genes (Christman et al., 1985; VanBogelen et al., 1987). Twelve of these thirty 
proteins are early proteins and are maximally synthesised during the first thirty 
minutes. The ahp gene is one of these genes (Christman et al., 1985; Morgan et a! 
1986; Storz et al., 1989, VanBogelen et al., 1987). There is evidence for a role for 
the ahp locus in osmotic stress in both Bacillus subtilis (Antelmann et al., 1996) and 
Staphylococcus aureus (Armstrong-Buisseret et al., 1995). Osmotic upshift is 
thought to be encountered in the intestine and it has been suggested that the ahp 
locus of Escherichia coli was induced approximately 3 fold with 0.5M NaCl (Galan 
and Curtiss 1990; Michan et al., 1999). 
Some of the toxic molecules produced during the respiratory burst can readily diffuse 
across the bacterial cell membrane to cause cellular damage (Imlay and Linn 1986; 
Fan and Kogoma 1991; Demple 1991). Lipids can be peroxidised, which increases 
the permeability of the cell membrane. DNA can also be deaminated and depurinated 
and amino acids may also be oxidised or decarboxylated (Fan et al., 1988). Thus the 
ahp locus may act to minimise damage to Salmonella typhimurium during the course 
of infection by protecting the cell membrane or other targets from lipid peroxidation 
(Christman et al., 1985; Tartaglia et al., 1990). Taylor et al. (1998) showed that the 
ahp gene of Salmonella lyphimurium was not essential for the virulence of the 
organism. Given that this promoter is activated during macrophage interaction, it has 
the potential for more controlled expression of foreign antigens. The ahpC promoter 
and its regulation are discussed in more detail in chapter 3. 
1.9. Organisms of interest for heterologous vaccination 
1.9.1 Listeria monocytogenes 
Listeria monocyto genes is a facultative gram-positive intracellular pathogen, 
responsible for serious infections in both animals (sheep and cows) and humans. In 
the latter case, it causes severe disease in mainly elderly, immunocomproniised, 
pregnant woman and neonates, and may result in meningitis, encephalitis and 
septicemia (Portnoy et al., 1992; Gouin et al., 1994). All clinical isolates produce a 
hemolysin called listeriolysin (LLO) encoded by the gene hly (Gouin et al., 1994). 
Resistance against a primary infection by Listeria depends on an early innate 
response involving macrophages and neutrophils, resulting in activation and 
recruitment of T cells and macrophages, accompanied by the production of cytokines 
(Ochsenben et al., 1999). Early in infection macrophages, neutrophils and natural 
killer cells are responsible for host defence. Later in infection specific T cell 
responses are developed to finally eradicate the bacteria and to protect against 
secondary infection (Kaufmann, 1993). In secondary exposure CD8 T cells are vital 
for exertion of their anti-listerial effect to enable direct lysis of infected cells. 
Infection of BALB/c mice with a sublethal dose (0.1 LD 50) of Listeria 
monocyto genes leads to intracellular replication in the first 24-48 hours, where the 
spleen and liver hepatocytes are the main target (Mielke et al., 1988). Six days after 
infection, Listeria monocytogenes is not detectable and coincides with the 
development of long-term T cell-mediated immunity (Mackaness, 1969). These mice 
are more resistant to challenges with greater than 100 times the LD 50 determined for 
naïve mice (Harty et al., 1996). Immunity to Listeria can be monitored by the 
enumeration of colony forming units (CFU) in homogenates of the liver or spleen of 
mice (Mackaness, 1969). In contrast to the situation with low infectious doses, 
infection of mice with high doses of Listeria results in systemic disease accompanied 
by uncontrolled replication in the liver and spleen for 2-4 days and generally results 
in death between day 4 and day 10 (Mackaness 1969). 
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Listeria monocyto genes is able to grow in professional phagocytes like macrophages 
and non-professional cells such as epithelial cells, hepatocytes and fibroblasts 
(Hanawa et al., 1995). M cells in peyer's patches are thought to be the primary site of 
invasion in the intestine. After breaching the intestinal barrier, Listeria 
monocyto genes are taken up by phagocytes in the lamina propria, then travel to the 
liver and spleen. The interaction of macrophages is important in this process of 
pathogenesis (Ireton and Cossart 1997). Listeria monocytogenes escapes from the 
extracellular environment into the phagosome of the host cell. Subsequently, Listeria 
uses listenolysin for lysis of the phagosomal membrane, gaining entry into the 
cytoplasm, where multiplication occurs. This enables its survival within 
macrophages (Gouin et al., 1994; De Chastellier and Berche, 1997). Due to the 
delivery of listerial antigens to endosomes and the cytoplasm of the cell, there is the 
potential for presentation of the antigen in the context of MHC-I and MHC-II. 
Listeria monocytogenes induces macrophages to secrete IL-12 that acts on CD4 T 
cells leading to a Thi response. This is characterised by the presence of large 
amounts of IFN-ö, which in turn activates macrophages, enhancing their ability to 
destroy the bacteria. It is these activated macrophages that are believed to engulf and 
kill the invading bacteria (Hsieh et al., 1993). Listeria infection induces a T cell 
response that involves both CD4 and CD8 T cells. The CD4 T cell response is of 
the TH1 type, with production of IL-12, IFN-y and TFN-a. IL-12 plays a major role 
influencing the TH1 response. Production of these cytokines can enhance antigen 
presentation by these infected cells and bias the immune response in the direction of 
cell mediated immunity (Weiskirch et al., 1997). IFN-6 plays a role in the 
development of constitutive activation of macrophages, particularly in liver Kupffer 
cells. After this stage, activated macrophages are detected by the second or third day 
of infection (Dighe et al., 1995). Later evidence was provided for roles of IL-12, 
TNF, IL-6 and IL-1, as well as negative regulatory cytokines such as IL-10. 
The primary role of IL-12 is mainly the induction of IFN-'y, and the differentiation of 
T cells towards a Thi response (Tripp et al., 1993). IL-12, TNF, IL-i and IL-6 drive 
the process towards protective immunity whereas other cytokines like IL-10 inhibit 
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TH-1 development and have a negative effect on macrophage presentation of antigen 
(Moore et al., 1993). In culture, Listeria induced the production of IL-12 and TNF by 
macrophages, and both in concert resulted in the production of IFN-y by Natural 
Killer cells, thereby establishing a role for IL-12. The ratio of IL- 10 I IL-12 is critical 
in the control of Listeria infection, as the balance influences whether macrophage 
activation predominates or lethal infection occurs (Tripp et al., 1993). The role of 
TNF in vivo is more complex and most likely involves more than one target with a 
possible role in inflammation (Wherry et al., 1991). The uptake of Listeria by 
macrophages is a strong stimulus for IL-i production, where IL-i seems to have a 
number of roles. IL-1 may be involved in the local early inflammation response of 
neutrophils, which helps to reduce the spread of infection (Havell et al., 1992). 
1.9.1.1 Listeriolysin (LLO) 
Listeriolysin (LLO) is a pore-forming cytolysin with a molecular mass of 58KDa and 
is produced by all virulent isolates (Portnoy et al., 1988; Safeley et al., 1991). LLO is 
known to be a dominant antigen in the immune response to Listeria monocytogenes 
(Portnoy et al., 1988; Pamer et al., 1991; Safley et al., 1991). LLO and 
phospholipases mediate the lysis of the phagosomal membrane, allowing the bacteria 
to gain access to the cytosol where they replicate (Geoffroy et al., 1987). The 
haemolytic activity of LLO is dependent on pH, and its activity is blocked by small 
amounts of cholesterol or oxidation. The generation of cell mediated immunity 
(CMI) is only achieved in mice with Listeria monocyto genes strains that produce 
LLO, producing cytokines early in infection (Xiong et al., 1994). 
LLO has a highly conserved undecapeptide sequence at the C-terminus which is 
required for the hemolytic activity and is thought to be required for binding to cell 
membranes (Jacobs et al., 1998). This region (LLO amino acids 483-493) near the 
carboxyl-terminus is invariant among cytolysins and is important for the lytic 
activity, oligomeric pore-formation and virulence of Listeria monocyto genes (Safeley 
et al., 1995). T cell epitopes have been identified from Listeria proteins, including 
LLO, which donates peptides to MHC-I and MHC-II molecules (Safeley et al., 1991, 
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Villanueva et al., 1995). Verma et al., (1995), cloned the region representing the 
MHC-II epitope of LLO (amino acid residues 215-226) and the MHC-I epitope of 
LLO (amino acid residues 91-99) into the hypervariable region of the Salmonella 
dublin flagellum system, creating a chimeric protein where LLO had flagellin 
sequence on either side. BALB/cBJ and C3HebIHej mice were immunised i.p. with 
the recombinant Salmonella (lx 106  c.f.u.) carrying the different epitopes. They 
concluded from their work, that both MHC-I and MHC-II T cell restricted responses 
were achieved but had the disadvantage that this vaccine only caused a 10 fold 
reduction in the number of organisms in the liver and spleen. 
LLO is an important antigen for the escape of Listeria from the phagocytic vacuole 
(by lysis of the phagosomal membrane) to the cytoplasm of the host cell, where 
replication begins. Presentation of peptides from Listeria monocyto genes by MHC 
class-I molecules of macrophages, occurs only when the bacteria escapes from the 
phagosome into the cytosol (Bouwer et al., 1992). Mutant strains of Listeria 
monocytogenes that do not produce LLO (LLO) do not escape from the 
phagolysome. These mutants do not enter the cytosol, and are not capable of 
presenting some MHC-I epitopes to T cells (Bouwer et al., 1992). 
LLO is rapidly degraded in the cytosol and has been identified as a major target for 
CD8T cells. The epitope (amino acids 91-99) is processed efficiently by MHC-class 
I molecules and has been detected in association with MHC-class I molecules on the 
surface of Listeria monocytogenes infected cells (Pamer et al., 1991; Bouwer et al., 
1992; Villanueva et al., 1995; Pamer 1993). This epitope was recognised by CTLs in 
mice previously immunised with virulent Listeria monocytogene.s. A mathematical 
equation can be used to calculate the efficiency of antigen processing based on the 
number of bacteria infecting a cell, the doubling time, the secretion rate of the 
antigen and the intracellular t112 of the antigen. LLO 91-99 epitopes accumulate to 
approximately 600 epitopes per cell after 5-6 hours of infection (Pamer 1994; 
Villanueva et al., 1994). 
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It has been proposed that MHC-1 epitopes (e.g. LLO 91-99) are nine residues long. 
At position 2 they contain a tyrosine (anchor residue) and at the C-terminus have 
either a leucine or an isoleucine. However, some other epitopes have a valine, 
alanine or a threonine at the C-terminus (Falk et al., 1991; Pamer etal., 1991). When 
the amino acid at position 92 was changed from a tyrosine to a phenylalanine, loss of 
CTL responses resulted suggesting that the tyrosine is important as an anchor residue 
(Bouwer et al., 1996). The presentation of CTL epitopes by infected cells is likely to 
be influenced by a number of factors. These include the number of MHC class I 
molecules, the affinity of the MHC molecule for the peptide, peptide dissociation, the 
amount of antigen present in the cytosol, the rate of antigen degradation in the 
cytosol, the efficiency that proteases process peptides from the antigen and the 
efficiency of peptide transport form the cytosol to the endoplasmic reticulum (ER) 
(Sijts et al., 1996). 
The processing of listerial proteins by MHC-II molecules occurs via the endocytic 
pathway, were mainly exogenous antigens are degraded and bind to MHC class II 
molecules (Harding and Unanue, 1991; Unanue, 1992). The highly charged, 
hydrophilic region, LLO amino acids 203-226, is readily available for cleavage at 
lysine226 by proteolytic enzymes such as cathepsin B (Safeley et al., 1995). The 
peptide region 215-226 was shown to elicit strong T cell responses from Listeria-
immune T cell population (Safeley et al., 1995). The LLO peptide 215-234 contains 
a T cell epitope that is immunodominant in C3HeB/FeJ mice (Safeley et al., 1991). It 
has been shown that the immunodominant epitope is located within residues 215 to 
220. However, the long length of the peptide may be important for correct processing 
and presentation (Safeley et al., 1991). It is well recognised that flanking regions can 
enhance or prevent the presentation of MHC-I or MHC-II assoéiated epitopes (Del 
Val et al., 1991; Sijts et al., 1996). 
Salmonella typhimurium aroA persists in the phagosome for a considerable length of 
time, and hence due to the time-scale, it is thought to promote the introduction of 
secreted antigen from the endosome into the MCH-I pathway. This possibly 
increases the vaccine efficacy due to residence in the cytoplasm, as Listeria mainly 
replicates in the cytosol. In this thesis, two fragments representing the MHC-I (91-
99) and MHC-II (215-226) epitopes of LLO are included in this study, to investigate 
if an immune response resulted, when these fragments were encoded on a plasmid 
(discussed further in chapter 5). 
1.9.2 Leishmania major 
Leishmaniasis is a major tropical disease that is caused by the parasite Leishmania, 
belonging to the Trypanosomatidae family (Antoine et al., 1998). Leishmaniasis is 
considered to be a zoonosis, were humans are accidental hosts. Nevertheless, 
infected humans are the reservoirs for cutaneous disease caused by Leishmania 
tropica in the Middle East and visceral disease in India. There are a number of 
animal reservoirs including rodents, dogs and other mammals. For example, desert 
and savannah rodents are reservoirs for both Leishmania dovanni and Leishmanja 
major (Handman, 2001). Leishmania infantum, causes visceral disease in both 
humans and dogs and in this case dogs are the main animal reservoir of the parasite, 
particularly during long incubation times before disease symptoms are visible (Soto 
et at., 1998). Leishmania braziliensis and Leishmania donovani tend to disseminate 
from the site of inoculation to other parts of the body, where they induce progressive 
lesions involving mucocutaneous and visceral tissues respectively (Rivier et at., 
1999). 
The World Health Organisation has estimated that there are 2 million new cases each 
year and that 1/10 of the worlds population are at risk from leishmaniasis. This 
disease currently affects 12 million people (WHO/CTD 1998; World health 
Organisation, Leishmaniasis Control home page: www.who.int/ctd/htn -fl/leis.html). 
The disease is endemic throughout parts of Africa, India, Middle East, Southern 
Europe, Central and Southern America. In Southern Sudan, 10% of the population 
died from visceral leishmaniasis over the last few years (Mc Gregor, 1998). 
Leishmania major, is the etiological agent of Old World cutaneous Leishmaniasis, 
and has been the most popular model for murine and human studies (Aebischer et al., 
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2000). Infection of humans with Leishmania results in a broad spectrum of disease 
profiles, whose characteristics depend on the infecting species and the immune 
response of the particular host to infection (Turk et al., 1971). Leishmania major is a 
dimorphic, obligate intracellular protozoan that causes a spectrum of cutaneous, 
mucocutaneous and visceral diseases (Russo et at., 1991). Proliferation of 
Leishmania major is restricted to the site of inoculation, where a cutaneous ulcer 
results, that usually resolves spontaneously thereby leaving the person immune 
against re-infection (Rivier et al., 1999). 
The parasite cycles between the insect vector the phlebotomine sandfly 
(Phiebotomus) and several mammals including humans. All species are transmitted 
via the bite of a sandfly. In the sandfly, Leishmania multiply in the form of 
flagellated promastigotes, which is an extracellular parasite of the digestive tract of 
their hosts. In mammals, inoculation of the infective promastigote occurs into the 
dermis via the sandfly and the pathogenic species adhere to and infect macrophages. 
Binding of the parasites to the macrophage occurs via receptors, with the main ones 
being complement receptors (Pearson et al., 1983). Growth of amastigotes occurs 
within organelles of macrophages that originate from the macrophage plasma-
membrane, and fuse with endocytic organelles. This results in the formation of 
parasitophorous vacuoles, which have properties similar to endocytic compartments 
(Alexander and Russell, 1992). 
In macrophages, promastigotes differentiate into non-motile amastigotes during the 
formation of these parasitophorous vacuoles, which takes 2-5 days to complete 
(Antoine et al., 1998). The amastigotes then multiply intracellularly (Pearson et al., 
1983). It is at this intracellular stage, that can continue in a chronic course locally, or 
spreads to mucutaneous or to visceral organs depending on the species involved 
(Chang and Chaudhuri, 1990). It is known that amastigotes are more infective than 
promastigotes. Pathogenic species of Leishmania are able to parasitise the 
macrophage phagolysosome, where they can survive, continue to differentiate and 
multiply (Pearson et at., 1983). It has been suggested that promastigotes can enter 
macrophages via receptor-mediated endocytosis and phagocytosis is the accepted 
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basic mechanism by which Leishmania enter these cells (Chang and Chaudhuri, 
1990; Antoine et al., 1998). Promastigotes have been shown to interact with 
macrophages by influencing complement fixing (Brittingham et al., 1995) and there 
are various molecules, mainly glycoconjugates, present on the cell surface of 
Leishmania which are linked to virulence. 
People, who have been infected with Leishmania and recover from the disease, 
develop strong immunity against re-infection. Therefore, vaccination against 
Leishmaniasis in principle is feasible (Yang et al., 1990). Mice have been utilised as 
an experimental model of Leishmania major, where the lesion at the site of 
inoculation depends on the strain of mouse used. In CBA mice the lesion will heal 
spontaneously within a few weeks. However, in BALB/c mice, after subcutaneous 
injection of parasites, uncontrolled lesion development occurs, resulting in death if 
the infection is allowed to run its course, (Stacey and Blackwell, 1999). BALB/c 
mice are therefore useful for evaluating immunoprophylactic procedures for this 
disease (Gurunathan et al., 1997). 
Successful immunisation against Leishmania infection is primarily dependent on 
cell-mediated immune responses mediated through the Thi subset of T cells. This 
Th 1 cell response involves the production of macrophage-activating cytokines like 
IFN-y, which is required to control replication of the parasite. In BALB/c mice the 
development of a Th2 response results in the inability to stimulate the activation of 
macrophages and abolish a Thi response (Liew and O'Donnell 1993; Muller et al., 
1989). A number of factors have been shown to influence the differentiation of CD4 
T cells into Th 1 or Th2 subsets. These include antigen dose, route of delivery, 
costimulatory factors and the strength of the signal received through the T cell 
antigen receptor (TCR). However, the major influential factor has been the secretion 
of specific cytokines after stimulation of the TCR (Abbas et al., 1996). 
Mice susceptible to infection with Leishmania major (deficient in IL-12 or IFN-y, 
(cytokines associated with a TH1 response) were shown to be unable to control 
Leishmania major infection, whereas mice resistant to Leishmania major were not 
overcome by Leishmania infection. TH1 cells secrete lymphokines, notably IFN-y, 
that activate macrophages to kill intracellular Leishmania rather than provide 
protection via humoral immunity (Muller et al., 1989; Liew 1989; Liew and 
O'Donnell 1993). This suggests that these cytokines modulate the ability of the host 
to overcome Leishmania infection (Mattner et al., 1996; Kopf et al., 1996). It has 
been suggested that CD4 T cells from BALB/c mice display an obvious bias towards 
the production of IL-4 and the outgrowth of Th2 cells after infection with 
Leishmania major (Hsieh et al., 1995). The association of antigen and MHC-II, has 
been proposed to occur after the antigen has entered the endosomal-lysosomal 
intracellular pathway thereby stimulation of CD4 T cells occurs (Yang et al., 1990). 
1.9.2.1 Glycoprotein 63 (Gp63) 
Glycoprotein 63 (Gp63), is a major surface antigen of 63 kDa. It is a metalloprotease 
which is highly conserved among the different species of Leishmania (Colmer-Gould 
et al., 1985; Etges et al., 1986; Button and McMaster, 1988). It has been shown to be 
a major surface determinant on both promastigotes and amastigotes of Leishmania 
donovani, Leishmania major, Leishmania mexicana amazonensus, Leishmania 
mexicana mexicana, Leishmania braziliensis guyanensis and Leishmania braziliènsis 
braziliensis (Colomer-Gould et al., 1985). It was shown to be the major antigen 
recognised from the sera of patients with visceral Leishmaniasis and has been used to 
generate protective immunity in mice (Russell et al., 1988). Gp63 is encoded by 
multiple copies of conserved 3.1kb genes, which consist of the 1.8kb coding region 
and a 1.3kb spacer region, tandemly arranged on a single chromosome (Button et al., 
1989). The protein of 602 amino acids is expressed as a precursor (Button and 
McMaster, 1988). Post-translational modifications include removal of 100 amino 
acids at the N-terminus and cleavage of the C-terminal with the attachment of the 
glycosyly-phosphatidyl-inositol (GPI) anchor and N-linked glycosylation (Button 
and McMaster, 1988; Chang and Chang, 1986; Ferguson and Williams, 1988). 
Bacille Calmette-Guerin (BCG), expressing Leishmania major gp63, induced a 
strong protective response in both CBAIJ and BALB/c mice, against challenge with 
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either promastigotes or amastigotes of Leishmania mexicana ( Connell et al., 1993). 
Highly susceptible BALB/c mice injected intra-muscularly with a plasmid expressing 
Gp63 from the human cytomegalovirus (CMV) promoter developed significant 
resistance against leishmaniasis as measured by DTH responses after challenge in the 
footpad with stationary-phase L. major promastigotes (Xu et al., 1995). Russo et al., 
(1991), observed that Gp63 elicits strong proliferative responses and IFN-y 
production from Leishmaniasis patients when both native and recombinant protein 
(expressed from E. coli) where tested, in agreement with human T cell lines. This, 
suggests that Gp63 is a potent human T cell immunogen. In vitro, Gp63 has been 
implicated in the attachment of the parasite to macrophages (Russell and Williams, 
1986; Chang and Chang, 1986). However, when T cells from normal donors were 
immunised in vitro with recombinant Gp63 (rGp63), and later challenged with both 
native and recombinant gp63, they responded strongly to stimulation with rGp63, 
and poorly to both native and promastigote lysate. Hence, immunisation with the 
recombinant form of the Gp63, unlike natural infection with native Gp63, 
sensitisation of T cells may not occur. Glycosylation and/or differences in folding, 
between the native and recombinant protein produced in E. co/i, could result in these 
differences in immunological responses. Equally, antigen uptake and processing 
could be indirectly affected, causing the differences in the induction of T cell 
responses. Another explanation could reside in the difference between in vitro and in 
vivo processing of parasite lysates (Russo et al., 1991). 
Yang et al., (1990) used Salmonella typhimurium SL3261 (aroA) to express full 
length Gp63 from Leishmania major and immunise CBA and BALB/c mice by the 
oral route. Mice immunised with this construct developed specific proliferative T cell 
responses, as well as antibody to the parasite. The T cells were typically CD4, 
secreting IL-2 and IFN-y, suggesting that a TH-1 response was the major response, 
which led to protection. However, surprisingly no detectable DTH reaction, which is 
normally associated with a TH- 1 response, was recorded. Moreover, protection was 
recorded against Leishmania major infection for resistant CBA mice, but no 
protection was shown for highly susceptible BALB/c mice (Yang et al., 1990). 
BALB/c mice immunised with the double deletion mutant of Salmonella 
yphimurium, GID101 (aroA aroD), expressing gp63 under the control of the 
constitutive tac promoter, developed significant resistance against a challenge 
infection with Leishmania major after two oral doses. High antibody levels of the 
IgG2a isotype were detected, consistent with the induction of a TH-1 response. 
However, there was no evidence of DTH reactivity in any of the immunised mice. 
This suggests that cells other than Th-1 cells may be involved in the induced 
protection (Xu et al., 1995). The heterogeneity of T cells involved in resistance to 
Leishmaniasis has been debated previously and remains an issue (Liew, 1989). 
Different promoters (nirB, and osmC) have also been used to express gp63 in the 
Salmonella typhimurium mutant GID101, for oral immunisation (McSorley et al., 
1997). The nirB promoter is regulated by nitrate and oxygen tension in the local 
microenvironment, whereas the osmC promoter responds mainly to elevated 
osmolarity and an increase in osmotic pressure (Gutierrez et al., 1990). Colonisation 
of the spleen and liver was recorded after immunisation with gp63 under the control 
of tac promoter in GID101 and the nirB promoter in GID105, but not with the osmC 
promoter in GID106. GID105 colonised the organs at higher levels, showing better 
plasmid stability and significant cellular responses after a single dose, perhaps 
providing more antigen to stimulate an immune response. Splenic T cells from mice 
immunised with GID 105 (gp63 under the control of the nirB promoter), proliferated 
strongly against live L. major and secreted IFN-y. However, no IL-4 was present 
when stimulated in vitro with leishmanial antigens, consistent with protective 
immunity generally resulting in a Th-1 response (Heinzel et al., 1989; Liew and 
O'Donnell, 1993; Reiner and Locksley, 1995). Yet again, a DTH response was not 
detected in these mice, suggesting that the DTH assay could be relatively insensitive 
for analysis in this system (Mc Sorley et al., 1997). Although there seemed to be a 
problem with the stability of GID 106, with no development of a Th-1 response, there 
was a significant increase in resistance against L. major infection. Other factors must 
therefore be contributing to resistance. 
me 
In one study, 24 overlapping peptides for the full length of Gp63 (503 amino acids) 
were screened for identification of host protective T cell epitopes (Yang et at., 1991). 
Two peptides which induced a T cell response were identified, corresponding to 
residuesl46-171 and 467-482, suggesting that they may induce protective immunity 
(Liew, 1989; Heinzel et al., 1989). Frankenburg et al. (1996), illustrated that peptide 
467-482 (without adjuvant) was protective in CBA mice when a cysteine and a lauryl 
group were successively added to the amino terminus (LC-p467). Each mouse 
received 2 injections 4 weeks apart, and challenged with parasites 2 weeks after the 
2'' injection. It elicited 80% reduction in lesion size when given subcutaneously into 
the rump (50p.g per injection). Lymph node cells from CBA mice, which had been 
immunised with these peptides (146-171 and 467-482), produced significant 
responses to live promastigotes. This suggests that these epitopes are expressed on 
native Gp63 to a sufficient level for recognition by T cells, which respond to these 
peptides. The majority of T cells were CD4 and the response was supported by the 
production of IFN-'y. 
Yang et at., (1991), showed that the peptide 146-171, was recognised by T cells from 
recovered CBA mice in vitro. A T cell response to live promastigotes as well as the 
peptide itself was recorded, whereas peptide 467-482 did not induce such a response. 
A classical DTH response was visible in CBA mice, and T cells primed with these 
peptides secreted IL-2 and IFN-'y but not IL-4, typical of a TH-  1 response by subset 
CD4 (Yang et al., 1991). The peptide (146-171) covers a highly conserved region, 
believed to contain a zinc co-factor binding site, which is thought to be essential for 
the endopeptidase activity of Gp63 (Chaudhuri et at., 1989, Bouvier et at., 1989 and 
Curry et al., 1994). 
Jardim et at., (1990), reported that a synthetic peptide containing a T cell epitope of 
Gp63 which spanned from residues 154-168, resulted in CD4 T cell proliferation 
and production of IL-2 but not IL-4, thereby resulting in a TH-1 response. When mice 
were immunised with this peptide (154-168) along with adjuvant (Complete 
Freund's adjuvant), half of the animals were found to be free of the disease 12-16 
weeks after inoculation of the parasite. Frankenburg et al. (1996), demonstrated that 
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immunisation with 154-168 (p154) with or without lauryl cysteinyl moieties were 
completely ineffective in protecting or exacerbating Leishmania lesions. 
Curry et al. (1994), conducted a study in vervet monkeys (Cercopithecus aethiops), 
is a suitable primate model for cutaneous leishmaniasis, mimicking human infection 
and overcoming many problems of rodent models. They used 4 different synthetic 
peptides spanning the length of Gp63, and found that the peptide spanning the region 
from residues 158-173 (PT4) caused T cell proliferation and lymphocyte stimulation. 
However, peptide 154-168 (PT3) was not recognised by lymphocyte populations. 
This suggests that the highly conserved amino acids 158-173, contain a dominant 
protective T cell epitope and have vaccination potential. Epitopes representing amino 
acids 146-171 and amino acids 467-482 were included in the immunisation studies 
carried out in this thesis. 
1.10 Aims of the project 
1.10.1 Osmotic regulation of ahpC::Mudlux 
It was found as classically described, that the ahp locus in Salmonella typhimurium 
SL1344 was activated by hydrogen peroxide (Christman et al., 1985). However, in 
contrast, the ahp gene when tagged with Mudlux (MPG203), was found to be 
unresponsive to hydrogen peroxide in a low osmotic environment (Taylor, 1997). 
The lux element therefore appeared to cause ahp to be osmoregulated. Moreover, 
luminescent studies indicated that a combination of high osmolarity (03M) and 
hydrogen peroxide (100iM) resulted in enhanced expression of ahp. The results 
obtained from Western analysis of the AhpC protein confirmed that the native ahp 
gene was not osmotically responsive, further supporting the view that the lux  
phenomenon is causing the anomaly (Taylor 1997). 
The anomalous expression of ahp when coupled with the lux reporter system 
indicates that a better understanding of the regulatory systems would be of benefit if 
the promoter is to be of value in vivo, for expression of foreign antigen. In particular, 
I-. 
51 
it is important to define whether the aberrant osmoregulation of ahp occurs via a 
transcriptional or translational mechanism. The option of this additional regulatory 
control could well prove beneficial if harnessed for in vivo expression. Therefore, the 
initial part of this project aimed to address the basis of this regulation. This was 
accomplished by using RT-PCR to study if this osmotic control of ahpC was under 
transcriptional control. Luminometery was utilised to investigate if the presence of 
luxAB or the complete lux element (1uxCDABE) affected the regulation of ahpC. 
This study and the background literature is outlined in chapter 3. 
1.10.2 Immunisation of mice using attenuated Salmonella typhimurium as a 
vector 
In vivo-activated promoters (ahpC, pagC and spvA), that are activated under certain 
conditions, have been utilised for the expression of guest antigens in this thesis. 
Attenuated Salmonella lyphimurium have been shown to provide stable high level 
expression of a heterologous antigen encoded on a plasmid, under the control of the 
in vivo induced pagC promoter (Dunstan et al. 1999). It has been shown that mice 
inoculated with Salmonella typhimurium (SL3261) containing a plasmid expressing 
the C fragment of Tetanus toxin (TetC) under the control of the spy promoter, 
resulted in good antibody responses to TetC (Marshall et al 2000). Because of its 
mode of activation, the ahpC promoter has the potential for in vivo expression of 
foreign antigens, in response to interaction with macrophage cells which play a 
central role in microbial destruction and stimulation of the immune response via 
antigen presentation (Francis and Gallagher, 1993; Taylor et al., 1998). Therefore in 
this thesis, all three promoters were chosen to investigate the in-vivo expression of 
the antigens from the different promoters. 
Chosen antigens from Listeria monocytogenes and Leishmania major have been 
included in this immunisation study. The major surface glycoprotein (Gp63) of 
Leishmania is a protease that is highly conserved among Leishmania species, and is 
expressed in both the promastigote and amastigote stages of the life cycle (Chang et 
al., 1986; Boudier 1987; Chaudhuri and Chang, 1989; Etges et al., 1989). Yang et 
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al., (1991) carried out an analysis of I cell epitopes present in gp63 of Leishmania 
major and concluded that gp63 is a dominant T cell inducer in vivo. They also 
concluded that peptides p146-171 and p467-482 were able to induce significant host 
resistance against L. major infection. Therefore, in this study these regions were 
included in the plasmid constructs used for immunisation of BALB/c mice. 
Listeria monocyto genes is a Gram positive, facultative intracellular bacterium, which 
contains class I (LLO 91-99) and class II (LLO 215-226) MHC-restricted T cell 
epitopes. Both of these epitopes have been shown to be important in protection 
(Safeley etal., 1991; Harty and Bevan, 1992; Safeley et al., 1995). In this study, both 
peptides were included in the plasmid constructs to investigate if protection would be 
obtained by delivery using live attenuated Salmonella typhimurium. 
The plasmid constructs with the antigens encoded under the control of different 
promoters were utilised for investigating humoral and cell mediated immunity after 
immunisation with such plasmid constructs, using Salmonella lyphimurium as a 
vector for immunisation. Humoral immunity was analysed using pooled sera from 
groups of mice immunised with a particular construct. Cell-mediated immunity was 
using the DTH test to compare the immune response after immunisation with the 
antigens under the control of different in-vivo activated promoters. The stability of 
the peptide fusion's were also studied, by comparing the immune response obtained 
using the plasmid constructs with the guest antigens to the response achieved using a 







2.1.1 Enzymes, isotopes and chemicals 
Enzymes were obtained from Boehringer Mannheim (Sussex, UK). Agarose was 
purchased from FMC BioProducts (Rockland, USA); antibiotics were supplied by 
Sigma Chemical Company Ltd. (Dorset, UK); Isopropyl-13-D-thiogalactoside (IPTG) 
and 5-bromo-4-chloro-3-indoyl-3-D-ga1actoside (X-gal) were obtained from 
Boehringer Mannheim. Rabbit anti-mouse antibodies were supplied by Scottish 
Antibody Production Unit (Sapou) Ltd. Other standard laboratory chemicals were 
supplied from Sigma Chemical company Ltd., BDH Chemicals Ltd. (Dorset, UK), 
and Fisons Scientific Equipment (Leicestershire, UK). Nitro-cellulose was obtained 
from Schleicher and Schuell (Dassel, Germany). X-ray film (AGFA Curix RP1, 100 
NIF) was supplied by H. A. West (Edinburgh, UK). Synthetic oligonucleotides were 
purchased from Genosys Sigma (UK) or Perkin Elmer Ltd. (Cheshire, UK). The 
oligonucleotides used in this study are listed in Table 2.1. 
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2.1.2 Bacterial strains and plasmids 
Table 2.1 E. coli and S. typhirnurium strains, and their derivatives, used during the 
course of this study 




BL21(DE3) HsdS gal (Xc1ts857 md! Sam7 nin5 Studier et al. (1990) 
lacUV5-T7 gene 1), pLysS 
DH5cx supE44 	ilacU169 	(4)80 	lacZAM15) Hanahan (1985) 
hsdRl7 recAl 	endA] 	gyrA96 	thi-1 
relAl 
JM101 supE 	thi-1 	A(lac-proAB) 	F' [traD36 Yanisch-Perron 
proAB ZAM151 (1985) 
Salmonella 
typhimurium 
SL1344 his Hosieth and Stocker 
(1981) 
SL3261 aroA Hosieth and Stocker 
(1981) 
MPG424 SL3261 aroA purA This thesis 
MPG203 SL1344 ahp::Mudlux Francis and 
Gallagher (1993) 
C1123 recAl C. Higgins 
TA4100 LT2 oxyRl Christman et al. 
(1985) 
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Table 2.2 Primers for Reverse Trancsipatse-Polynerase Chain Reaction (RT-PCR). 
Primer Primer Sequecnce Comments 
Name  
Ahp145 5'- GAAAACACGGAGGAAGTATAG-3' RI primer 
For for ahpC 
(165-145) (3'-5') 
Ahp-RI 1 5 1 - Sense primer 
(25 1-283) GGTAGAAGAAGAAGACGCTCCAGCGGCCTFCG for ahpC 
G-3' (5'3') 
KatGl 5'- Tfl'GATI'CAAAAGATCCACGC-3' RI primer 
RI for katG 
(294-273) (3'-5') 
KatG2 5'- AIGAGCACGACCGACGATAC-3' Sense primer 
(151-169) for katG 
(5'-3') 
SS-3 5'- AGAGATGCCGGAGCGGCTGAA-3' RI primer 
(1404-1382) for sertRNA 
(3'-5') 
SS-4 5'- ATAAAGTGGCGGAGAGAGGGG-3' Sense primer 
(1311-1333) forsertRNA 
(5'-3') 
Shown is a list of primers (oligonucleotides) that were used during the course of this investigation. 
The numbers shown in parentheses refer to the position at which each of the primers lay with respect 
to the published sequence from which they are derived; ahpCF (Tartaglia et al., 1990); katG (Loewen 
and Stauffer, 1990) and tRNA-ser-1 (Tamura et al., 1984). 
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Table 2.2b Primers used for construction of plasmids in this thesis. 
Primer Primer Sequence Comments 
Name  
PurA-268 5'-AACTGCAGGCATGGAAGAAGATG-3' Sense primer 
(268-290) Pst I for purA 
PurA-Anti 5' AACTGCAGATCAACCTCAAAAGGG3' Antisense 
2012 PstI primer for 
(2012-1988) purA 
Sal I-ahpC 5'- ACGCGTCGACTATCACAGACATAG-3' Sense primer 
(1-22) SaIl for ahpC 
Sph I-ahpC 5'-ACATGCATGCTGTCGAAGTFACGG-3' Antisense 
anti739 SphI primer for 
(739-716) ahpC 
His 1 5'- AAGCATGCGATATACCATGGGCC-3' Sense primer 
(4 12-405) Sph I for His Tag 
His 2 5'- CCGGATCCYFATFCTAGAATATGCTFGTCG-3' Antisense 
(356-32 1) Barn HI 	Xba I primer for 
His Tag 
Lis-1 5'-TATCTAGAAGATGCAGTGACAAATG-3' Sense primer 
(1719-1744) XbaI for Ito 
Lis-2 5'- TJI'GGATCCTCAGGTACCGCCGAAGTVFACA-3' Antisense 
(2216-2186) Barn HI 	Kpn I primer for lb 
Leish-1 5'- AGGGTACCTCTGACGGGCCATCCAG-3' Sense primer 
(891-913) KpnI forgp63 for 
Gp63(1) 
Leish-2 5'- Antisense 
(1080-1047) GAGGATCCTTCATAGATCTVFCGGAACGTTCGC primer for 
3' 	Barn HI 	BglII gp63 for 
Gp63(1) 
Leish-3 5'-TCAGATCTACATGCT7CGTFGCTG-3' Sense primer 
(1608-1632) BglII forgp63 for 
Gp63(2) 
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Table 2.2b. continued 
Primer Primer Sequence Comments 
Name  
Leish-4 5'- AGGGATCCCTAATGCATCGCCGTCGCCGC-3' Antisense 
(1988-1958) Barn HI 	NsiI primer for 
gp63 for 
Gp63(2) 
PagC- xhol 5'- GACTCGAGCGCGTGTTCAATATVFGCGT-3' Sense primer 
(44-71) XhoI for pagC 
promoter 
PagC- rev 5'- GAGCATGCTI'GTAGTAATAACTAAAG-3' Antisense 
(776-75 1) Sph I primer for 
pagC 
promoter 
Spv-xhol 5'-GCTCGAGATCATAACAGGTC-3' Sense primer 
(961-970) Xho I for spvA 
promoter 
Spv-sphl 5'- CGCATGCCGGTVFCGACCTG-3' Antisense 
(2619-2599) Sph I primer for 
spvA 
promoter 
Gfp-sphl 5'-CCAGCATGCTGAGCAAGGGCG-3' Sense primer 
(283-304) Sph I for eGFP 
Gfp- bam}{I 5'- GGGATCCTAGAGTCGCGGCC-3' Antisense 
(1031-1012) Barn HI primer for 
eGFP 
Linker 1 5'- 	 Nco I Linker 5'-3' 
GATCCCCACTCTAGACATAGGTACCATGGT for cloning 
Barn HI 	XbaI 	KpnI of GST 
AGATCTI'GATATGCATACAAGGCCT Q3' fusion 
Bgl II 	Nsi I 	Stu I 	Eco RI proteins in 
pGEX-5X- 1 
Linker 2 5'-AATTC AGGCCTT'GTATGCATATCAAGATCTA Linker 3'-5' 
Eco RI 	Stu I 	Nsi I 	Bgl II for cloning 
CCATGGTACCTATGTCTAGAGTGG&3' of GST 




Table 2.2b. continued. 
Primer 
Name  
Primer Sequence Comments 
RI-orfO 5'- CGGAATTCGCCTATCACAGAC-3' Sense primer 
(1-18) EcoRI for ahpC 
AhpC-bgl II 5'- GAAGATCTTCACCGITI -F1GAACG-3' Antisense 
(468-445) Bgl II primer of 
ahpC 
Shown is a list of primers (oligonucleotides) that were used during the course of this investigation. 
The numbers shown in parentheses refer to the position at which each of the primers lay with respect 
to the published sequence from which they are derived; purA (Wolfe and Smith, 1988); ahpCF 
(Tartaglia et al., 1990); lb (Mengaud et al., 1988); gp63 (Mc Master 1988); spvA (Krause, 1990) and 
pagC (Pulkkinen and Miller, 1991). Plasmids include pEGFP (Clontech USA) and pET-19b 
(Novagen). 
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Table 2.2c Primers used for sequencing 
Primer Primer Sequence Comments 
Name  
Seq-pTMB 5 CGCTACTFGGAGCCACTATCGAC3' Sense primer on 
(321-343) pBR325 upstream of 
the BamHI for 
sequencing. 
Seq-sal I 5' GTGCGGCGACGATAGTCATGCC3' Antisense primer on 
(728-707) pBR325 for 
sequencing ahpC. 
Seq- ahpC 5'- AATATGCGATGATCGGCGAC-3' Sense primer for 
(679-699) sequencing ahpC. 
Spv-seqF 5' GGGTAAAACGAAACAACTAGAAAT- Sense primer for 
(1421-1445) 3' sequencing spvA. 
Spv-seqR 5'- TFCAGTAAAGTGGCGTGAGC-3' Antisense primer for 
(2263-2243) sequencing spvA. 
Gfp-seqR 5' ATGCGGTITCACCAGGGTGTC3' Antisense primer for 
(659-640) sequencing GFP. 
pGEX-S'seq S'. GGGCTGGCAAGCCACGTTFGGTG3' Sense primer for 
(869-890) sequencing fusion 
proteins. 
pGEX-3'seq 5'- CCGGGAGCTGCATGTGTCAGAGG-3' Antisense primer for 
(1554-1532) sequencing fusion 
proteins. 
pBR322- 5'-CCATACCCACGCCGAAAC-3' Antisense primer on 
518 anti pBR322 for 
(518-501) sequencing ahpC in 
pTMB1. 




Table 2.3 Plasmids and their derivatives mentioned in this thesis 
Plasmid Relevant Features Source 
Reference 
pBR322 pMB 1 replicon, AmpR , TetR Bolivar et 
al. (1977) 
pBR325 pMB 1 replicon, Amp,TetR , Cm1R Bolivar et 
al. (1978) 
pGEM-T ColE 1 replicon, Amp', lacZa Promega 
pET- 1 9b ColE!, Amp', P7 Novagen 
pGEX- P, Amp", GST Amersham 
5X-1 Pharmacia 
pEGFP Plac,  Amp', eGFP Clontech 
pTMB 1 pBR322 derivate containing a 0.470kb PCR fragment of This thesis 
ahpC amplified using primers RI-orfl) and ahpC-BglII. 
pTMB2 pBR325 derivative containing a 1.734 kb PstI fragment This thesis 
of the purA promoter and gene from Escherichia coli, 
amplified using primers purA-268 and purA-anti2012 
pTMB3 pTMB2 derivative containing a 0.857kb Sal I-SphI This thesis 
fragment of the ahpC promoter and part of the gene 
from Salmonella typhimurium SL1344, amplified using 
primers Sall-ahpC and SphI-ahpC anti739. 
pTMB4 pTMB3 derivative containing a 0.09 1kb SphI-BamHI This thesis 
fragment encodingthe His Tag from pET 19b amplified 
using primers His 	and His 2. 
pTMB5 pTMB4 derivative containing a 0.487kb XbaI-BamHI This thesis 
fragment of Ilo from Listeria monocyto genes, amplified 
using primers Lis-1 and Lis-2, then digested and cloned 
from pTMB 11 using XbaI and BamHI. 
pTMB6 pTMB5 derivative containing a 0.177kb KpnI-BamHI This thesis 
fragment of gp63 from Leishmania major, amplified 
using primers Leish- 1 and Leish-2, then digested and 
cloned from pTMB12 using KpnI and BamHI. 
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Table 2.3. continued 
Plasmid Relevant Features Source 
Reference 
pTMB7 pTMB6 derivate containing a 0.370kb BglII-BamHI This thesis 
fragment of gp63 from Leishmania major, amplified 
using primers Leish-3 and Leish-4, then digested and 
cloned from pTMB 13 using BglII and BamHI. 
pTMB8 pTMB7 derivate containing a 0.727kb XhoI-SphI This thesis 
fragment of the pagC promoter and gene fragment 
amplified using primers pagC-xhol and pagC-rev. The 
ahpC promoter/gene was removed and the pagC 
promoter and part of the gene was cloned into this 
position. 
pTMB 11 pGEM-T derivate containing the 0.487kb XbaI-BamHI This thesis 
PCR product of Ho from Listeria monocyto genes, 
- amplified using primers Lisi and Lis 2. 
pTMB 12 pGEM-T derivate containing the 0.177kb KpnI-BamHI This thesis 
PCR product of gp63 from Leishmania major, amplified 
using primers Leish-1 and Leish-2. 
pTMB13 pGEM-T derivate containing the 0.370kb BglII-BamHI This thesis 
PCR product of gp63 from Leishmania major, amplified 
using primers Leish-3 and Leish-4. 
pTMB14 pGEX-5X-1 derivate with Linker-1 and Linker-2 This thesis 
annealed together and cloned via BamHI and EcoRI 
sites. 
pTMB15 pTMB14 derivate with 0.487kb 110 fragment i from This thesis 
pTMB 11 digested and cloned using XbaI and KpnI. 
pTMB 16 pTMB 14 derivate with 0.177kb gp63 fragment from This thesis 
pTMBi2 digested and cloned using KpnI.and BglII. 
pTMB17 pTMB14 derivate with 0.370kb gp63 fragment 2 from This thesis 
pTMB 13 digested and cloned using BglII.and NsiI. 
pTMB 18 pTMB 14 derivate with a 0.763kb fragment of GFP This thesis 
digested and cloned from pEGFP via xbal sites 
62 
Table 2.3. continued 
Plasmid Relevant Features Source 
Reference 
pTMB20 pTMB7 derivate containing a 0.727kb XhoI-SphI This thesis 
fragment of the pagC promoter and part of the gene, 
amplified using primers spv-XhoI and spv-SphI. The 
ahpC promoter/gene was excised using sal I and sph I 
and the spvRA promoter/gene was cloned in this 
position using xho I and sph I. 
pTMB21 pTMB7 derivate containing a 0.734kb SphI-BamHI This thesis 
fragment of eGFP amplified using primers gfti-sphl and 
Gfp-B amHI. 
pTMB22 pTMB8 derivate containing a 0.734kb SphI-BamHI This thesis 
fragment of eGFP amplified using primers gfr-SphI and 
gfr-BamHI. 
2.1.3 Solutions 
All solutions were made up in dH 20 and sterilised by autoclaving at 15 pounds per 
square inch for 20 minutes, prior to use. Heat labile components were separately 






Ampicillin 100 mg ml - ' 50 .tg ml -1 H20 
Chioramphenicol 25 mg ml -1  5 ig ml-1 Ethanol 
Kanamycin 10 mg mE' 50 tg ml-1  H20 
Tetracycline 5 mg ml-1  10 tg mE' 70% Ethanol 
Table 2.4 Antibiotics used during this investigation. 
Antibiotics were filter sterilised and stored at -20°C. 
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6x DNA loading buffer: 
6x concentrate loading buffer for nucleic acid gel electrophoresis consisted of a 40% 
(w/v) sucrose in water with 0.25% (w/v) bromophenol blue. 
EDTA: 
EDTA (ethylenediaminetetraacetic acid, di-sodium salt) was dissolved in dH 20 to a 
concentration of 0.5 M and was adjusted to pH 8.0 by addition of NaOH. 
Ethidium Bromide: 
Ethidium bromide was dissolved as a stock solution of 10 mg mF' in dH 20 and 
stored at room temperature in the dark. DNA was resolved by agarose gel 
electrophoresis containing 0.5 jig ml-1 ethidium bromide. 
Phosphate buffered saline (PBS -lOx stock) 
2.964g Sodium Dihydrogen Orthophospahte, 29.03g Disodium Hydrogen 
Orthophosphate and 87.75g Sodium chloride in water and made up to of 1 Litre 
PBS (lx) 
PBS was prepared by diluting lOOmls of lOX concentrated stock solution (lOX) in a 
final volume of 1 litre, pH 7.4. 
Sodium Acetate buffer: 
Sodium acetate was dissolved in dH 20 to a final concentration of 3 M and the pH 
adjusted to 5.2 with glacial acetic acid. 
TE buffer: 
1 litre of buffer contained 10 m Tris Cl (pH 8.0) and 1 mM EDTA. 
]Ox TBE buffer: 
1 litre of buffer contained 0.9 M Tris Cl (pH 7.5), 0.9 M Boric acid and 0.02 M 
EDTA. 
Tris Cl: 
Tns base (iris [hydroxymethyl] aminomethane) was dissolved to the desired molarity 
in dH20 and the pH was adjusted to the required value by addition of concentrated 
HC1. 
2.1.4 Media 
Luria-Bertani (LB) medium and agar: 
LB media consisted of Difco bacto-tryptone (10 g), Difco yeast extract (5 g) and 
NaCl (10 g), unless otherwise stated, dissolved in 1 litre of dH 20. The pH was 
adjusted to pH 7.2 with 5 M NaOH and the solution was sterilised by autoclaving. 
LB agar was formed by adding 15 g 11 of Difco bacto-agar. 
LC top agar: 
LC top agar consisted of Difco bacto-trptone (10 g), Difco yeast extract (5 g), NaCl 
(5 g) and Difco bacto-agar (7 g) dissolved in 1 litre of dH 20. The pH was adjusted to 
pH 7.0 and the solution was sterilised by autoclaving. 
Soc medium: 
Soc medium was made from Difco bacto-tryptone (20 g), Difco yeast extract (5 g), 
NaCl (10 mM), KC1 (2.5 mM), MgC12 (10 mM), MgSO4 (10 mM) and glucose 
(20mM) dissolved in 1 litre of dH20. The solution was sterilised by autoclaving. 
M9 medium 
M9 medium consisted of lOOmi (4x) M9 salts (28g Na2HPO4, 12g KH2PO 4, 2g 
NaCl, 4g NH4C1 dissolved in IL of water), 0.5% glucose, 1% casamino amino acids 
and 0.5m1 thiamine B  (1 mg ml - ') dissolved in 400mls. 
2.2 METHODS 
2.2.1 Manipulations of bacteria and phage 
Growth of bacterial cultures 
Cultures of S. typhimurium and E. coli were inoculated into 5 ml of LB broth (plus 
antibiotic if required) from a single bacterial colony. These were grown at 37°C 
overnight with shaking (300 rpm), unless otherwise stated. Larger cultures were 
prepared by diluting an overnight culture 100-fold in conical flasks, with an overall 
capacity 5-10 fold greater than that of the culture volume, then grown as stated 
above. 
Storage of bacterial cultures 
For long term storage of bacterial cultures, 1 ml of overnight culture was mixed with 
70 tl of DMSO and stored in a sterile vial at -80°C. The culture was recovered by 
streaking onto an agar plate, containing antibiotic if necessary, using a sterile 
toothpick. After overnight incubation at the correct temperature a single colony was 
picked and a fresh culture propagated. For short term storage (4-6 weeks) bacteria 
were stored as streaks on agar plates at 8°C. 
2.2.2 Preparation of P22 phage lysates 
S. typhimurium strain (CH23) carrying the desired chromosomal alteration 
(purA: :TnlO) was cultured overnight in the presence of antibiotic. A culture was 
diluted 100-fold into 10 ml of fresh LB medium and incubated until the 0D 600 had 
reached 0.2-0.3. 10 t1 of a P22 stock (titre 10 9 phage ml -1 ) was added to the culture 
and the incubation was continued for at least 6 hours. 200 .x1 of chloroform (CHC1 3 ) 
was then mixed with the culture, by inversion, several times and the mixture was left 
for 2 hours at 8°C. The culture was then centrifuged at 3, 000 g for 15 minutes in a 
bench-top MSE Centaur 1 centrifuge to remove cell debris. The supernatant was 
transferred to a fresh universal bottle, a further 200 j.il of CHC1 3 was added and the 
sample was mixed as before. The sample was then left at 8°C overnight and 
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centrifuged to remove any further debris. The supernatant from this final spin, 
containing the P22 phage, was filter sterilised using a 0.45 micron filter and stored in 
a fresh universal bottle at 8°C. 100 p.1 of CHC1 3 was added to minimise bacterial 
growth. 
Phage P22 transduction 
Phage P22 transduction was performed by the method of Roth (1970). The recipient 
strain (SL3261) to be transduced was grown as an overnight culture in LB medium. 
100p.1 aliquots of the recipient strains were dispensed into 5 sterile micro-centrifuge 
tubes, and 100 p.1 of a serially diluted P22 phage lysate (dilution range 10 9-105 phage 
ml-1 ) was added to each. Tubes were mixed by inversion and incubated at 30°C for 
30 minutes. The contents of each tube was then plated onto LB agar plates 
containing the appropriate antibiotic, and incubated overnight at 37°C. Controls 
containing P22 phage or cells only were also included. Following overnight 
incubation transductants were sequentially streaked several times on selective LB 
agar plates to remove residual P22 phage. 
Phage P22 titration 
An appropriate host strain was cultured overnight in LB. 100 p.1 volumes of culture 
were dispensed into a set of 9 sterile micro-centrifuge tubes, and 100 p.1 volumes of a 
serially diluted phage lysate (typically diluted from 108105  phage ml') were added. 
Tubes were then incubated at 30°C for 30 minutes. 100 p.1 volumes of each tube were 
added to 3 ml of LC top agar (50°C) and poured onto LB plates. Controls containing 
P22 phage or cells only were also included. Plates were incubated overnight at 37°C 
and titres were calculated by enumerating the number of plaques formed at each 
dilution. 
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2.2.3. Measurement of bioluminescence from strains bearing a Mudlux element 
S. typhimurium strains bearing a Mudlux luminescent light reporter system in the ahp 
locus (Taylor et al., 1998) were examined for light emission in response to osmotic 
upshift. In order to test the osmotic inducibility of the ahp::Mudlux strain (MPG203) 
and plasmid pTMB 1 (ahpC-IwAB), an LB medium containing low salt (LSLB) was 
used containing 1 g 11 NaCl, (instead of 10 g was used for growth, so that the 
osmolarity of the medium could be raised to the required level. For comparison the 
cells were also grown in N9 minimal media. Cultures (MPG203 and SL1344 
carrying pTMB1) to be tested were grown at 30°C with shaking in LSLB or M9 
medium containing the appropriate antibiotic. Overnight cultures were diluted to a 
density of 105 cells ml -1 and pre-incubated for a further 2 hours at 30°C to re-
establish exponential growth prior to osmotic upshift. Osmotic stress was then 
monitored by splitting the culture into four aliquots. They were treated in the 
following way; 
Left untreated and grown for another hour. 
Induced with 100 jiM hydrogen peroxide. 
Induced with 0.3M sodium chloride. 
Induced with 100 jiM hydrogen peroxide and 0.3M sodium chloride. 
Cells were then recorded for light emission in a 96-well plate-reading luminometer 
as relative light units per second (RLU s'), at 30°C, recording light production every 
5 minutes for the duration of the experiment. 
2.2.4 Nucleic acid manipulation and detection methods 
Agarose gel electrophoresis 
DNA was resolved by agarose gel electrophoresis. The gel consisted of 
electrophoresis grade agarose (0.8% w/v in lx TBE unless otherwise stated) 
containing 0.5 jig ml-1 ethidium bromide. DNA samples were mixed with 1/6th 
volume of 6x loading buffer and electrophoresed at 100 V, in a 110 mm x 150 mm 
(60mls) horizontal gel unless otherwise indicated, until suitable resolution had been 
obtained. Nucleic acid size was estimated in relation to the position of pre-digested 
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HindIII phage Lambda DNA fragments (Boehringer Mannheim). DNA was 
visualised under UV light (X=313 nm) and photographed using a Mitsubishi video 
copy processor. 
Polymerase Chain Reaction 
The polymerase chain reaction (PCR) was used for amplification of DNA fragments. 
Primers specific for the region of DNA of interest were designed as required (Table 
2.1 lists the primers used in this study). Reactions were performed in 50 tl volumes 
containing template DNA (10 ng), 1.0 jil of each primer (10 pM), 5 p.1 of a lOx PCR 
reaction buffer (Boehringer Mannheim), 4 p.1 of dNTP mix (containing 2.5 MM of 
each dNTP), 0.5 p.1 Taq DNA polymerase (2 U p.F') and dH20. The PCR was carried 
out in a Techne Gene E" thermal cycler dry-block. 
Amplification of the DNA was gnereally performed over 25 cycles. Each cycle 
consisted of the following three steps: Denaturation at 94°C for 1 minute, annealing 
at 50°C-60°C (depending on the primer set) for 1 minute and elongation at 72°C for 
2 minutes. At the end of the 25 cycles, a final single cycle of 72°C for 10 minutes 
was performed to complete the process. PCR reaction mixtures were examined under 
agarose gel electrophoresis. 
Small-scale preparation of E.coli and S.typhimurium plasmid DNA 
Plasmid DNA was isolated from 5ml of an overnight using the Wizard Miniprep Kit 
according to manufacturers insturctions (Promega). 
Preparation of genomic DNA from E. coli and S. iyphimurium 
Preparation of genomic DNA from bacteria was accomplished using the selective 
precipitation properties of hexadecyltrimethyl ammonium bromide (CTAB) (Murray 
and Thompson, 1980). Cell debris, polysaccharides and proteins can be removed 
from a bacterial lysate using CTAB and high-molecular weight DNA can be 
recovered by isopropanol precipitation. The bacterial strain of interest was inoculated 
into 5 ml LB broth, with the appropriate antibiotic(s), and was grown overnight at 
37°C with shaking. 1.5 ml of culture was transferred to a micro-centrifuge tube and 
cells were pelleted at 20 000 g. The supernatant was discarded and the cells were 
resuspended in 567 p1 of TE buffer. 30 p.1 of a 10% (w/v) SDS solution and 3 p.1 of 
proteinase K (100 pg ml -1 ) were added and the sample was mixed thoroughly. The 
tube was then incubated for 1 hour at 37°C with occasional mixing. 100 p.1 of 5 M 
NaCl was added and mixed by inversion, prior to the addition of 80 p.1 of a 
CTABINaC1 solution (10% [w/v] CTAB in 0.7 M NaC1). The sample was incubated 
at 65°C for 10 minutes and was then centrifuged at 20000 g for 5 minutes to spin out 
the CTAB-proteinlpolysaccharide complexes. The upper aqueous layer of viscous 
supernatant was then transferred to a new tube and an equal volume of 
phenol/chloroform (1:1) was added and mixed in thoroughly. The tube was again 
spun at 20 000 g for 5 minutes and the upper aqueous layer was transferred to a fresh 
tube, where 0.6 volumes of isopropanol was added. The tube was gently inverted 
several times until a stringy white precipitate of DNA appeared. The DNA was 
spooled out of the sample using a capillary tube and was transferred to a new tube 
containing 0.5 ml of 70% (v/v) ethanol, to remove the residual CTAB and NaCl. The 
DNA was then pelleted by centrifugation at 20000 g for 5 minutes, then dried and 
resuspended in 100 p.1 of dH 20. 
Phenol/Chloroform and ethanol extraction of DNA 
This was preformed as described by Sambrock et al., 1989. 
Restriction endonuclease digestion 
Performed as according to manufacturers instructions. 
Dephoshorylation of vector DNA 
Plasmid vectors digested with restriction enzymes were treated with shrimp alkaline 
phosphatase (SAP) to aid cloning of inserts into the vector. The cut vector DNA was 
incubated at 37°C for 1 hour in d14 20 containing 1/10th volume of a lOx SAP buffer 
and 1 unit of SAP. The SAP was then inactivated by incubation at 65°C for 
20 minutes, and the DNA was purified by phenol/chloroform extraction, followed by 
ethanol precipitation. 
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Recovery of DNA from agarose gels and ligation 
DNA fragments of interest were resolved on an agarose gel as described previously. 
A slice of gel containing the DNA was removed, weighed and purified using Qiagen 
Gel purification Kit. Ligation was carried out as outlined by Sambrock et al., 1989. 
Transformation of E. co/i and S. lyphimurium by electroporation 
The bacterial strain to be transformed was grown overnight in 5 ml LB broth, with 
the appropriate antibiotic(s), at 37°C with shaking. 5 ml of this overnight culture was 
dispensed into a conical flask containing 500 ml LB broth and grown under the same 
conditions until the 0D600 had reached 0.45-0.5. The culture was split into 2 
centrifuge pots and chilled on ice for 1 hour. Cells were then pelleted at 4, 000 g for 
10 minutes in a Beckman JA-21 (JA-14 rotor) at 4°C. The supernatant was discarded 
and the cells were resuspended in 200 ml ice-cold sterile dH 20 and then further 
centrifuged and resuspended in the same way twice more. After the final spin, the 
bulk of the dH20 was removed such that the cells (originally from 500 ml of culture) 
were resuspended in 500pJ of dH 20. The cells were given a final spin in a microfuge 
at 4°C and resuspended in final volume of 500tl of dH 20. Cells were then dispensed 
as 100 .tl aliquots into pre-chilled electroporation cuvettes. Between 5 pg and 0.5 tg 
of the DNA to be transformed was added to each cuvette and the samples were 
mixed gently by pipette. Electroporation was performed using the BIORAD 
"Gene-Pulser" apparatus, with the voltage set at 2.5 kV and the Pulse controller set 
to 200 ohms. Cuvettes were wiped to remove excess moisture and pulsed under the 
conditions described. After the pulse, 8001.11 of SOC medium was added to the 
cuvette, and the whole contents were transferred to a fresh micro-centrifuge tube. 
The cells were then incubated at 37°C for 1 hour, prior to plating on selective agar. 
Blue/white screen for pGEM-T transformants 
The vector pGEM-T (Promega) is specifically designed for the direct cloning of PCR 
products. PCR-generated DNA fragments commonly contain an additional 3' 
deoxyadenosine residues, added in a non-template dependent fashion by the 
thermostable Taq polymerase. The vector pGEM-T contains 3'-end deoxy 
thymidine overhangs, thus allowing direct ligation between the vector and the PCR 
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fragment without the need for restriction digestion of DNA prior to ligation. The 
cloning site lies within the coding sequence for the 3-galactosidase a-peptide, such 
that when a fragment of DNA is inserted, the lacZa gene is inactivated. Such 
recombinant clones, when transformed into DH5a (an E. coli derivative lacking 
lacZ), can be selected using the 5-bromo-4-chloro-indolyl-l3-D-galactoside (X-gal) 
based blue/white screen which directly tests for -galactosidase activity (Short et al., 
1988). For this purpose 40 .t1 of a 20mglml X-gal solution (w/v, dissolved in 
dimethylformamide) was spread on the selection plate. After overnight incubation of 
the plates at 37°C, colonies harbouring pGEM-T appear as blue colonies, while 
colonies bearing recombinant pGEM-T plasmids generally appear as white colonies. 
Sequencing of double-stranded DNA 
DNA sequencing was performed by an automated and non-isotopic method first 
described by Ansorge and colleagues (1986), using fluorescent dye terminators from 
the Big Dye Terminator Kit (Applied Biosystems, USA). DNA sequencing was 
preformed according to the manufacturers instructions from the ABI Prism Cycle 
Sequencing Kit. 
DNA was prepared using the Promega Wizard Kit and an ethanol precipitation step 
was performed to concentrate the DNA. The DNA pellet was resuspended in dH 20 
and the DNA concentration determined by agarose gel/ethidium bromide 
quantitation. PCR products were purified prior to cycle sequencing, by silica-based 
gel filtration using the Qiaquick PCR Purification Kit (Qiagen GmbH, Germany). 30 
to 90 ng PCR products and between 200 to 500 ng plasmid DNA were used as 
templates in cycle sequencing. DNA sequencing was carried out in 10 tl volume 
containing template DNA, 5 pmol primer for sequencing and 4 tl of terminator mix 
(A-dye terminator, T-dye terminator, C-dye terminator, G-dye terminators, dATP, 
dYTP, dCTP, dGTP, Tris.HCI pH 9.0], MgCl2 , thermostable pyrophosphatase and 
AmpliTaq DNA polymerase), supplied as part of the kit. Reactions were cycle 
sequenced in a Techne "Gene E" thermal cycler dry-block over 25 cycles, each cycle 
including 30 seconds at 94 0C, 30 seconds at 500C and 30 seconds at 72 0C. and then 
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used directly for the reactions. Dye terminators and excess nucleotides were removed 
using Centriflex Gel Filtration Columns (Edge BioSystems, Inc.). The cartridge and 
microtube was spun at 750g for 2 minutes to remove excess moisture from the 
cartridge. The cartridge was placed in a clean microtube and the sequencing reaction 
(10p.1) was added to the packed column and spun at 750g for 2 minutes. The eluate 
(lOp.!) was dried down in a speedvac for 10-15 minutes prior to processing on the 
automated DNA sequencer. Raw data were analysed using GeneJockey (Biosoft) 
software. 
2.2.5. RNA procedures 
Isolation of total RNA 
Salmonella typhimurium strains MPG203 and SL1344 were grown overnight at 
30°C, with or without antibiotic as required, in LSLB or in N9 media. The cultures 
were then diluted 1 in 100 and grown to an optical density of 0.2 at 30 °C prior to 
extraction of the total RNA. Total RNA was extracted using the Qiagen RNeasy 
Mini kit, according to the manufacturers instructions. A DNase step was included in 
this procedure using the Qiagen RNase-free DNase Set Protocol according to the 
manufacturers instructions for use with the Qiagen RNeasy Mini Kit. Total RNA was 
eluted in a total volume of 60p.l RNase-free dH20. The concentration and puritty of 
the RNA was determined by measuring the absobance ar 260nm (A260) and 280(A280) 
in a spectrophometer. Absorbance readings at 260nm measure RNA concentration. 
An absorbance of 1 corresponds to 40p.g of RNA per ml (A 260=1=40p.g/nil).The ratio 
between the absorbance at 260nm and 280nm gives an estimate of RNA purity with 
an absorance of between 1.8-2.0 suggesting pure RNA. RNA was stored in aliquots 
at —70°C. 
Formaldehyde Agarose (FA) Gel Electrophoresis (1.2%) 
1.2g Agarose was mixed with lOmi lOx FA gel buffer (see below) and made up to a 
total volume of lOOm! with Rnase-free water. 
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The agarose was melted in a microwave and cooled to 65°C in a waterbath. 1.8m1 of 
37% (12.3M) formaldehyde and 1111  of ethidium bromide (lOmg/ml) was added to 
the dissolved agarose and mixed in a fume hood. The gel was poured and allowed to 
set in a gel tray. The gel was equilabrated in lx FA gel running buffer in the 
electrophoresis tank for at least 30 minutes prior to loading and running the gel. One 
volume of 5x RNA loading buffer (see below) per 4 volumes of RNA sample was 
used for loading the gel. The RNA sample in the loading buffer was incubated at 
65°C for 3-5minutes and chilled on ice prior to loading on the equilibrated FA gel. 
The gel was run at 5-7 Volts per cm using lx FA gel running buffer composed of 
lOOmls of lox PA gel buffer (200 mM 3-(N-morpholino) propanesulfonic acid 
(MOPS), 50 mM Sodium acetate, 10 mM EDTA, corrected to pH to 7.0 with NaOH), 
20m1 37% formaldehyde and 880ml RNase free dH 20. 5x RNA Loading buffer 
contained 16 tl saturated bromophenol blue solution, 80tl 500mM EDTA (pH 8.0), 
720 tl 37% formaldehyde, 2m1 Glycerol, 3.084m1 formamide and 4m1 lOx 
concentrated FA Gel buffer. This buffer was made up to lOml with RNase-free dH 20 
and was stable for approximately 3 months at 4°C. 
Electrophoresis tanks were cleaned with a 0.5% (w/v) SDS, rinsed with water, dried 
with ethanol, then filled with 3% (v/v) hydrogen peroxide and left at room 
temperature for 10 minutes. The tanks were then rinsed with RNase-free water 
before use. All solutions including water were treated with 0.1% (vlv) Diethyl 
pyrocarbonate (DEPC), to inactivate RNases by covalent modification. For this, 
0. lml of DEPC was added to lOOml of solution, shaken vigorously to bring the 
DEPC into solution, and then left to stand at 37 °C for 12 hours. The solutions were 
autociaved for 15 minutes to remove any trace of DEPC. DEPC can react with 
primary amines, so was not used in the preparation of Tris buffers. For preparation of 
Tris buffers, autoclaved DEPC treated water was used to dissolve the Tris and then 
autoclaved as usual. 
Reverse- Tanscription Polmerase Chain Reaction (RT-PCR) 
RT-PCR was performed using Ready To Go RT-PCR beads from Amersham 
Pharmacia Biotech. These beads use Moloney Murine Leukemia Virus (M-MuLV) 
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Reverse transcriptase and Taq DNA polymerase to generate PCR product from an 
RNA template. Each bead is optimised to allow the first-strand cDNA synthesis and 
PCR reactions to proceed sequentially in a single tube (Amersham Pharmacia). 
The Two-Step procedure was preformed using 25ng- 1 5Ong of Total RNA isolated 
from Salmonella typhimurium. The firt part of the reaction was carried out by 
rehydrating the beads (containing both reverse transcriptase and Taq polymerease) 
on ice with RNase-free water, then adding the particular concentraion of total RNA 
along with the primer required for reverse transcription. The reaction was incubated 
at 42°C for 30 minutes in the PCR machine, followed by 95 °C for 5 minutes for 
inactivation of Reverse transcnptase and complete denaturation of DNA. The second 
primer required for the PCR was added and allowed to proceed into the PCR 
reactions. 
Denaturation was carried out at 95 °C for 30 seconds, followed by annealing at 52°C 
for 30 seconds for both ahpC and ser tRNA and at 55°C for katG. Finally 
polymerisation was performed at 72°C for 60seconds for all samples. This cycling 
sequence was repeated for 25 cycles, followed by a final cycle of 72 °C for 10 
minutes. RT-PCR products were analysed on a 1.2% agarose gel. 
2.2.6. Protein detection procedures 
SDS-polyacrylamide gel electrophoresis 
SDS-polyacrylamide gel electrophoresis (SDS-PAGE) was performed essentially as 
described by Laemmli (1970). The procedure dissociates pr.oteins into their 
individual sub-units and subsequently separates them according to their size. Proteins 
were resolved on 7x8 cm SDS-polyacrylamide gel, using a MINI-PROTEAN II Dual 
Slab Gel apparatus (BIORAD). The composition of the gel was dependent upon the 
protein to be investigated. A 12.5% or 10% (w/v acrylamide/bisacyrylamide) gel was 
used routinely used and the stacking gel was always used at a 4% (w/v) 
polyacrylamide concentration. The composition of the protein gel is shown below 
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Stacking Gel Resolving Gel 
(4%[vlv] (12.5% [v/v1 
polyacrylamide): polyacrylamide): 
30%(w/v) 1.4 ml 4.0 ml 
acrylamidefbisacrylamide( 19:1)  
Tris. Cl 2.3 ml (0.5M, pH 6.8) 2.5 ml (1.5M, pH 8.8) 
20% (w/v) SDS 50 jtl 50 .tl 
dH20 6.2 ml 3.4 ml 
10% Ammonium persuiphate (APS). 100 t1 50 p.! 
N,N,N'- 10 g 5 g 
Tetramethylethylethylenediamine 
(TEMED)  
Laemmli (Loading) Sample Buffer (]Ox) for SDS-polyacrylamide gels: 
25 mM Tris.Cl (pH 6.8), 2%(w/v)SDS, 10%(v/v)Glycerol, 0.2 M 13-Mercaptoethanol 
and 0.002% (w/v) Bromophenol Blue, was dissolved and made up to a final volume 
with dH2O. 
Samples to be loaded were mixed with 2x Laemmli sample buffer (LSB) and boiled 
for five minutes, unless otherwise stated, prior to loading. Unless otherwise stated, 
electrophoresesis was carried out at 15niA per gel gel for 1.5- 2 hours (MINI-
PROTEAN II). Running buffer contained 144 g Glycine, 30 g Tris-base and 5 g SDS 
in 1 litre dH20. Molecular size markers (Table 2.5) were included to allow 
determination of the molecular sizes of polypeptides seen on the gel. Pre-stained 
molecular size markers (New England Biolabs PTT08S) were used for 
immunoblotting (Table 2.6). 
Molecular weight standard markers 
Protein Standard Approximate MolecularWeight (Da) 
a -Lactalbumin 14,200 
Trypsin Inhibitor 20,100 
Trypsinogen 24,000 
Carbonic Anhydrase 29,000 
Glyceraldehyde-3-P-Dehydrogenase 36,000 
Albumin (egg) 45,000 
Albumin (bovine) 66,000 
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Table 2.5 Molecular weight markers (MW-SDS-70L, Sigma) were used as a mixture 
of standards for SDS-PAGE. 
Protein Standard Approximate MolecularWeight (Da) 
MBP-3-Galactosidase 175,000 
MBP-paramyosin 83,000 
Glutamic dehydrogenase 62,000 
Adolase 47,500 
Triosephosphate isomerase 32,500 
- Lactoglobulin A 25, 000 
Lysozyme 16,500 
Aprotinin 6,500 
Table 2.6. Pre-stained molecular size marker (New England Biolabs PTT08S) used 
for inmiunoblotting 
Staining SDS-polyacrylamide gels 
Polypeptides were visualised by staining with Coomassie Brilliant Blue. Once the 
polypeptides had been separated by electrophoresis, the gels were immersed in a 
fixing/staining solution (0.1% [w/v] Coomassie Brilliant Blue R250 (BIORAD), 
45% [v/v] Methanol, 10% [v/v] glacial acetic acid) and 45% dH 20), filtered through 
a Whatman 3MM cellulose paper. Gels were left to stain on a shaking platform for 
30-60 minutes at room-temperature. The gels were destained by using a destaining 
solution (45% [v/v] methanol, 10% [v/v] glacial acetic acid, 45% dH 20) for 4-8 
hours at room temperature. 
Estimation of protein concentration 
The concentration of a protein in a solution was estimated using the modified method 
of Bradford (1976), following a BIORAD standard assay procedure. BSA solutions 
of 0, 2, 4, 6, 8, 10 and 12 ..tg ml -1 were prepared in 1 ml of dH 20, and 800 jtl of each 
standard was added to 200 t1 of BIORAD protein assay dye-reagent. Each sample 
was mixed by gentle inversion, taking care not to cause foaming, and after 5 minutes 
the optical density of the solution was read at 595 nm (OD 595 ) in a 
spectrophotometer. For each BSA standard solution, triplicate measurements of the 
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0D595  were obtained and the average reading plotted against concentration to give a 
standard curve. The protein concentration of the solution of interest was then 
determined by appropriately diluting the sample in 1 ml of dH 20 and adding 800 p.1 
of this solution to 200 p.1 of the dye-reagent. The optical density was then determined 
as outlined above. This reading was used in conjunction with the standard curve, to 
determine the concentration of protein in the solution of interest. 
2.2.7. Protein overexpression and purification 
Purification of Glutathione-S-transferase (GST) tagged proteins using a Gluathione 
column 
For each GST fusion protein, 1 litre of culture was grown at 37 °C to an optical 
density (600nm) of 0.4. The fusion proteins were then induced with 1mM IPTG for 
3hours. The cells were pelleted at 4,000g for 10 minutes at 4 °C, stored at —70°C 
overnight. The cells were resuspended in 30mls of lysis buffer (50mM Tris HC1 
containing 50mM NaCl, 50mM EDTA, Lysosyme (1p.g/ml), RNase A (5p.g/ml), 
Pepstatin A (5p.g/ml), Aprotinin (5p.g/ml), Leupreptin (5p.g/ml), AEBSF (1mM), 1% 
Triton-X-100 and 10mM 3-mercapethanol) on ice for 20 minutes prior to sonication. 
Sonication was carried using a Lucas Dawes Ultrasonics Soniprobe with probe size 
60 x 12 mm. Sonication was performed on ice for 40% of each second for 4 xl 
minute, on an ouput setting of 5, with 1 minute sitting on ice between each burst. The 
lysed cells were then centrifuged at 8,000g for 30 minutes at 4 °C to pellet DNA and 
other cell debris. The supernatant was retained for purification of the GST fusion 
protein. All the subsequent steps were performed at 4°C, until the point of elution. A 
lml bed volume of Glutathione Sepharose 4 Fast Flow with a total binding capacity 
of 10mg recombinant GST/ml gel (Amersham Pharmacia Biotech) was transferred to 
a column and allowed to settle. The column was washed with 5-10 column volumes 
of PBS, followed by 1-2 column volumes of Lysis Buffer. The cleared sonicate was 
loaded on the column and collected as it flowed through. This flow-through was re-
applied to the column over a period of approximately 40 minutes to allow maximun 
binding of the GST fusion proteins to the gluathione beads. The bound proteins were 
washed 4-6 times with 5-10 column volumes of Lysis Buffer to remove any unbound 
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proteins. The column was then capped and shifted to room temperature for the 
elution of the fusion proteins. GST fusion proteins were eluted using a total of 3x 
lml volumes of Elution buffer (100 mM NaCl and 20mM Gluathione in 50mM Tris 
HC1 pH 8). The elution procedure was carried out by incubating the first ml of 
elution buffer on the column for 10-15 minutes at room temperature before 
collecting the eluate. The remaining 2mls of buffer was then passed through the 
column, until all the fusion protein was eluted. After purification the columns were 
regenerated for use in the next purification. 
Regeneration of Gluathione columns 
Columns were regenerated with 5-10 volumes of Regeneration Buffer (3M NaCl in 
PBS), and this was repeated another 3 times, before washingwith 10 volumes of 
PBS, followed by 5-10 volumes of 6M Guanidine Hydrochloride to remove 
associated proteins. Subsequently, the columns was washed with 5-10 volumes of 
PBS, followed by 5-10 volumes of 70% ethanol to remove hydrophobically bound 
proteins. Finally, the column was equilibrated again with 5-10 volumes of PBS and 
flushed with 5 volumes of 20% ethanol to prevent the growth of micro-organisms 
and stored at 4 °C until further use. Before re-use, the columns were re-equilibrated 
with 5-10 volumes of PBS. 
Purification of histidine-tagged AhpC using a nickel-nitrolotriacetic acid (NTA) 
column 
Affinity purification of Polyhistidine (His) tagged proteins were performed at 4°C. 
The nickel (Ni 2 ) groups in Ni2 -NTA resin (Qiagen) are capable of binding the 
imizadole ring of histidine amino acids. Proteins containing a His-tag can therefore 
be selectively bound and separated from non-His-tagged proteins with relative ease. 
Approximately 1.5 ml of resin was transferred to a column and allowed to settle 
(forming a 1 ml column). The column was washed with 10 ml of dH20 and 
equilibrated using a further 10 ml of Buffer A (10 mM Tris Cl pH 7.9, 10% (v/v) 
glycerol, 0.5 M NaCl, 0.1% (v/v) NP40, 5 mM DTT and 0.5 mM AEBSF). 10 ml of 
cell extract prepared as described, was defrosted. Imizadole was added to a final 
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concentration of 1 mM and the sample was loaded onto the column repeatedly, over 
a period of 40 minutes. The column was then washed with 20 ml of Buffer B (20 MM 
Tris Cl pH 7.9 containing 100 mM KC1, 20% (v/v) glycerol, 5 mM DTT, 0.5 mM 
PMSF and 20 mM imizadole) to remove any non-His-tagged proteins. The His-
tagged protein was eluted by the addition of 6 ml of Buffer B containing 80 MM 
imizadole. The eluted fraction was diluted 4-fold in Buffer B, so that the resulting 
concentration of imizadole in the sample was 20 mM). All column fractions were 
kept at -80°C until further use. The purification of the His-tagged protein was 
monitored by examining the composition of column fractions by SDS-PAGE. 
Typically 20 tl of each column fraction was mixed with 10 p.1 2x LSB, boiled for 10 
minutes and loaded onto 7 x 8 cm 12.5% (vlv) polyacrylamide gels. Gels were then 
run at 25-50 mA for 2 hours, stained with Coomassie Brilliant Blue stain and 
destained. Purification was stopped when the protein was considered to be >95% 
pure. Eluates containing the purified AhpC protein were then pooled, dialysed 
against several changes of PBS and the protein was concentrated (page 29). 
The Ni2 -NTA columns could be regenerated, after elution of the protein had 
occurred, by adding buffer R (6 M guanidine HC1 dissolved in 0.2 M acetic acid). In 
this way a column could be used many times. Columns were stored at 4°C in either 
dH20 or Buffer R until re-use. Standarly Buffers A and B contained the following 
protease inhibitors (Sigma): 1 p.M pepstatin A, 1 p.M chymostatin and 5 p.M 
leupeptin) 
2.2.8. Immunodetection of polypeptides 
Following electrophesis, proteins were blotted onto nitro-cellulose membrane 
(Schleicher and Schuell) and the blot was exposed to serum (antibody) specific to 
that protein. Bound serum was detected using antiserum conjugated to horse radish 





Transfer of proteins to nitro-cellulose membranes by electrophoresis 
The procedure for transferring proteins to nitro-cellulose membranes from 
polyacrylamide gels was essentially as described by Towbin and colleagues (1979). 
Six pieces of 3MM Whatman paper (6cmx9cm) and nitro-cellulose (Schleicher and 
Schuell) were cut and soaked in lx transfer buffer containing 25 mM Tris. Cl, pH 
8.3, 0.15 M Glycine and 2 % [v/v] methanol. Three pieces of the soaked whatmann 
paper were laid on the base of the Biorad Semi-dry trans-blotter, with the dampened 
nitro-cellulose placed on top. The gel was then carefully placed on top of the nitro-
cellulose, ensuring no bubbles were trapped between the gel and the membrane. 
Three pieces of soaked Whatman paper were carefully placed over the gel, again 
taking care to avoid bubbles. The entire sandwich was then rolled using a test-tube to 
ensure that no bubbles were trapped between any of the layers of the sandwich. The 
membrane "side" of the sandwich was placed closest to the anode. Polypeptides were 
then transferred from the gel to the membrane by electrophoresing at 15 Volts and 
5 mAmps per cm square for 15-20 minutes at 4°C. A maximum of 4 minigels were 
transferred concommintantly using the Biorad semi-dry trans-blotter for 30 minutes. 
After blotting the polypeptides, the membrane was used immediately for 
immunodetection experiments. 
Immunodetection of Salmonella typhimurium polypeptides 
Detection of polypeptides followed the method of Knecht and Diamond (1984). A 
blotted membrane, carrying S. typhimurium-derived proteins, was shaken for 1 hour 
at room temperature in 10-20 ml of Blocking Solution (5% w/v safeway dried milk, 
0.05% Tween 20 dissolved in PBS). The milk proteins blocked sites on the 
membrane not already filled by proteins following transfer from the gel. The 
membrane was then rinsed four times, each for 5 minutes, with 10-20m1 of Wash 
Solution (PBS with 0.05% v/v Tween 20). Following washing, the membrane was 
shaken at room temperature for one-hour with lOml of dilution buffer (1% v/v milk 
protein, 0.05% Tween 20 dissolved in PBS) containing mouse serum (polyclonal 
anti-S. typhimurium protein antisera) for one hour at room temperature. After this 
time, the membrane was washed four times, each for five minutes with 10-20ml of 
wash buffer. Following washing, the membrane was shaken at room temperature for 
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one hour, with lOml of horseradish peroxidase-conjugated anti-mouse antibody in 
dilution buffer. The solution was discarded and unbound serum was removed by 
washing a further four times, each for 5 minutes with wash buffer. Bound antisera 
was detected by the addition of 5m1 of a developing solution (Pierce). The reaction 
was allowed to proceed for five minutes. The excess solution was removed from the 
membrane, which was then wrapped in cling-film and exposed to x-ray film for 
development. 
Enzyme-linked immunosorbent assay (ELISA) 
ELISA (enzyme-linked immunosorbent assay) was performed essentially as 
described previously (Engvall and Penman, 1971). Ninety-six well microtitre plates 
(Immulon 2, Dynex) were coated with the purified protein at a concentration of 
1tg/m1 (100 ng antigen per well in 100 pA coating buffer (15 mM Na2CO3 , 35 MM 
NaHCO3, pH 9.5), unless otherwise specified, and were incubated overnight at 4 0C. 
The plates were then washed 3 times with 200pA washing buffer (0.05% [v/v] Tween 
20 in PBS) per well to remove excess antigen, and unoccupied protein binding sites 
were blocked for 1 hour at 37 °C with 200 p1 per well blocking buffer (1% [w/v] 
skimmed milk powder in washing buffer). After 3 washes (200p1 washing buffer per 
well), doubling dilutions of serum samples, made up in diluting buffer (0.25% [w/v] 
skimmed milk powder in washing buffer), were added to duplicate antigen coated 
wells (100 jtl per well) and incubated for 4 hours at room temperature. After 3 
washes (200tl washing buffer per well), the wells were incubated for 30 minutes at 
370C with 100 p1 per well of horseradish peroxidase-conjugated anti-IgG antibody 
(SAPU, Scotland, UK) at a dilution of 1:500 in blocking buffer. The plates were 
washed a further 3 times (200pA washing buffer per well), with washing buffer before 
incubating for 15 minutes at room temperature with 100 p1 per well of substrate 
buffer. The substrate buffer (10 ml) contained 2.4 ml of 0.1 M citric acid, 2.56 ml of 
0.2 M Na2HPO4, 4 pA of 30% (v/v) H202 , 5 ml dH20 and 4 mg O-phenylenediamine 
(OPD, from Sigma). The reaction was stopped with 25 tl of 2M H2SO4  and the 
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absorbance was read at 492 nm using a Titertek Multiskan Plus plate reader and the 
software ELISA LITE v. 3.01.03 (1986-1991 Meddata Inc.). 
2.2.9. Murine model studies 
Innately susceptible (itys)  female BALB/c mice (8-10 weeks of age ) were used for 
the immunisation with S. typhimurium strain MPG424 carrying various different 
plasmids. Mice were obtained from Edinburgh University and segregated into cages, 
with never more than three to a cage. They were supplied with a commercial pellet 
diet and water ad libitum. 
Preparation of bacterial cells for injection into mice 
The S. typhimurium strain of interest was grown overnight in 20 ml LB medium, 
containing the appropriate antibiotic, with shaking at 37°C. Bacteria were pelleted in 
a bench-top centrifuge at 5,000 g for 15 minutes. The cells were then washed and 
resuspended in 10 ml sterile PBS. This process was repeated twice and finally the 
bacterial pellet was resuspended in 2mls of PBS. Serial dilutions were then 
performed in PBS until the required bacterial dilution had been obtained. The 
bacterial inoculum was determined by plating out 100tl of the serial dilutions. Mice 
were injected by the intra-peritoneal (i.p.) route with 100 tl aliquots of the PBS-
diluted bacteria, ranging from 1 x iO 4-5 x107 cfu. 
Obtaining S. typhimurium-specific serum from mice 
The mice were lightly anaesthetised and bled, prior to infection (day 0) and on days 
14 and 28 post-infection. On one occasion (Section 5.2.4) serum was also removed at 
day 21. Approximately 100 tl of blood was obtained per mouse, and bleeds from the 
same group of mice were pooled. The blood was allowed to clot at room temperature 
for 5-6 hours or overnight at 4 °C and the cell-free portion of the blood, the serum, 
was then obtained by spinning the samples at 1, 800 g in an MSE Centaur bench-top 
centrifuge for 15 minutes. Serum was aliquoted and stored at -80°C until further use. 
Preparation of S. typhimurium proteins for footpad analysis 
Proteins which had been purified were dialysed against PBS. Dialysis membrane 
(Medicell International Ltd.) was prepared by boiling in a solution containing 2% 
(w/v) sodium bicarbonate and 0.05% (w/v) EDTA for 10 minutes, ensuring that the 
membrane remained submerged. This solution was then discarded and the membrane 
then boiled twice in dH 20 for 10-15 minutes. After this final step, the membrane was 
allowed to cool, was submerged in dH 20, and transferred to a solution containing 
20% (v/v) ethanol and stored at 4°C until further use. Prior to dialysis, the membrane 
was rinsed with sterile dH 20 to remove the ethanol and the protein solution then 
placed into an appropriately sized dialysis membrane bag. The proteins were 
concentrated in dialysis tubing by sprinkling Polyethanolglycol (PEG 8000) sprinkled 
over the surface. Proteins were dialysed against several changes of ilitre of PBS at 
4°C. After quantification, the concentrated proteins were stored at -80°C until use. 
Delayed-type hypersensitivity testing 
S. typhimurium proteins were examined for their ability to induce a delayed-type 
hypersensitivity (DTH) reaction in mice, using a footpad swelling assay. Female 
BALB/c mice were injected by the i.p. route with 100 .tl of PBS (control group) or a 
100 tl of PBS containing a suitable level of attenuated S. typhimurium strain 
(MPG24) carrying the appropriate plasmid (see chapter 5). On days 35 post-
infection, uninfected mice and mice infected with S. typhimurium were challenged 
with proteins (GST-LLO, GST- Gp63(1), GST- Gp63(2), GST-GFP, GST, GroEL or 
Ahp-His) (see chapter 5). One day before the challenge, the proteins were diluted to 
0.8 mg ml-1 in PBS and heat aggregated at 70°C for one hour. The proteins were then 
stored at 4°C overnight until needed. Mice were subsequently injected 
subcutaneously with 20 j.tg of protein in 50 p1 of PBS, into the RHFP and 50 p1 of 
PBS (only) was injected into the LHFP. After 24 and 48 hours, the thickness of the 
RHFP and LHFP was measured, taking three measurements per footpad using dial-
type callipers. The footpad thickness was measured in thousandths of an inch. The 
RHFP and the LHFP were compared to establish whether a DTH reaction had 
occurred (see chapter 5). 
CHAPTER 3 
Aberrant regulation of 
ahpC 
3. Aberrant regulation of ahpC 
The host has many levels of defense against invading pathogens. These defences 
include the low pH of the stomach, proteases and detergent (bile salts) produced by 
the pancreas, low oxygen levels and the enhanced osmolarity of the intestine, as well 
as the antimicrobial peptides secreted by the epithelial cells of the small intestine 
(Foster and Spector 1995). Invasive Salmonella also must be able to avoid and 
survive the oxygen dependent and independent killing mechanisms of professional 
phagocytes following contact and internalisation, in order to result in systemic 
diseases. 
Salmonella are capable of surviving and multiplying within phagocytic host cells 
such as macrophages. In macrophages and polymorphonuclear monocytes (PNMs), 
the oxidative or respiratory burst is one of the primary antibacterial functions and 
results in reactive oxygen intermediates (ROTs) such as superoxide, peroxide, 
hydroxyl radicals and hypochlorous acid (Hasett and Cohen 1989). For aerobically 
growing bacterial cells, endogenous 02 and H202 are also unavoidable products of 
the respiratory chain (Gonzalez-Flecha and Demple, 1997). Salmonella typhimurium 
deals with these by-products in a co-ordinated manner, where different sets of genes 
are switched on or off by regulatory systems, which are modulated during the course 
of infection. 
Alternative bacterial sigma factors also play a role in the anti-microbial environment 
of the macrophage and subsequent survival of the bacterium (Fang et al., 1992; 
Hengge- Aronis 1996a). The defence mechanisms against intracellular stresses seem 
to result at least in part, from RpoS inducing certain stimulons and groups of genes. 
It is also worth noting however that RpoS can be present in exponentially growing 
cells but during active growth is generally much less abundant than the vegetative 
sigma factor RpoD (Hengge-Aronis 1996a). However RpoS levels can increase 
substantially even in exponential phase in response to osmotic stress or other 
conditions or stresses which reduce growth (Hengge-Aronis 1993a; Hengge-Aronis 
1996a, 1996b). 
3.1 Oxidative stress 
A bacterial cell in a stressful oxidising environment responds by firstly trying to 
destroy the offending oxidants and secondly, by repairing the macromolecules that 
have been damaged by exposure to the stress. When exposed to ROIs during 
exponential growth, Salmonella induces the expression of a number of genes 
encoding enzymes that degrade active oxygen species including catalase, superoxide 
dismutase and alkyl hydroperoxide reductase (AhpCF) (Fan and Kogoma 1991). 
However, at the same time, repair enzymes like endonuclease III and endonuclease 
IV attempt to repair any damage to DNA (Fan and Kogoma 1991). These genes are 
organised into at least two independent regulons (SoxRS and OxyR) that are 
essentially induced by different oxidative stresses. In addition, a number of soxRS or 
oxyR-independent genes are expressed in response to H 202 or 02 exposure 
(Christman et al., 1985; Morgan et al., 1986). The superoxide anion (02) and 
hydrogen peroxide (H 202) are formed when molecular oxygen chemically oxidises 
electron carriers (Storz and Imlay, 1999). 
3.1.2 Defense against hydrogen peroxide stress 
The peroxide stress response is regulated by OxyR induced by H 202 and nitric oxide 
(Christman et al., 1985; Greenberg and Demple 1989; Walkup and Kogoma 1989). A 
regulated adaptive response to H 202, was first discovered in Escherichia coli and a 
similar adaptive response was observed subsequently for Salmonella typhimurium 
(Christman et al., 1985; Storz et al., 1989). Hydrogen peroxide is formed in the cell 
upon detoxification of superoxide by superoxide dismutases, by the net two-electron 
reduction of oxygen (Storz et al., 1990). Christman et al. (1985) showed that when 
cells are exposed to hydrogen peroxide, the OxyR protein activates transcription of 
the genes needed to overcome the hydrogen peroxide stress, and this involves the 
direct oxidation of OxyR (Storz et al., 1987). OxyR is discussed below in more 
detail. 
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Salmonella typhimurium mounts a defensive response to hydrogen peroxide stress, 
and becomes resistant to lethal doses of H202 (5-10mM) after pre-treatment with low 
doses of H202 (10-60pM) in exponentially growing cells. Salmonella typhimurium 
and Escherichia coli cells treated with 60tM H202 revealed an increase in the rate of 
synthesis of 30 proteins in the first 60 minutes after addition of H 202 (Christman et 
al., 1985; VanBogelen et al., 1987). Moreover, two major temporal classes of 
hydrogen-peroxide inducible proteins were revealed. Twelve of these thirty proteins 
are early proteins are induced within 10 minutes and eighteen of these proteins are 
maximally synthesised between 10 and 30 minutes, after addition of hydrogen 
peroxide (Zheng et al., 2001). Several of the late proteins are induced to a certain 
degree before 20 minutes and most of the late proteins continue to be synthesised at 
an elevated rate in the following thirty minutes reaching a maximum level at 50-60 
minutes (Christman et al., 1985). 
A number of these early proteins are constitutively expressed at an abnormally 
elevated level in Salmonella typhimurium OxyRl mutants, where OxyR is 
permanently activated and are not induced by H 202 in an OxyRA2 strain where the 
oxyR gene is deleted (Christman et al., 1985). However, in the OxyR\2 strain the 
other 21 or more proteins can still be induced by H 202, suggesting that only twelve 
of the 30 peroxide stress proteins are regulated by the OxyR locus (Christman et al., 
1985, Altuvia et al., 1994). Two of these early genes encode heat shock proteins, two 
encode electromorphs of HPI catalase and two encode subunits of AhpCF 
(Christman et al., 1985; Morgan et al 1986; Storz et al., 1989, VanBogelen et al., 
1987). The gene katG, encodes a catalase (HP-1 hydroperoxidase), which is active as 
a tetramer of 81Kda subunits. (Storz et al., 1990). The expression of katG is induced 
as cultures enter stationary phase and is regulated at the level of transcription by 
RpoS. However, in exponential phase cultures, induction of katG by hydrogen 
peroxide is regulated at the level of transcription by OxyR (Christman et al., 1985; 
Morgan et al., 1986). Both catalase and AhpCF function to destroy potential 
oxidising agents before they can damage biological molecules such as DNA, lipids 
and proteins. Oxidised DNA can be repaired, but the oxidation of lipids and various 
amino acids such as lysine, histidine and tryptophan appears irreversible (Christman 
et al., 1985; Demple and Harrison 1994). 
Francis and Gallagher (1993) identified a hydrogen peroxide inducible locus ahpCF, 
induced upon interaction of Salmonella typhimurium cells with macrophages. The 
gene ahpC is located upstream of ahpF and encodes the C22 protein (AhpC), while 
ahpF encodes the F52a protein (AhpF) (Tartaglia et al., 1990). Both genes are 
located near 13 min on the Salmonella lyphimurium and Escherichia co/i 
chromosome. Previously, using two-dimensional electrophoresis, AhpC and AhpF 
were identified as H 202-inducible proteins. AhpF has a subunit mass of 
approximately 57kDaltons and was found to contain a bound FAD cofactor. AhpCF 
uses NAD(P)H to reduce alkyl hydroperoxides to the corresponding alcohol. This is 
carried out by the tetramer composed of 2 monomers of AhpF (NAD(P)H-oxidising 
flavoprotein) and the 2 monomers of AhpC (peroxide reducing part) (Chen et al., 
1998). The synthesis of both proteins is regulated by the OxyR locus, with the 
presence of an oxyR-regulated promoter just upstream of the ahpC promoter 
(Tartaglia et al., 1989). It has been demonstrated that Escherichia co/i maintains an 
intracellular concentration of H 202 below 0.2tM, but the generation of H202 during 
growth may vary by >10 fold. This study also suggested that the physiological 
trigger for activation of OxyR was a set point close to 0.2tM (Gonzalez-Flecha and 
Demple 1997). 
Another hydrogen peroxide inducible gene, dps was also induced by Salmonella 
typhimurium within macrophages and is also part of the OxyR regulon (Valdiva et 
al., 1996). Dps is a 19Kda protein that is highly abundant in stationary phase cells. 
Mutants of E.coli lacking Dps are very sensitive to H202 in stationary phase 
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dependent) and show an altered pattern of protein synthesis. It has also been found 
that dps is expressed after treatment with low doses of H 202 during exponential 
growth as part of the oxyR regulon, suggesting that Dps is involved in survival during 
oxidative stress (Altuvia et al., 1994). 
3.1.2.1 OxyR regulon 
OxyR is a member of a large family of bacterial regulators that is sterotyped by the 
Escherichia coli regulatory protein LysR and the Rhizobium regulatory protein NodD 
(Christman et at., 1989; Tao et al., 1989). The OxyR protein was found to be 305 
amino acids long (34.4 kDa) (Christman et al., 1989; Tao et at., 1989). Similar to 
many members of the LysR family, OxyR acts as both a positive and a negative 
regulator of its own synthesis (Storz et at., 1990). 
OxyR mediates its effect upon the genes of the OxyR regulon by binding to the oxyR 
operator which partially overlaps with the -35& ° promoter consensus sequence 
(Christman et al., 1989; Tartaglia et al., 1989; Tartaglia et al 1992). Toledano et at. 
(1994) proposed a model for OxyR mediated regulation, where the OxyR tetramer 
could not bind to the promoter region when it is in the reduced state. Activation of 
transcription is thought to occur via direct contact with RNA polymerase (Tao et al., 
1993; 1995). The confirmation of OxyR is altered when oxidised, resulting in the 
formation of a disulphide bond. OxyR binds to the promoter recognising ATAG 
nucleotide elements in the 4 adjacent grooves initiating transcription of genes such as 
ahpC and katG (Storz et al., 1990; Kullik et al, 1995, 1995b). When OxyR is 
reduced, recognition of the ATAG element occurs in 2 pairs of adjacent grooves at 
positions C199 and C208 (Toledano et at., 1994; Zheng et at., 1998). 
The role of OxyR seems to be critical for mediating hydrogen peroxide resistance in 
exponentially growing Salmonella typhimurium cells and operates mainly at the level 
of transcription. OxyR is an activator of katG and ahpCF expression, whilst 
negatively autoregulating its own expression (Morgan et al., 1986; Christman et al., 
1989; Tartaglia et at., 1989). In OxyR constitutive mutants (OxyRl) of Salmonella 
typhimurium, there are elevated levels of the ahp and katG transcripts and of the 
corresponding proteins. Thus, there is a correlation between the transcript levels and 
the amount of enzyme activity in the cells (Christman et at., 1985; Tartaglia et at., 
1989). The expression of an oxyR regulated katG-lacZ fusion increases within 5 
minutes of treatment with hydrogen peroxide (Tartaglia et at., 1989). 
3.1.2.2 The SoxRS regulon 
SoxR and SoxS regulate the superoxide stress response. The SoxRS response is 
triggered when cells are exposed to nitric oxide (NO) or to superoxide (02) 
generating agents such as paraquat (PQ) (Nunoshiba et al., 1993). It has been 
suggested that the SoxR protein may act as a sensor, sensitive to superoxide anions in 
the cell, while SoxS activates the expression of the genes in the regulon (Ahern 
1991). This occurs by a two-stage process: firstly SoxR is converted to an active 
form that enhances transcription of soxS, and then the increased level of SoxS 
activates the expression of the regulon (Hidalgo and Demple, 1996). 
SoxS is thought to regulate approximately 15 genes in response to superoxide stress, 
including for example superoxide dismutase (sodA), glucose-6-phosphate 
dehydrogenase (zwf) and a DNA repair gene endonuclease IV (nfo) (Pomposiello 
and Demple 2000). Mutations that inactivate these genes result in cells, which are 
sensitive to superoxide (Greengberg and Demple 1989; Walkup and Kogoma 1989). 
Nunoshiba et al., (1993), showed that Escherichia coli soxRS mutants were 
hypersusceptible to killing by murine macrophages. In Escherichia coli and 
Salmonella typhimurium it has been demonstrated that an elevated level of the SoxS 
protein is sufficient for activation of important antioxidant genes (Pomposiello and 
Demple 2000). Alternative sigma factors also play a role in the anti-microbial 
environment of the macrophage and subsequent survival of the bacterium (Fang et 
al., 1992; Hengge- Aronis 1996a). 
MarA is another transcriptional activator closely related to SoxS and is known to 
activate sodA expression in Escherichia coli. This protein could also play such a role 
in Salmonella typhimurium (Seoanne and Levy, 1995). MarA has been identified as 
part of an operon conferring multiple antibiotic resistance when activated in the cell. 
marA expression is induced by antibiotics such as tetracycline and a variety of 
phenolic compounds including salicylate and 2,4-dinitrophenol (Miller and Sulavik, 
1996). In Escherichia coli, the synthesis of MarA was reported to be slightly 
induced with paraquat and this could be an effect that underlines soxS-independent 
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induction of sodA in both Salmonella iyphimurium and Escherichia coli (Seoanne 
and Levy, 1995). Another E.coli protein called Rob has an N terminal domain very 
similar to SoxS and MarA (Ariza et al., 1995). It can also facilitate multiple 
antibiotic resistance. All three proteins (SoxS, MarA and Rob) activate a number of 
oxidative stress genes such as sodA. The expression of almost all genes in the soxRS 
regulon is controlled by MarA and Rob (Ariza et al., 1995; Seoanne and Levy, 
1995). 
3.1.2.3 Response to nitric oxide 
Nitric oxide (NO) occurs widely and has diverse effects. The immune system uses 
NO as a cytotoxic weapon to kill pathogens. NO is produced in activated 
macrophages by NO synthases in response to bacterial lipopolysaccharide or 
interferon y (MacMicking et al., 1997). The mechanisms by which phagocytes kill 
Salmonella are still being investigated but phagocyte NADPH oxidase has an 
important role. It was found that the early induction of phagocyte NADPH oxidase 
(phoX) results in rapid killing of Salmonella. This phase was rapidly followed by a 
prolonged plateau phase which eventually lead to clearance of the bacteria dependent 
on the subsequent production of NO (Mastroeni et al., 2000). The phagocyte 
NADPH oxidase catalyses the production of superoxide (02) that can be metabolised 
to a variety of toxic reactive oxygen species (Collins 1974). The SoxRS system is 
activated by nitric oxide. Induction of the SoxRS system provides the micro-
organism with some resistance against macrophages-generating NO (Nunoshiba et 
al., 1993). Chen et al., (1998), reported that AhpC in Salmonella typhimurium has 
antinitrosative activity that is independent of the AhpF subunit. However, the AhpF 
subunit is required for the antioxidative activity of AhpC (Chen et al., 1998). It is 
thought that some of the protective effect by the OxyR regulon may be due to its 
ability to restore thiol/disuiphide homeostasis. This basis for this has not yet been 
resolved. 
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3.2 Response to Osmotic stress 
Bacterial cells are surrounded by a cytoplasmic membrane which is freely permeable 
to water but not to most biological molecules (reviewed in Csonka, 1989). Enteric 
bacteria like Salmonella typhimurium and Escherichia coli normally maintain a 
cystolic concentration of soluble substances of approximately 300mOsm, a 
concentration greater than that of the external environment, to produce an outward 
pressure on the cell wall (turgor) (Ingraham 1987). However, when cells are exposed 
to a sudden increase in non-permeable external osmolytes, dehydration occurs 
causing the cytoplasm to shrink. Growth is inhibited, as water moves out of the cell 
into the external environment, to facilitate equilibration (Csonka and Hanson 1991). 
Water can freely permeate across the cytoplasmic membrane whilst most solutes 
cannot. Salmonella typhimurium and Escherichia coli respond to elevated osmotic 
stress by synthesising compatible solutes or by their uptake of compounds such as 
proline and glycine-betaine (Csonka and Hanson 1991). This net increase in 
cytosolic solutes raises the intracellular osmolarity, thereby restoring turgor. 
Compatible solutes are compounds that can be accumulated up to molar 
concentrations in the cytoplasm without disturbing the cellular physiology (Poolman 
and Glaasker, 1998). In general, they are polar, highly soluble molecules that usually 
do not have a net charge at physiological pH (Bremer and Kramer, 2000). These 
solutes include sugars (trehalose, sucrose), amino acids (e.g. glutamate, proline), 
amino acid derivatives (e.g. ecotine, proline betaine), and methylamines (e.g. glycine 
betaines, carnitines) (Martin et al., 1999). Glycine betaine, proline, ecotine and 
trehalose are the most widely used compatible solutes in microbes (Bremer and 
Kramer, 2000). In response to hyperosmotic stress Escherichia coli and Salmonella 
typhimurium initially accumulate potassium glutamate. This leads to the activation 
and induction of enzymes and transport systems specific for osmoregulation which 
include the two glycine betaine carriers ProU and ProP. ProU is encoded by an 
operon and is regulated mainly at the level of transcription, whereas ProP is a 
secondary sodium-dependent uptake system that is constitutively expressed and 
regulated mainly at the activity level (Crainey et al., 1985, 1985a). The pathways of 
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the uptake of glycine betaine are essentially identical in Salmonella lyphimurium and 
Escherichia coli (Higgins et al., 1988). 
The gene hns is involved in the cellular response to osmotic stress. HNS is a major 
component of chromatin in enteric bacteria and has been reported to mediate the 
signals for gene expression by changing the topology of the DNA (Higgins et al., 
1990). The major role of H-NS is to modulate the synthesis of a large number of 
gene products, mainly by negatively affecting transcription (Atlung and Ingmer, 
1997). Many of the target genes that are negatively affected by H-NS are regulated 
by environmental factors such as osmolarity, temperature, pH or growth phase 
(Atlung and Ingmer, 1997). One of the interesting target genes of H-NS is rpoS 
which encodes the RNA polymerase sigma factor cy s (Hengge-Aronis, 1996). The 
amount of cy s increases in high osmolarity, in low carbon or phosphate starvation, at 
low temperature and upon entry into stationary phase (Lange and Hengge-Aronis, 
1991). H-NS has affinity for all types of nucleic acids, but binds preferentially to 
intrinsically curved DNA or double-stranded DNA. The H-NS binding sites in 
Escherichia coli hns and Salmonella typhimurium proU are found outside the 
promoter sequences. Therefore, if H-NS is suppressing transcription by altering 
DNA structure, only H-NS-dependent structures are affected by such changes 
(Atlung and Ingmer, 1997). 
RpoS encodes the cys subunit of RNA polymerase, which is an additional regulator 
for survival against oxidative stress in E.coli. The regulation of rpoS itself has been 
shown to be affected by hns (Barth et al., 1995). The cys regulon incorporates a large 
number of genes including katG, gorA and dps, which are also controlled by OxyR 
(Altuvia et al., 1994; Becker-Hapak and Eisenstark, 1995). Expression of is firmly 
controlled at transcriptional, translational and post-translational levels (Lange and 
Hengge-Aronis, 1991). Another gene katE codes for the monofunctional catalase 
hydroperoxidase II (HP-TI) and is under the control of rpoS, which is activated in 
stationary phase cells or under various types of starvation or stress (Loewen et al., 
1985). 
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The defence mechanisms against intracellular stresses seem to result from RpoS 
inducing groups of genes. RpoS is present in exponentially growing cells, but the 
RpoS levels can increase substantially in response to osmotic stress or a number of 
other stresses (Hengge-Aronis 1993; Hengge-Aronis 1996a, 1996b). In Salmonella 
iyphimurium, when cells are starved of nutrients (for example carbon, phosphorous 
and nitrogen) the induction of a starvation stress response occurs (reviewed in Foster 
and Spector 1995; Hengge-Aronis 1996a). This is seen when cells are growing in 
rich medium to the stationary phase of growth (where the growth of cells naturally 
depletes nutrients). 
In stationary phase the response is regulated partly by an alternative sigma factor 
RpoS or (Y' (reviewed in Hengge- Aronis 1996a). Alternative sigma factors provide a 
mechanism of regulating developmental pathways or stress responses by 
reprogramming the core RNA polymerase to transcribe an alternative set of genes 
(Lonetto et al., 1992). For example, under exponential growth conditions Cr70 is the 
sigma factor employed, but during starvation it is replaced at some promoters with 
which regulates genes that are appropriate for starvation conditions (Foster and 
Spector 1995). Starved cells display defence mechanisms which protect them against 
a wide variety of environmental stresses, including heat, osmolarity, pH and 
oxidants. Stationary phase cells are considerably more resistant to H202 than actively 
growing cells (reviewed in Hengge- Aronis 1996a). 
A sigma factor called & encoded by rpoE in Escherichia coli plays a role in the 
response of the bacteria to extracytoplasmic stress (Lipinska et al., 1988). It is also 
thought that plays a role in the defense of Salmonella typhimurium against 
hydrogen peroxide (Humphreys et al., 1999). This sigma factor may also play a role 
in controlling c 32-mediated responses to hydrogen peroxide damage in the 
cytoplasm. It is not known at present, which signals lead to the activation of & in 
vivo (Humphreys et al., 1999). 
3.2.1 Involvement of AhpC in oxidative and osmotic stress 
Osmotic upshift is thought to be encountered in the intestine (Galan and Curtiss 
1990) and there exists the possibility that expression of the ahp locus could be 
induced with increased osmolarity. There is evidence for a role for the ahp locus in 
osmotic stress in both Bacillus subtilis (Antelmann et al., 1996) and Staphylococcus 
aureus (Armstrong-Buisseret et al., 1995). In the case of Staphylococcus aureus, 
when osmotically challenged, a number of proteins have been shown to increase, and 
one of these proteins exhibited 50% similarity in its amino acid sequence to 
Salmonella typhimurium ahpC. 
Experiments carried out using the pathogenic Salmonella typhimurium strains 
SL1344 and a derivative MPG203 which carries a Mudlux insertion in ahpC 
indicated that expression of ahp by MPG203 did not accurately mimic that of the 
wild type locus (Taylor, 1998). It was found as classically described, that the ahp 
locus in Salmonella typhimurium SL1344 was activated by hydrogen peroxide. 
However, in contrast, the ahp gene when tagged with Mudlux, was found to be 
relatively unresponsive to hydrogen peroxide in a low osmotic environment (Taylor, 
1997). Under low osmolarity, it seems that the lux fragment may well act to keep the 
ahp promoter in the inactive configuration, preventing access of activated OxyR and 
thereby repressing the response. The lux element therefore appeared to cause ahp to 
be predominately osmoregulated. Moreover, luminescent studies indicated that a 
combination of high osmolarity (03M) and hydrogen peroxide (100pM) resulted in 
enhanced expression of ahp. The results obtained from Western analysis of AhpC 
protein confirmed that the native ahp gene was not osmotically responsive, further 
supporting the view that the lux fragment is the cause of the anomaly (Taylor, 1998). 
Experiments on MPG203 and SL1344 showed that an LD 50 of approximately 4 logs 
was attributed to the insertion of Mudlux in MPG203 (Taylor et al., 1998). However 
in contrast, when ahpCF was directly inactivated by insertion of a chloramphenicol 
cassette, the strain was found to be as virulent as wild type SL1344. It seemed that 
attenuation of MPG203 was unlikely to be due to loss of ahp, but instead was 
mediated via the effects of the Mudlux element (Taylor et al., 1998). It may be for 
example that the induction of ahp: :Mudlux upon macrophage interaction results in a 
metabolic burden from the channelling of cellular pools of metabolites towards the 
synthesis of the lux proteins, or from overproduction of aldehyde to levels that may 
be toxic to the bacterial cell, or utilisation of NAD(P)H and FMNH in the luciferase 
reaction. The luciferase reaction occurs as follows: 
RCHO +02+ FMNH2 	No RCOOH + FMN + H20 + hv (490nm). 
R is an aliphatic moiety containing at least 7 carbons; RCHO is the aldehyde 
substrate; RCOOH is the corresponding fatty acid product; FMN is a flavin 
mononucleotide and FMNH 2 is reduced flavin mononucleotide (Olsson et al., 1988). 
The Mudlux used in the study of Taylor, also encodes a fatty acid reductase 
(encoded by 1uxCDE), which regenerates aldehyde from the fatty acid product. The 
depletion of NAD(P)H is of special importance in oxidative stress, since the ability 
to maintain a reduced cellular environment has been linked to the level of this 
compound in control of the superoxide stress response (Liochev and Fridovich 
1992). Loss of such compounds increases the susceptibility of the cell to oxidative 
stress. 
The anomalous expression of ahp when coupled with the lux reporter system 
indicates that a better understanding of the regulatory systems would be of benefit if 
the promoter is to be of value in vivo, for expression of foreign antigen. In particular, 
it is important to define whether the aberrant osmoregulation of ahp occurs via a 
transcriptional or translational mechanism. The option of this additional regulatory 
control could well prove beneficial if harnessed for in vivo expression. The chapter 
therefore aims to address the basis of this regulation. 
3.3 Results 
3.3.1 Investigation of the osnioregulation of ahpC when tagged with a Mudlux 
element 
Initially, luminometer studies were performed to confirm that expression of 
ahp::Mudlux, was as reported previously by Taylor, 1997. From the graph in Figure 
3.1 it can be seen that when MPG203 cells were treated with hydrogen peroxide and 
sodium chloride in combination, there was four fold greater induction of light 
compared to cells treated with sodium chloride. A slight induction was observed in 
response to hydrogen peroxide. Likewise, SL1344 cells were treated in the same way 
and no light was detected from the SL 1344 cells (data not shown). These findings are 
in agreement with the studies of Taylor, 1997. 
Also, as part of this study, osmoregulation of ahpC was investigated in Salmonella 
typhimurium, where the ahpC promoter and only part of the lux operon (luxAB) was 
present on a plasmid construct, pTMB1 (pBR322 derivative)-see materials and 
methods for details of construction. The plasmid was transformed into the 
Salmonella lyphimurium strain SL1344 (the parent background strain from which 
MPG203 was derived) for this study. The plasmid pTMB1 was utilised for the 
comparison of ahpC expression from the plasmid compared to ahpC expression in 
MPG203. MPG203 contains the complete Mudlux element on the chromosome 
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Figure 3.1. Osmotic induction of MPG203 in LSLB (lgfL NaCl). 
The cells were grown overnight and then diluted 1 in 1000 and grown for a further 2 hours. The cells 
were then aliquoted into 4 volumes and treated with 100iM H 202 , 03M NaCl, both in combination 
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Figure 3.2. Osmotic induction ofpTMBl in LSLB. 
The cells were grown overnight in LSLB (lgfL NaCl) and then diluted 1 in 1000 and grown for a 
further 2 hours. The cells were then aliquoted into 4 volumes and treated with 100.tM H 202, 0.3M 
NaCl, both in combination or left untreated. Light emission was detected by the Luminometer and 
recorded as relative light units (RLU). 
In the case of pTMB 1, a different result from MPG203 was obtained. It can be seen 
from Figure3.2, that light production from cells carrying pTMB1 was only induced 
with hydrogen peroxide. Light emission from pTMB 1 peaked at approximately 1 
hour after induction with a maximum light reading of 0.4, which contrasts with the 
results for MPG203 which, when induced with hydrogen peroxide had a peak value 
of 0.15. The maximum induction of MPG203 occurred when both hydrogen 
peroxide and sodium chloride were present in combination with a peak value of 1.0. 
This result suggests that the curiosity of the sodium chloride induction in MPG203, 
relates to the presence of the complete Mudlux unit (containing lux ICDABE) or due 
to the presence of the Mudlux element on the chromosome in MPG203 as a single 
copy. 
3.3.2 RT-PCR studies of ahpC and katG expression in MPG203 and SL1344 in 
grown in low salt LB (LSLB). 
In order to determine whether osmoregulation of ahpC in MPG203 occurs at the 
transcriptional level, Reverse Transcription-Polymerase Chain Reaction (RT-PCR) 
was performed. This was done on total RNA extracted from MPG203 and SL1344 
(wild-type) Salmonella typhimurium cells, using Ready-to-go beads (Amersham 
Pharmacia) that contained both the Reverse Transcriptase and Taq polymerase. 
These beads to ensure that the same amount of Reverse Transcriptase and Taq 
polymerase was used in each RT-PCR reaction. Firstly cDNA was synthesised from 
the total RNA, then heating at 95 for 5 minutes inactivated the Reverse Transcriptase 
and denatured the DNA template. The PCR reaction then proceeds using the Taq 
polymerase, and DNA was synthesised from the cDNA, The DNA was then loaded 
on gels and quantified using Image Quant. A control RT-PCR reaction was also 
performed with each sample for sertRNA, which has been used in other studies as an 
invariant control (He et al., 1993; Binnie et al., 1999) and the results were 
standardised against these volumes. 
RNA was isolated from cells grown to an optical density of 0.2 in LSLB and then 
treated with 100tM hydrogen peroxide, 0.3M sodium chloride or both in 
combination. Samples of the cells were taken at time zero, before treatment and at 2, 
5 and 10 minutes after treatment. Total RNA was extracted from the cells by using 
the Qiagen RNA kit according to the manufacturers instructions and loaded on 1.5% 
formaldehyde gels (Figure 3.3) to ensure equal concentrations were used for 
downstream RT-PCR. 
The integrity and size distribution of total RNA was checked on denaturing agarose 
gel electrophoresis and ethidium bromide staining. The respective ribosomal bands 
(25S, 23S, 18S and 16S) appear as 4 ribosomal bands on the stained agarose gel 
(figure 3.3). The RNA was quantified at an optical density of 260nm using a 
spectrophotometer and then verified by quantifying the rRNA bands using Image. 
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Figure 3.3. Total RNA extracted from cells over a period of 10 minutes, after stress 
induction. 
Cells were removed from the growing cultures at various time intervals and total RNA was extracted. 
RNA was loaded in the following order. The rRNA bands were quantified using Image- Quant to 
ensure accurate quantification: Lane loading is as follows. 
1, 2- Uninduced MPG203 and SL 1344 respectively 
9, 15- MPG203 induced with hydrogen peroxide 
10, 16- MPG203 induced with sodium chloride 
11, 17- MPG203 induced with hydrogen peroxide and sodium chloride. 
12, 18- SL344 induced with hydrogen peroxide 
13, 19- SL 1344 induced with Sodium chloride 
14, 20- SL 1344 induced with hydrogen peroxide and sodium chloride. 
RNA was extracted from MPG203 and SL1344 cells (Figure 3.4) induced with the 
various different stresses (hydrogen peroxide, sodium chloride or both in 
combination) for 2, 5 and 10 minutes. A Sample was also removed at time zero 
before induction with the stress. Initially 75ng and lSOng of total RNA was used to 
perform RT-PCR using the ahpC primers. RT-PCR was performed using the Ready-
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Figure 3.4. RT-PCR performed on MPG203 (Panels A and B) and SL1344 (Panels C 
and D) using a/ipC specific primers. 
Total RNA was extracted at time zero and 2, 5 and 10 minutes after treatment with the various stimuli 
outlined below. Primers Ahp-RT1 and Ahp-145For were used for RT-PCR and PCR respectively. 
Panels A and C are using 75ng of total RNA and Panels B and D using 150ng of total RNA. Lane 
loading is as follows: 
1: Untreated cells 
5 and 8: Cells induced with lOOj.tM hydrogen peroxide 
6 and 9: Cells induced with 03M sodium chloride 






From both the results of the RT-PCR performed on both SL1344 and MPG203 
(Figures 3.4), no major induction was observed. It seemed possible that the level of 
RNA used for RT-PCR was in excess and may have limited the reaction, so a 
titration of the total RNA used for the RT-PCR reaction was performed (Figure 3.5). 
From Figure 3.5 it can be seen that at 75ng and above, that the reaction became 
limiting and product formation remained static or declined slightly. In contrast, when 
lower levels of RNA were used, the level of product formed increased in proportion 
to the amount of RNA used in the reaction. 25ng of RNA was utilised for all 
subsequent RT-PCR reactions, to ensure that the reaction was not limited by the 
RNA concentration. 
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Figure 3.5. RT-PCR on total RNA isolated from MPG203 induced with hydrogen 
peroxide for 2 minutes using ahpC specific primers. 
A range of amounts of RNA was examined by RT-PCR to determine when saturation of the reaction 
occurred. Primers Ahp-RTI and Ahp-l45For were used for RT-PCR and PCR respectively. Samples 
were separated on a 1.2% formaldehyde gel and the results were imaged using a Mitsubishi video 
copy processor. The results are shown in Panel A. The RT-PCR products were quantified by Image 







MPG203 carries a Mudlux insertion in ahpC and it was previously found that 
expression of ahp by MPG203 did not accurately mimic previous expression 
characteristics reported for that of the wild type locus ahpC in SL1344 (Storz et al., 
1989; Taylor, 1997). The ahpC locus in Salmonella typhirnurium SL1344 is 
classically activated by hydrogen peroxide. However, in contrast, the ahp gene when 
tagged with Mudlux, was found to be relatively unresponsive to hydrogen peroxide 
in a low osmotic environment (Taylor, 1997). Therefore, the expression of ahpC was 
investigated as part of this thesis, to find if there were any differences at the level of 
transcription, between the responses of MPG203 and SL1344 cells following 
exposure to appropriate stresses. The expression of katG was also included in the 
investigation, as katG is known to be induced by exposure to hydrogen peroxide 
(Christman, 1985; Morgan et al., 1986; Francis et al., 1997; Gonalez-Flecha and 
Demple, 1997). RT-PCR was also performed using sertRNA as an internal control 
(He et al., 1993; Binnie et al., 1999). 
Initially MPG203 and SL1344 cells were grown to an optical density of 0.2 in LSLB 
and then treated with 100.tM hydrogen peroxide, 0.3M sodium chloride or both in 
combination. Samples of the cells were taken at time zero, before treatment and at 2, 
5 and 10 minutes after treatment. Total RNA was extracted from the cells by using 
the Qiagen RNA kit and 25ng of total RNA (standardised by 0D260) was used for 
subsequent RT-PCR using Ready-To-Go beads (Amersham Pharmacia Biotech). 
RT-PCR was performed using ahpC (Figure 3.6) and katG specific primers (Figure 
3.7). As an internal control, RT-PCR was also performed using a sertRNA specific 
primer (Figure 3.8). 
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Figure 3.6. The effect of H 202 NaC1 or a combination of both on ahpC expression. 
RT-PCR was performed using the two-step Ready to—Go beads (Amersham Pharmacia Biotech). 
RNA levels were adjusted based on quantification of rRNA bands on ethidium bromide stained gels 
prior to RT-PCR using Image Quant (Figure 3.3). Results of RT-PCR using ahpC primers and 25ng 
RNA are shown from cells grown in Low Salt LB (lg/L NaCl) treated by different stresses. Primers 
Ahp-RTI and Ahp-145For were used for RT-PCR and PCR respectively. RNA from MPG203 or 
SL1344 is shown in panels A and B respectively. Samples in lanes are as follows: 
1: Untreated cells 
5 and 8: Cells induced with lOOj.tM hydrogen peroxide 
6 and 9: Cells induced with 0.3M sodium chloride 
7 and 10: Cells induced with lOOj.tM hydrogen peroxide and 0.3M sodium chloride. 
Panel A: Using total RNA from MPG203 
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Figure 3.7. The effect of NaCl or H202 on expression of katG. 
RT-PCR was performed using the two-step Ready to—Go beads (Amersham Pharmacia Biotech). 
RNA levels were adjusted based on quantification of rRNA bands on ethidium bromide stained gels 
using Image Quant prior to RT-PCR (Figure 3.3). Results of RT-PCR using katG primers and 25ng 
RNA are shown from cells grown in Low Salt LB (lg/L NaCI) treated by different stresses. Primers 
KatGl-RT and KatG2 were used for RT-PCR and PCR respectively. RNA from MPG203 or SL1344 
is shown in panels A and B respectively. Samples in lanes are as follows: 
1: Untreated cells 
2,5 and 8: Cells induced with 100l.LM hydrogen peroxide 
6 and 9: Cells induced with 03M sodium chloride 
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Figure 3.8. The effect of NaCl or H 202 on expression of sertRNA. 
RT-PCR was performed using the two-step Ready to—Go beads (Amersham Pharmacia Biotech). 
RNA levels were adjusted based on quantification of rRNA bands on ethidium bromide stained gels 
prior to RT-PCR (Figure 3.3). Results of RT-PCR using sertRNA primers and 25ng RNA are shown 
from cells grown in Low Salt LB (lgfL NaCl) treated by different stresses. Primers SS-3and SS-4 
were used for RT-PCR and PCR respectively. Samples in lanes are as follows: 
1 and 2: Untreated MPG203 and SL 1344 cells respectively 
6, 9, 12, 15 and 18: Cells induced with 100l.tM hydrogen peroxide 
7, 10, 13, 16 and 19: Cells induced with 03M sodium chloride 
8, 11, 14, 17 and 20: Cells induced with 100jtM hydrogen peroxide and 0.3M sodium chloride. 
Lanes 3-5, 9-11, and 15-17: Using total RNA from MPG203 
Lanes 6-8, 12-14 and 18-20: Using total RNA from SL 1344. 
The results from the ser tRNA samples were used as an internal control for variation 
between the samples (He et at., 1993; Binnie et al., 1999). Ratios were calculated for 
the RT-PCR products for the RNA from ahpC or katG transcripts, compared to the 
ser tRNA levels prior to treatment and at 2, 5 and 10 minutes after treatment. The 
ratios for MPG203 and SL1344 (RT-PCR product/ ser tRNA product) are shown in 
Figures 3.9 and 3.10. 
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Figure 3.9. Ratios of DNA fragments obtained from RT-PCR performed on RNA 
extracted from exponential SL 1344 cells grown in LSLB. 
RT-PCR products were analysed for both ahpC and kaiG, and ratios were calculated compared with 






















induced with hydrogen pered€ 	 Induced with sodiLar :hIo 	in ndjced with hydrogen paraxide and sodium chloride 
Figure 3.10. Ratios of DNA fragments obtained from RT-PCR performed on RNA 
extracted from exponential MPG203 cells grown in LSLB. 
RT-PCR products were analysed for both ahpC and katG, and ratios were calculated from 
densitometer reading by comparison with the results for the sertRNA RT-PCR control. 
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In LSLB, ahpC in SL1344 cells were found to be induced to a certain degree when 
treated with H 202, salt, or both in combination. The highest induction of ahpC for 
SL1344 cells was recorded after 5 minutes of treatment with H 202, followed by both 
stimuli in combination. All of the induction profiles for the ahpC transcript of 
SL1344 in LSLB peaked at 5 minutes and then declined again. The katG transcript 
was induced similarly, but to a lesser degree by all stimuli in SL1344 cells grown in 
LSLB. 
In the case of MPG203 cells grown in LSLB, a similar trend was visible, where 
induction of the ahpC transcript was maximal after 5 minutes of treatment with the 
stimuli. The rate of induction was also maximal after 5 minutes, when cells were 
treated with a combination of hydrogen peroxide and sodium chloride. The lowest 
induction of ahpC was noted in cells induced with sodium chloride. Therefore, in 
both SL1344 and MP0203, the lowest rate of induction of ahpC was detected in 
cells treated with sodium chloride. However, an enhanced response was recorded in 
SL1344 and MPG203 following a combination of both sodium chloride and 
hydrogen peroxide, which was slightly more pronounced for MPG203 extracts. 
In LSLB, MPG203 cells treated with H202, salt, or with both in combination, 
demonstrated between 3-4 fold induction of katG expression (Figure 3.10). MPG203 
cells induced with salt had maximum katG expression of 4-fold after 5 minutes of 
treatment. In the luminometer experiment, when MPG203 cells were induced with 
salt, they emitted light, whereas in MPG203 cells induced with H 202, there was 
practically no light detected. Maximum light emission occurred when MPG203 cells 
were induced with both salt and hydrogen peroxide in combination (Figure 3.1) and 
this is in agreement with ahpC transcript data obtained form the RT-PCR reactions 
(Figure 3.10). The result of RT-PCR ahpC expression in MPG203 cells treated with 
hydrogen peroxide is curious, because it was higher than the ahpC expression 
obtained from MPG203 cells treated with salt (Figure 3.10). This is in disagreement 
with the results obtained from the luminometer (Figure 3.1). 
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3.3.3 RT-PCR studies of ahpC and katG expression in MPG203 and SL1344 
grown in minimal media. 
Michan et al. (1999), found that induction of gene expression in Escherichia coli of 
katG, dps, ahpCF and gorA was higher in M9 minimal medium than in LB. In this 
study, Escherichia coli cells were grown to an optical density of 0.2 in M9 minimal 
media and then induced with 10pM hydrogen peroxide for time-scales of between 5-
20 minutes. Gene expression was measured by semi-quantitative reverse 
transcription multiplex PCR (RT-MCR) using specific fluorophor-labelled primers 
(Michan et al., 1999). In minimal medium, it was found that ahpC and katG were 
induced 3.3-fold and 12.9-fold respectively with lOj.iM H202 (Michan et al., 1999). 
In the study outlined in the previous section, gene expression of ahpC and katG was 
investigated after treatment of MPG203 and SL1344 cells grown in LSLB with 
hydrogen peroxide, sodium chloride or both in combination. The highest induction 
in niRNA levels of 6.5-fold compared to time zero of ahpC, was recorded after 
MPG203 cells were treated with hydrogen peroxide and sodium chloride for 5 
minutes (Figure 3.10). In SL1344, the highest induction of 6-fold of ahpC mRNA 
was recorded after induction with hydrogen peroxide for 5 minutes. A 5-fold 
induction of ahpC extracted from SL1344 cells treated with hydrogen peroxide and 
salt in combination was also noted (Figure 3.9). The possibility existed, that a greater 
expression of the genes in question may be seen, if the cells are grown in minimal 
medium prior to treatment. Firstly, a luminometer experiment was performed, to 
assess the response of MPG203 (ahpC::Mudlux) when grown in minimal media and 
exposed to H202, NaCl or in a combination of these. MPG203 cells were grown to 
an optical density of 0.2 at 600nm as before and then the culture was split into four 
different aliquots. A sample was removed prior to and after the various treatments. 
The cells where then added to a microtitre plate and analysed in the luminometer. 
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Figure 3.11. Osmotic induction of MPG203 in M9 minimal media 
The cells were grown overnight and then diluted I in 1000 and grown until they reached an optical 
density of 0.2. The cells were then aliquoted into 4 and treated with l00tM H 202 , 0.3M NaCl, both in 
combination or left untreated. Light emission was detected by the Luminometer and recorded as 
relative light units (RLU). 
From the graph, it can be seen that MPG203, when grown in M9 minimal media, 
displays a similar expression profile in response to treatment as similarly treated 
MPG203 cells grown in LSLB. In minimal media, MPG203 cells were not induced 
to any detectable level with 100tM H 202, but were induced slightly with 0.3M NaCl 
(Figure 3.11) A similar trend was noted for MPG203 cells when grown in LSLB 
(Figure 3.1). MPG203 cells grown in minimal media were induced approximately 
4.5 fold when treated with lOOp.M H 202 and 0.3M NaCl in combination compared to 
a 5 fold induction following a combination of H 202 and NaC1 in LSLB (Figure 3.1). 
Since a similar trend was detected in the luminometer with regard to the induction of 
ahpC with the various treatments, RT-PCR analysis was therefore performed. 
MPG203 and SL 1344 cells were grown in minimal media to an optical density of 0.2 
at 600nm. The cultures were then split into four and one was left untreated. The 
others were treated with either lOOp.M H 202 , 0.3M NaCl, or both hydrogen peroxide 
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and salt in combination. The untreated sample was regarded as the time zero sample, 
while samples were taken from the other cultures at 2, 5 and 10 minutes after 
treatment with the various stimuli. RNA was extracted from all the samples using the 
Qiagen RNA kit as before. Initially RNA (Figure 3.12) was quantified following 
electrophoresis using Image Quant, then normalised and RT-PCR was performed 
using the Ready-To Go beads (Amersham Pharmacia Biotech), utilising ahpC 
(Figure3.13), katG (Figure 3.14) and sertRNA (Figure 3.15) specific primers. 
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Figure 3.12. Responses of SL1344 and MPG203 cells to H202, NaCl or the 
combined stresses. 
Total RNA was extracted from cells over a 10 minutes induction period following different 
treatments. Cells were grown to an optical density at 600nm of approximately 0.2. The rRNA bands 
were quantified using the densitometer and samples were adjusted to ensure accurate quantification of 
the RNA before RT-PCR. Sampling times after exposure to the stimuli are indicated above the 
samples. Lanc loading is as follows: 
1,7 and 13 - MPG203 induced with hydrogen peroxide 
2, 8 and 14 - MPG203 induced with sodium chloride 
3,9 and 15 - MPG203 induced with both in combination. 
10 and 16— SL 1344 induced with hydrogen peroxide 
11 and 17- SL 1344 induced with sodium chloride 
12 and 18 - SL1344 induced with both in combination. 
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Figure 3.13. The effect of NaCl, H 202 or a combination of both on expression of 
ahpC. 
RT-PCR was performed using the two-step Ready To Go RT-CPR beads (Amersham Pharmacia 
Biotech). RNA levels were adjusted based on quantification of rRNA bands on ethidium bromide 
stained gels prior to RT-PCR (Figure 3.12). Results of RT-PCR using ahpC primers and 25ng RNA 
are shown from cells grown in M9 minimal media and treated with different stimuli. Primers 
Ahp-RT1 and Ahp-145For were used for RT-PCR and PCR respectively. RNA from MPG203 or 
SL1344 is shown in panels A and B respectively. Samples in lanes are as follows: 
1: Untreated cells 
2.5 and 8: Cells induced with lOOj.tM hydrogen peroxide 
3. 6 and 9: Cells induced with 0.3M sodium chloride 
4, 7 and 10: Cells induced with I00iM hydrogen peroxide and 0.3M sodium chloride. 
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Figure 3.14. The effect of NaCl, H202 or a combination of both on expression of 
katG. 
RT-PCR was performed using the two-step Ready To Go RT-PCR beads (Amersham Pharmacia 
Biotech). RNA levels were adjusted based on quantification of rRNA bands on ethidium bromide 
stained gels prior to RT-PCR (Figure 3.12). Results of RT-PCR using katG primers and 25ng RNA 
are shown from cells grown in M9 minimal media and treated with different stimuli. Primers 
katG 1-RI and KatG2 were used for RT-PCR and PCR respectively. RNA from MPG203 or SL1344 
is shown in panels A and B respectively. Samples in lanes are as follows: 
1,2: Untreated cells (25ng and 50ng) 
6 and 9: Cells induced with 100.tM hydrogen peroxide 
7 and 10: Cells induced with 0.3M sodium chloride 
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Figure 3.15. The effect of NaCl, H 202 or a combination of both on expression of 
sertRNA. 
RT-PCR was performed using the two-step Ready to Go RT-PCR beads (Amersham Pharmacia 
Biotech). RNA levels were adjusted based on quantification of rRNA bands on ethidium bromide 
stained gels prior to RT-PCR (Figure 3.12). Results of RT-PCR using sertRNA primers and 25ng 
RNA are shown from cells grown in M9 minimal media and treated with different stimuli. 
Primers SS-3 and SS-4 were used for RT-PCR and PCR respectively. RNA from MPG203 or 
SL 1344 is shown in panels A and B respectively. Samples in lanes are as follows: 
1: Untreated cells 
2,5 and 8: Cells induced with 100l.LM hydrogen peroxide 
6 and 9: Cells induced with 03M sodium chloride 
7 and 10: Cells induced with 1004M hydrogen peroxide and 0.3M sodium chloride. 
Specific primers for ahpC, katG and ser tRNA were used for the RT-PCR procedure 
and products were measured by densitometer analysis. Ratios were calculated for the 
RT-PCR products for RNA from ahpC and katG transcripts, correcting for the 
sertRNA levels in each case using Image Quant (Figures 3.16 and 3.17). The results 
from the studies in LSLB and minimal media are expressed numerically in table 3.1 
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Figure 3.16. Ratios after RT-PCR performed on total RNA extracted from 
exponential SL 1344 cells grown in Minimal media. 
RT-PCR products were analysed for both ahpC and kaiG and ratios were calculated compared with 
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Figure 3.17. Ratios after RT-PCR performed on total RNA extracted from 
exponential MPG203 cells grown in Minimal media. 
RT-PCR products were analysed for both cihpC and kaiG and ratios were calculated compared with 







ahpC katG ahpC katG 
LSLB Minimal LSLB Minimal LSLB Minimal LSLB Minimal 
Untreated 0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 
Hydrogen 2 4.4 0.5 2.4 1.0 2.8 1.3 2.0 0.6 
peroxide 5 8.1 1.1 3.5 3.3 3.3 0.4 3.7 0.2 
10 4.1 1.1 2.5 3.5 2.2 4.7 4.1 2.8 
Sodium 2 3.0 1.0 2.4 4.6 0.8 0.6 1.8 0.3 
Chloride 5 3.7 0.7 1.8 2.3 2.0 0.9 5.0 0.5 
10 0.9 1.8 1.1 11.4 0.5 2.8 1.6 3.8 
Both in 2 5.0 2.4 2.4 4.0 3.4 1.5 3.4 0.7 
combination 5 7.0 0.5 3.0 2.6 5.9 0.1 4.0 0.1 
10 2.2 4.0 1.6 4.0 2.1 37 2.9 22 
Table 3.1. Summary of the fold induction of ahpC and katG in MPG203 and 
SL1344, compared to time zero for all the treatments in LSLB and minimal media. 
These results are a summary of figures 3.9 and 3.10 (for LSLB) and figures 3.16 and 3.17 (for 
minimal media). The fold induction was calculated by dividing the sample/sertRNA ratio at each 
particular treatment and time, by the ratio for the untreated samples at time zero. (E.g. Fold induction 
of the ahpC transcript of MPG203, grown in minimal media after treatment with salt and hydrogen 
Peroxide in combination for 10 minutes was 37 fold (302.5/8.18). The untreated sample was then 
given a value of 1(8.18/8.18) for the above comparison. 
It can be seen from table 3.1, for SL1344 cells grown in LSLB, ahpC was induced to 
a certain degree when induced with H 202, salt, or both in combination. The highest 
induction of 8.1 fold for ahpC for SL1344 cells was recorded after treatment with 
H202, whereas cells treated with salt or combination were elevated 3.7-fold and 7.0-
fold respectively. All of the induction profiles for the ahpC transcript of SL1344 in 
LSLB peaked at 5 minutes and then declined again. The katG transcript was also 
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induced, but to a lesser degree by all stimuli for SL1344 cells grown in LSLB. The 
profiles peaked after 5 minutes of treatment with hydrogen peroxide or a 
combination of both sodium chloride and hydrogen peroxide, with a 3.5 fold and 3 
fold induction respectively. In the case of treatment with sodium chloride the cells 
were induced 2.4 fold compared to untreated SL1344 cells, but the response declined 
more rapidly 
In the case of MPG203 cells grown in LSLB, a similar trend was visible, where 
induction of the ahpC transcript was maximal after 5 minutes of treatment with the 
stimuli. The level of induction varied at 5 minutes between 2 fold for cells induced 
with salt, to 3.3-fold and 5.9-fold for H202 exposure or a combination of sodium 
chloride and hydrogen peroxide respectively. Therefore, in both SL1344 and 
MPG203, the lowest rate of induction of ahpC was visible in cells treated with 
sodium chloride. However, an enhanced response was seen in SL1344 and MPG203 
following a combination of both sodium chloride and hydrogen peroxide. In 
MPG203 cells treated with H202 or with both salt and H 202 in combination, a 4-fold 
induction of the katG transcript was observed in both scenarios. MPG203 cells 
induced with salt had maximum katG expression of 5-fold after 5 minutes of 
treatment. 
- 	Overall, the results in - LSLR were slightly -suprising as it was expected that the 
induction of ahpC would be more pronounced in cells induced with salt compared 
with H202 (Figure 3.10), in line with the luminometer data (Figure 3.1). In the 
luminometer experiment, when MPG203 cells were induced with salt, they emitted 
light, whereas in MPG2O3 cells induced with H 202, there was practically no light 
detected. Maximal light emission occurred when MPG203 cells were induced with 
both salt and hydrogen peroxide in combination (Figure 3.1) and this is in agreement 
with ahpC transcript data. Nevertheless, it is perhaps surprising that a more 
pronounced increase in ahpC transcript did not occur in MPG203 cells when grown 
in LSLB treated with both sodium chloride and hydrogen peroxide, in line with the 
luminometer data (Figure 3.1). Wei et al., (2001), used micro-arrays to look at 
differences in gene-expression caused by growth of Escherichia coli in minimal or 
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rich medium and associated changes with the transition from exponential to 
stationary phase growth in minimal media. They found that fewer genes were 
expressed in LB compared to minimal media and that the fraction of rare transcripts 
detected in cells grown in LB was small. The majority of the highly expressed genes 
detected in LB, encoded proteins involved in translation and protein folding (Wei et 
al., 2001). The results from the RT-PCR (Table 3.1) performed on total RNA 
extracted from MPG203 and SL1344 cells grown in minimal media revealed a 
number of differences compared with LSLB grown cells, when treatments were 
applied. 
For SL1344 cells grown in minimal media, there was only a slight increase in the 
ahpC transcript levels, compared with time zero, for cells induced with either H202 
or salt, with a maximum of 1.8 fold induction occurring after 10 minutes in sodium 
chloride treated cells. The maximum induction of ahpC was noted in SL1344 cells 
induced with a combination of both salt and hydrogen peroxide, with a 2 fold 
induction after 2 minutes, which increased to 4 fold after 10 minutes. However, there 
was a noticeable decline, below the level of untreated cells at 5minutes, which is 
difficult to explain. 
The results of the RT-PCR for katG niRNA from SL1344 cells grown in minimal 
medium, showed an average increase of 3.5-fold for cells treated with H 202. An 
increase of 4-fold at 5 minutes for cells induced with a combination of both salt and 
H202 was also recorded. However, the largest increase was detected after 10 minutes 
of induction with salt, with an increase of 11.4-fold compared with untreated cells. 
Overall, the response in minimal media for katG expression appears delayed by 
treatments and it remains to be determined whether higher induction would be 
observed over a larger time period. It is notable that compared to time zero, there 
was also a decrease in katG mRNA after 5 minutes of treatment with salt or a 
combination of salt and hydrogen peroxide, which then increased again after 10 
minutes. 
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In the case of MPG203 grown in minimal medium, the ahpC RT-PCR products were 
maximum after 10 minutes of treatment with the various stimuli. There was a 4.7-
fold and 2.8-fold increase in transcript levels in H 202 or salt induced cells, 
respectively. Moreover, an increase of 37 fold was recorded for the RT-PCR product 
of cells treated with a combination of both salt and H 202 . However, it was noted that 
in MPG203 cells, the level of induction remained at or below the levels recorded for 
untreated cells until after 10 minutes of treatment with the various stimuli. 
Therefore, in minimal medium the response to the stimuli would appear to be 
induced more slowly. This is in accordance with the observed delay in luminescence 
from MPG203 cells in minimal medium after treatment (Figure 3.11), although the 
significance of this observation remains to be established. 
In MPG203 cells grown in minimal medium, katG increased by 2.8 fold and 3.8 fold 
in cells treated with either H 202 or salt respectively. Cells treated with a combination 
of both salt and H202 had a factor of induction of approximately 22-fold compared 
with untreated cells. With minimal media, the maximum induction of katG in 
MPG203 cells was also recorded after 10 minutes of treatment, in agreement with 
similar observations for SL1344. This suggests that the response is delayed for both 
cell types cells when grown and treated in minimal medium. However, it has been 
noted, that after 2 minutes and 5 minutes of treatment in MPG203 cells, there is a 
decrease in the ratio of katG:sertRNA induction in minimal media when compared 
with untreated cells. A possible explanation for these low values could be attributed 
to small fluctuations in the levels of ser tRNA (figure 3.15). 
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3.4 Discussion 
In Salmonella typhimurium and Escherichia coli, AhpCF is a heterodimeric protein 
encoded by the ahp operon, which is required for the elimination of alkyl 
hydroperoxides by their reduction to their corresponding alcohol (Caizi and Poole, 
1997). AhpC reduces physiological lipid peroxides such as linoleic acid, 
hydroperoxide and thymine hydroperoxide and other non-physiological 
hydroperoxides to their respective non-toxic alcoholic form (Jacobson et al., 1989). 
AhpC acts as a specific alkyl hydroperoxide-scavenging enzyme for protection 
against oxygen radical damage. In turn, AhpF uses NADH or NADPH as electron 
donor to restore AhpC to a reduced state (Jacobson et al., 1989). In the presence of 
excess oxidised oxygen radicals, AhpF becomes a limiting factor in the reduction of 
AhpC (Poole and Ellis, 1996). Furthermore, AhpC is specifically reduced by AhpF 
and cannot be reduced by other electron transport systems such as thioredoxin 
reductase (Calzi and Poole, 1997). Another study highlighted that AhpC in 
Salmonella typhimurium requires AhpF to detoxify alkyl hydroperoxides, whereas 
defence against reactive nitrogen intermediates does not involve AhpF (Chen et al., 
1998). 
Experiments previously carried out using the pathogenic Salmonella typhimurium 
strains SL1344 and a derivative MPG203 which carries a Mudlux insertion in ahpC 
indicated that expression of ahp by MPG203 did not accurately mimic that of the 
wild type locus (Taylor, 1997). When the ahp gene was tagged with Mudlux, it was 
found to be relatively unresponsive to hydrogen peroxide in a low osmotic 
environment (Taylor, 1997 1) , whereas the ahp lOCUS in Salmonella .'yphimuriuin 
SL1344 was activated by hydrogen peroxide as expected. The lux element therefore 
appeared to cause ahp to be predominately osmoregulated and luminescent studies 
indicated that a combination of high osmolarity (0.3M) and hydrogen peroxide 
(10O.xM) resulted in enhanced expression of ahp (Taylor, 1997). In this study the 
aberrant regulation of ahpC when tagged with the Mudlux element was investigated 
further. RT-PCR studies using ahpC specific primers was carried out, to see if the 
response at the level of RNA was similar to the results obtained from the 
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luminometer studies. Since katG is also induced with hydrogen peroxide, RT-PCR 
studies were also performed for the transcript for cells grown in both low salt LB 
(LSLB) and minimal media, to determine if a similar trend to ahpC expression 
occurred and, if the trend was similar for both SL1344 and MPG203. Overall, these 
studies were performed to investigate if it was the Mudlux element present in 
MPG203 that mediated the osmoregulation or caused modification of ahpC 
expression. 
Initially a plasmid pTMB 1 was constructed that contained the ahpC promoter and 
only luxAB, to see if a similar response to MPG203 was recorded after the cells were 
induced with hydrogen peroxide and sodium chloride. Luminometer experiments 
were carried out where the cells were grown to exponential phase and then left 
untreated or induced with 100.tM hydrogen peroxide, 0.3M sodium chloride or both 
in combination (Figures 3.1 and 3.2). In the case of pTMB1, a different result from 
MPG203 was obtained. It can be seen from Figure 3.2, that light production from 
cells carrying pTMB1 was only induced with hydrogen peroxide and did not show 
significant osmoregulation, nor was the response subsequently elevated by a 
combination of H 202 and NaCl. In contrast, maximal induction of MPG203 occurred 
when both hydrogen peroxide and sodium chloride were present in combination. 
This result suggests that the curiosity of osmoregulation in MPG203, relates to 
components in the larger Mudlux unit (containing lux I, CDABE) or related to the fact 
that the Mudlux resided on the chromosome in MPG203 as a single copy element. 
In order to determine whether osmoregulation of ahpC in MPG203 occurs at the 
transcriptional level, RT-PCR was performed. Initially both MPG2O3 and SL1344 
(wild-type) Salmonella typhimurium cells, were grown in low salt LB (LSLB), 
which was the media that was used for the original luminometer studies. Cultures 
were grown to an optical denisty of 0.2 at 600nm and then induced with the range of 
stimuli. Samples were removed at time zero and then 2, 5 and 10 minutes after 
- 	- addition of the stimulus. Total RNA was extracted from MPG203_and SL1344 cells 
- 	- 	uingRady-1&-go beads (Anirsharn Pharmacia, and theiiRT:PCR was 5fôrrned 
on the RNA. 
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- In LSLB, ahpC from SL1344 is induced approximately 8-fold when induced -  with 
H202 and induced 7-fold when induced with a combination of both H 202 and salt 
(Table 3.1). The expression of ahpC in SL1344 cells grown in LSLB, induced by 
sodium chloride peaked at a maximum of 3.7 fold (Table 3.1). Therefore, ahpC 
expression was not enhanced with a combination of both H 202 and salt, but instead 
was maximum after treatment with hydrogen peroxide (Figure 3.10). However, in 
the case of MPG203 cells grown in LSLB, ahpC was induced nearly twice as much 
by a combination of both H 202 and salt (3.3 fold to 5.9 fold respectively) compared 
-with .H202alone (Table 3.1). However, the induction of ahpC expression-in MPG203 
cells by salt was 2-fold compared with untreated cells. This suggests that ahpC 
expression in MPG203 is induced a certain degree with both salt and hydrogen 
separately, but is enhanced when the cells are induced with a combination of both 
stimuli (Figure 3.10). It is worth noting that ahpC expression was higher in SL1344 
cells reaching a maximum of 8.1 (induced with hydrogen peroxide), whereas the 
maximum induction of MPG203 cells was 5.9 (induced with a combination of 
sodium chloride and hydrogen peroxide). Therefore, it could be suggested that the 
Mudlux element present in MPG203 is causing a slight reduction in ahpC 
expression, or due to the expression studies being investigated after growth of the 
cells in LSLB. 
In LSLB, katG expression is relatively consistent for cells treated with each of the 
different stimuli. The peak induction of katG in SL1344 cells ranged between 2.4 
fold and 3.5 fold compared to time zero (Table 3.1). A similar trend was visible in 
MPG203 where the peak induction of katG varied between 4.1 fold and 5 fold 
(Table 3.1). However, it was noted that katG induction was maximum in MPG203 
cells treated with salt (5 fold) whereas in SL1344 cells, maximum ahpC expression 
was noted in cells treated with hydrogen peroxide (3.5 fold). 
In minimal media, maximal induction occurred when MPG203 cells were treated 
with both stimuli, whereas in SL1344 cells, the highest induction was noted in salt 
treated cells (Figure 3.16 and 3.17). Moreover, in minimal media, katG, expression 
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ranged between 3.5-11.4 fold in SL1344 cells and 2.8 -22 fold in MPG203 cells 
(Table 3.1). It is worth remembering that MPG203 was derived from the parent 
strain SL1344 by P22 transduction of ahpC::Mudlux. Therefore, the RT-PCR results 
- TOokingiiat. kátQ xprcssThñ Were R ëcted to biiilãr for bQthSL1344rid - 
MPG203. However, from the time-course it would appear that the response may not 
have peaked and is still rising, so it is difficult to predict the exact outcome. The 
luminometer data from MPG203 cells grown in minimal media (Figure 3.11) 
induced with the different stimuli is in agreement with the results from the RT-PCR 
reactions. There was a delay in the production of light from any of the MPG203 cells 
until approximately 20 minutes after exposure to the stimuli, and the light production 
peaked between 40 minutes and 1 hour and then started to decline. Therefore, this 
suggests that there is a difference in the induction of both genes (ahpC and katG) 
when LSLB and minimal media are compared. 
Looking at the RT-PCR data as a whole, certain trends are visible. MPG203 cells 
were induced to a maximal level in LSLB, when cells were induced with a 
combination of salt and hydrogen peroxide (Table 3.1). The lowest induction for 
MPG203 cells grown in LSLB or minimal media was recorded in cells treated with 
salt (Table3.1). In comparison, from the luminometer data, MPG203 showed 
maximal induction after treatment with salt and hydrogen peroxide. Induction was 
substantially less with salt, but was slightly more than observed with hydrogen 
peroxide alone in LSLB and to a lesser extent, in minimal media (Figures 3.1 and 
3.11). Hence, there is a discrepancy between the induction of ahpC by salt in 
MPG203 between the luminometer data and the RT-PCR data. In agreement with 
this, the ahpC transcript from SL1344, which is the parent strain (from which 
MPG203 was constructed), was induced most highly when cells, grown in LSLB 
were induced with both salt and hydrogen peroxide in combination. This may 
indicate a degree of post-transcriptional regulation occurring in MPG203. 
The gene encoding AhpC was first identified from studies on Salmonella 
typhimurium and Escherichia coli as a protein induced by oxidative stress under the 
control of OxyR (Jacobson et al., 1989; Storz et al., 1989; Tartaglia et al., 1990). It 
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has been shown that the ahpC locus plays an important role in protecting both of 
these organisms against mutagenic alkyl hydroperoxides (Storz et al., 1989). Wei et 
al., (2001), looking at gene-expression in Escherichia coli using micro-arrays, found 
that fewer genes were expressed in LB medium compared to minimal media, as cells 
made a transition from exponential phase growth to stationary phase growth. In LB, 
the most highly transcribed genes in actively growing cells often encode proteins 
involved in translation, whereas in minimal media many more biosynthetic genes are 
activated. They also found an increased expression of several rpoS controlled genes 
in the transition from exponential to stationary phase (Wei et al., 2001). Micro-array 
analysis performed on the response of wild-type Escherichia coli MG 1655 grown in 
LB and induced with 1mM H 202 for 10 minutes, found that both ahpC and katG 
were induced 20-fold and 44-fold respectively (Zheng et al., 2001). It is of note that, 
in the experiments outlined in this thesis, the cells were induced with lOOp.M H 202 
in LSLB (LB with a low salt content -lgfL) and these differences provide an 
explanation for the low induction observed, in LSLB compared with minimal media. 
A number of other studies have examined expression of ahpC or katG. Previously, 
Michan et al. (1999), reported that induction of gene expression for ahpC, katG, 
gorA and dps in Escherichia co/i K-12 was higher in M9 minimal medium than in 
LB. In this study, Escherichia coli cells were grown to an optical density of 0.2 at 
600nm and then induced with 10iM hydrogen peroxide over a period of 20 minutes. 
In minimal media, it was found that ahpC and katG were induced 3.3-fold and 12.9-
fold respectively with 10tM H 202 within 5 minutes and then expression started to 
decline (Michan et al., 1999). In an alternative study using micro-array technology, it 
was shown that ahpC was highly expressed in Escherichia co/i cells in minimal 
medium, but this was not the case in cells grown in LB (Wei et al., 2001). In 
Escherichia co/i (wild-type), ahpC was found to be induced to a maximum of 
approximately 6- fold and katG was induced to a maximum of 15-fold. These cells 
where grown in minimal media to an optical density at 600nm of 0.2 and induced 
with lOOp.M H202 for one minute before isolation of RNA and detection of 
transcripts by multiplex PCR (Manchando et al., 2000). 
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The results from the RT-PCR (Table 3.1) do not agree with the result from the 
luminometer, which previously suggested that MPG203 was induced to a higher 
degree with salt and became initially unresponsive to H202 alone in LSLB (Figure 
3.1). In Escherichia coli K-12 cells, induction of katG and ahpCF was found to 
occur in response to increased osmolarity (500mM NaC1). However, the response 
was not as fast in 500mM NaCl (10-15 minutes), as induction with H 202 (within 1-
5minutes), when cells were grown to an 0D 600 of 0.2, prior to treatment (Michan et 
al., 1999). A 3-fold increase in expression of ahpCF relative to untreated cells was 
not visible until 15 minutes after the same level of osmotic upshift. In comparison, 
induction of katG and ahpC was 12.9 and 3.3 fold respectively within 5 minutes of 
induction with 10xM H202. No further time-points were reported, so -it is not know if 
ahpCF gene expression had peaked in this study (Michan et al., 1999). This is in 
agreement with the RT-PCR results obtained in this thesis. Expression of ahpC in 
SL1344 cells (wild-type) grown in LSLB, where induced 8.1 fold with hydrogen 
peroxide compared with 3.7 fold when induced with salt within the first 5 minutes of 
treatment (Table 3.1). 
In the present study when MPG203 was grown in minimal medium, the RT-PCR 
products remained below or around background levels at 2 and 5 minutes for all 
conditions and then started to increase after 10 minutes. Also, with the luminometer 
data, in minimal media, light emission occurred after 20 minutes, whereas in LSLB 
light emission started to occur after the initial stimulus was added. Therefore, the 
points at which the RNA was analysed could also be a factor in the differences in the 
results in the LSLB and minimal media for the RT-PCR results. Perhaps, if RNA 
was analysed over a longer time-span, a clearer picture of the induction of both these 
genes with salt could become more visible. 
The active process where by an organism responds to the osmolarity of its 
environment is termed osmoregulation (Csonka, 1989). To survive osmotic stresses, 
bacterial cells need to adapt by accumulating specific compatible solutes under 
hyperosmotic conditions and then releasing them under hypoosmotic conditions. 
Such solutes include potassium (K), amino acids (proline, glutamate), quaternary 
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amines (glycine betaine, carnitine) and sugars (sucrose, trehalose). These solutes can 
be accumulated to high levels by de novo synthesis or transport, without interfering 
with vital cell processes (Csonka, 1989a). This net rise in solutes raises the 
osmolarity of the cytoplasm and restores turgor. 
Hyper-osmotic. stress -results in increased -intracellular. K in Escherichia coli and 
- concomitant changes in supercoiling fesult in pro Uexrëssion (Higgins et al., 187). 
The proU operon (proVWX) encodes a high-affinity binding protein-dependent 
transporter for betaine with some affinity for proline. The ProP and ProU proline 
transport systems are responsible for the accumulation of proline to high levels 
(Cairney et al., 1985; Csonka, 1989). A sudden osmotic shock causes a rapid 
induction of proU transcription up to 100 fold in both Salmonella typhimurium and 
Escherichia coli. ProP and ProU were found to be enhanced by 2-10 fold and 100 
fold respectively, in media of elevated osmolarity (Dunlap and Csonka, 1985). 
Optimal activation of ProP and ProU transport systems in Escherichia coli occurs at 
0.2M and 0.3M NaCl respectively (Koo et al., 1991; Bremer and Kaemer, 2000). It 
has been suggested that glycine-betaine is much more potent as an osmoprotectant 
than proline (Csonka, 1989). 
An increase in osmolarity leads to an immediate increase in the intracellular 
potassium and glutamate concentrations and an increase in DNA negative 
supercoiling (Higgins et al., 1988; Atlung and Ingmer, 1997). The nucleoid-binding 
protein HNS (component of bacterial chromatin) plays an important role as a 
modulator of expression of proU (Higgins et al., 1988: Atlung and Ingmer, 1997). It 
has been reported, that the in vivo osmotic induction of the proU promoter might be 
mediated by a combination of increased intrinsic promoter activity (due to an 
increase in supercoiling and potassium concentration) and a partial relief of H-NS 
repression due to the increased potassium concentration (Atlung and Ingmer, 1997). 
The expression of proU is repressed in medium of low osmolarity by the presence of 
a downstream regulatory element (DRE), which exists in the coding sequence of the 
first gene of the polycistronic operon, proV (Owen-Hughes et al., 1992). In one 
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study, the pro  promoter was fused to either luxAB or lacZ, and expression of these 
constructs was compared. In the pro U-lacZ fusion, expression of the proU promoter 
occurred even under low osmolarity. In contrast, when luxAB was used as the 
reporter system, the proU promoter behaved as in the wild type situation and was 
repressed under low osmolarity and induced 10 fold at high osmolarity 
(Owen-Hughes et al., 1992; Forsberg et al., 1994). However, it is note-worthy that in 
this study the proU promoter did not contain the DRE, which is thought to be 
-necessary to keep the promoter  in a repressed state during low osnio1rity. ThuS, 
luxAB appeared to substitute for the absence of a DRE and mediate repression in low 
osmolarity. 
Activation of proU correlates with increases in DNA supercoiling. The DRE 
elements in proU and luxAB have been shown to bind H-NS (Owen-Hughes et al., 
1992). Therefore, in low osmolarity binding of H-NS to the DRE or luxAB, causes 
the proU promoter to be inflexible and thereby prevents an interaction between RNA 
polymerase and the promoter (Jordi et al., 1995). However, previously the effect of 
the lux system on the ahp locus was shown to be H-NS independent, but the strain 
carried a mild H-NS mutation (Taylor, 1997). Thus, in that case some functional H-
NS could still have been present. Alternatively, another factor such as the H-NS 
paralogue StpA, may have mediated this effect. It has been suggested that StpA 
exhibits similar DNA-binding activities to H-NS, and both H-NS and StpA have 
-been shown to have a preference for binding to- curved DNA (Sonnenfield et al., 
2001). 
The lux element is inserted within the ahp locus of MPG203 carries 1uxCDABE 
from Vibrio fischeri, flanked by Mu phage sequence (Engerbrecht et al., 1985). In 
this scenario, luxA is approximately 4Kb downstream from the 5' end of Mudlux 
element and so, is at least that distance from the beginning of the ahpC transcript. 
Thus if curvature in luxA is responsible for the anomalous behaviour of the ahp 
locus, it must act over a sizeable distance. A transcriptional fusion to the luxAB 
genes on a plasmid (pTIVIB1) places the luxA gene directly adjacent to the region of 
DNA of interest. In this case (figure 3.2), no osmoregulation of ahpC was detected. 
130 
However, the importance of the spacing of this phenomenon remains to be 
determined. Curvature of DNA by the lux element in MPG203 cannot be the only 
explanation for the results seen from the luminometer and the RT-PCR. Expression 
of ahpC in SL1344 was also seen to be induced with salt after growth in both LSLB 
and minimal media, although SL1344 does not contain the lux element (Table 3.1). 
- Whether other factors such as the DNA binding proteins -IHF, HU or FIS, which are 
known to influence supercoiling or topology of DNA (Dorman and NiBhriain, 1992) 
play a role in the ahp phenomenon also remains unknown. Thus, the lux element 
may act as a modulator of the osmotic control system, perhaps in conjunction with 
another, as yet unidentified component. 
The way in which luxAB elicits unnatural behaviour from genes is not entirely clear, 
but this phenomenon has been reported using lux genes from Vibrio harveyi and 
Vibrio fischeri (Owen-Hughes et al., 1992; Forsberg et al., 1994). LuxA contains a 
tract of adenine residues in the first 200 nucleotides, and it has been suggested that 
this may cause the DNA to curve. It has been shown that curved DNA influences the 
promoter activity of genes and this can be facilitated by the nucleoid-binding protein 
H-NS (Hulton et al., 1990; Owen-Hughes et al., 1992). H-NS is considered to act 
like a scaffold binding curved sequences of DNA, holding the DNA in a particular 
configuration, thereby affecting the local topology of the DNA (Yamada et al., 
1990). - - 
It has been documented that H-NS controls a number of Scontro1led  genes. H-NS 
was found to increase the cellular content of cys  per se by more than ten-fold 
(Yamashino et al., 1995). Also, it has been suggested that cy
s can relieve 'r'1-NS 
repression of certain promoters (Olsen et al., 1993). Mechthild et al., (1995), 
demonstrated that under hyperosmotic shock, repression of DNA bound by H-NS 
(due to the release of H-NS) was relieved due to the accumulation of K ions in 
E.coli. The RpoS —encoded cys subunit of RNA polymerase is important for the 
expression of a number of genes induced under stress, including osmotic stress. 
Furthermore, RpoS levels can increase substantially even in exponential phase in 
response to osmotic stress or other stresses (Hengge-Aronis 1993; Hengge-Aronis 
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1996a, 1996b). It could be suggested that in this experiment, katG is induced in 
response to osmotic stress via elevation of RpoS. However, the ahp locus of 
Salmonella typhimurium is not thought to be influenced to any degree by RpoS 
(Taylor, 1997). It has been reported that, in cells grown exponentially, levels of a s 
are low normally because of continuos proteolysis. The half-life of Cys of exponential 
Escherichia coli cells is in the range of 1-4 minutes. However, after a shift to high 
osmolarity, cys is stabilised (Muffler et al., 1996). The corresponding situation for 
Salmonella typhimurium has not been reported. 
Studies of a SoxRS-regulated micF::1uxCDABE fusion, looking at soxS transcript 
levels, suggested that SoxR is activated by hydrogen peroxide, suggesting an overlap 
between the superoxide and peroxide responses of Escherichia coli (Belkin et al., 
1997). Zheng et al. (2001), found that soxRS was also induced with hydrogen 
peroxide. Another study suggested that soxR in Escherichia coli was activated by 
high concentrations of hydrogen peroxide (Manchando et al., 2000). This contrasts 
with previous studies, which reported that H 202 was unable to switch on the SoxRS 
regulon in Escherichia coli (Greenberg and Demple, 1989) and that induction of 
soxS was shown to be apparently due to a superoxide by-product of the luciferase 
reaction (Gonzalez-Flecha and Demple, 1994). Another study looking at 
luminescence using a katG::lux fusion, found that the presence of ethanol had a 
synergistic effect on induction when a combination of H202 and ethanol were used 
as a stimulus, as opposed to H 202 alone. In this scenario, the luminescence recorded 
was 7-fold higher in the presence of both inducers compared to either hydrogen or 
ethanol alone. Also there was a time-delay on the response, where it started to 
increase from approximately 30 minutes after addition of the stimuli, then peaked at 
approximately 60 minutes before starting to decline (Belkin et al., 1996). It is 
possible that an overlap between the osmotic and peroxide induction of ahpC occurs 
to a mild degree, but the response is accentuated or anomalous as a result of the lux 
element. 
In conclusion, the results from this chapter are hard to interpret. The experiments 
were performed to investigate if the lux anomaly of ahpC was under transcriptional 
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or post-transcriptional control, so that use of the ahpC promoter for antigen 
expression (see chapters 4 and 5) could be better defined. In the case of MPG203 
cells grown in minimal media, maximum induction of 37 fold was noted when cells 
were induced with a combination of salt and hydrogen peroxide. Furthermore, cells 
induced with salt showed only a 2.8 fold induction and a 4.7 fold induction with 
hydrogen peroxide alone (Table3. 1). This suggests that in some way, salt has a 
synergistic effect on ahpC expression using the lux construct. This expression of 
ahpC in MPG203 cannot be explained by either transcriptional or post-
transcriptional control alone. If this expression was under transcriptional control, an 
increase in expression of ahpC when MPG203 cells were induced with salt would be 
expected. From the data it could be argued that, since a large increase in expression 
of ahpC in MPG203 induced with a combination of salt and hydrogen peroxide, was 
noted in both the RT-PCR and luminometer experiments, an increase in ahpC 
transcript collates with the increase in light production. However, perhaps in conflict 
with this view, in the RT-PCR results from MPG203, ahpC is induced to a larger 
degree in cells induced with hydrogen peroxide as opposed to salt in both LSLB and 
minimal medium. Also, in conflict with this view, ahpC in MPG203 in the 
luminometer experiment was not found to be induced with hydrogen peroxide when 
grown in LSLB or minimal media and therefore a clear explanation this anomaly of 
ahpC expression, is not apparent. Since expression of ahpC is dependent of 
tetrameric OxyR function (Toledano et al., 1994, Zheng et al., 1998), and local 
chromosomal arrangement of the ahp region is not defined in terms of other DNA 
binding proteins or complexes and how these vary in relation to growth medium or 
phase much still remains to be determined. Direct effect of osmolarity-mediated 
changes on luciferase also remains an open issue. Due to the advances in technology, 
Real Time RT-PCR would be an ideal method of investigating the changes of gene 
expression using several house-keeping genes to standardise the RT-PCR procedure. 
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CHAPTER 4 
Cloning and expression of fusion proteins 
encoding T-cell epitopes from pathogenic 
organisms 
4.1 Cloning and expression of fusion proteins encoding epitopes from 
pathogenic organisms. 
For an effective and lasting vaccine, activation of both strong cell mediated 
immunity and humoral immunity is required). Attenuated bacteria are thought to 
persist in the body long enough to stimulate protective immunity and so afford 
greater protection than that elicited by dead cell vaccines. Indeed, live attenuated 
Salmonella strains may persist in the host for several months and may elicit 
immunity against the onset of infection and subsequent challenge (Chatfield et al., 
1992; Ivanoff et al., 1994). They may also be considered as a vehicle for 
heterologous immunisation, by expressing foreign antigens. In this thesis, peptide 
epitopes from Listeria monocyto genes and Leishmania major were examined as 
model antigens for heterologous immunisation. 
The discovery that aroA mutants of Salmonella typhimurium, were attenuated in vivo 
but able to persist in the host long enough to produce protective immunity was a 
major development in terms of rational vaccine design (Hoiseth and Stocker, 1981). 
Live attenuated aroA strains of Salmonella typhimurium have been shown to be safe 
and effective for use in chickens, sheep and calves (Mukkur et al., 1987; Cooper et 
al., 1990; Jones et al., 1991). Pashine and colleagues (1999) demonstrated that both 
aroA and purA attenuated strains of Salmonella typhimurium developed the same 
type of dominant IFN-y T cell response, and persist for sufficient time to stimulate an 
immune response. They concluded from their work that invasion into macrophages is 
necessary for effective generation of Thi-like immune responses. However, 
persistence of Salmonella beyond 48 hours is not required for this (Pashine et al., 
1999). 
Salmonella typhimurium purA mutants administered by the i.p. route, were found to 
be highly attenuated in mice (McFarland and Stocker 1987). Moreover, studies have 
shown, that Salmonella enterica strains are good vehicles for displaying foreign 
microbial antigens and may be used to elicit simultaneous protection against 
Salmonella and another pathogen (Chatfield et al., 1992; Gonzalez et al., 1994; 
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Verma et al., 1995; Chabalagoity et al., 1996). However, it has been shown that the 
efficiency of such a system is partially dependent on the level of antigen expression 
and its regulation in Salmonella and in other systems (Bretscher et al., 1992; Hosken 
et at., 1995). 
Previously, a technique called in vivo expression technology (IVET) was used to 
specifically identify bacterial genes that were induces in vivo during bacterial 
infection. These in vivo induced (ivi) genes were poorly expressed in laboratory 
medium, but demonstrated increased expression in host cells or cultured 
macrophages (Mahan et al., 1993 and 1995). In this method a promoterless lacZ gene 
was fused downstream of a promoterless purA gene. The purA gene was used as a 
marker for in vivo selection, whilst the lacZ gene was used as a marker for 
constitutive expression on laboratory medium. The need to complement the purA 
deficiency acts as a positive selection for ivi genes. Mahan et al. (1993, 1995), 
showed that mutations in pur genes (e.g. purA), block the synthesis of adenosine 
monophosphate (AMP) from inosine monophosphate (IMP) resulting in a 
requirement for adenine. 
In this thesis, a Salmonella typhimurium strain (MPG424) that contained both an 
aroA and a purA mutation, was used as a vector for heterologous immunisation. The 
Salmonella typhimurium strain MPG424 was confirmed for auxotrophy by growth on 
minimal media with the addition certain constituents outlined below. The aroA 
mutation required the addition of p-amino benzoic acid and 2,3-dihydroxybenzoate 
and the purA mutation required the addition of adenine to minimal media (Hoiseth 
and Stocker 1981; Sigwart et at., 1989). The plasmids encoding the antigens for 
immunisation contained a purA promoter and gene, as a means of in vivo selection 
for Salmonella typhimurium survival in the murine host, by complementation of the 
purA mutation. Salmonella typhimurium pur mutants are unable to grow well in mice 
because of the auxotrophic requirement for purines. Therefore, only the bacteria that 
maintain their plasmids during the course of infection are able to survive. This 
modification of the procedure of Mahan et al. (1993, 1995) was used as a means for 
antibiotic-free plasmid maintenance, thereby providing an alternative to the use of 
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antibiotics. This approach allows us to explore the merits of other in vivo-expressed 
promoters for immunisation with heterologous antigens. 
4.2 Promoters used for in-vivo expression in the current studies 
When using Salmonella for expression of heterologous antigens as a route to 
vaccination, a number of factors have been shown to be important. In the majority of 
cases, immunisation of BALB/c mice intraperitoneally or orally with live Salmonella 
typhimurium expressing heterologous antigens have been found to elicit Th 1 type T -
cell responses (Nauciel et al., 1990; Yang et al., 1990; Thattle et at., 1993; George 
1996; Xu et at., 1995). However, studies have shown, that the T cell pattern can be 
biased towards a Thi or a Th2 response depending on the construct (Medina et at. 
2000). 
Both the carrier and the promoter used to drive the antigen expression have been 
shown to influence the immune response to an antigen (Medina et al. 2000). If the 
antigens are plasmid encoded, both plasmid instability and toxicity of the expressed 
protein in the bacterial host need to be considered. If plasmid number is increased, 
sometimes the immunogenicity of the vaccine is also increased (Molina and Parker, 
1990; Covone et al. 1998). If a plasmid with a lower copy number is selected, this 
may result in more stable expression of the antigen especially if the heterologous 
antigen is toxic. However, a reduction in the immunogenicity of the antigen may 
result (Coulston et at., 1994a, 1994b; Turner et al., 1993). To overcome the problems 
of instability and poor immunogenicity, alternative expression strategies, such as the 
use of in vivo activated promoters have been investigated (Medina et al., 2000). In 
the present study, plasmid constructs were designed in which expression of the 
antigens was placed under the control of different in vivo promoters (PahpC, PpagC 
and PspvA). The development of humoral and cell-mediated immune responses were 
then analysed against the heterologous antigens encoded on plasmids following 
infection. Attention was focused on two foreign antigens, listeriolysin from Listeria 
monocyto genes (LLO) and glycoprotein 63 from Leishmania major (Gp63). 
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In previous studies, Francis and Gallagher (1993) reported that a hydrogen peroxide 
inducible locus ahpCF (Alkyl hydroperoxide reductase) was induced upon 
interaction of Salmonella typhimurium cells with macrophages. The ahp locus 
encodes the heterodimeric enzyme alkyl hydroperoxide reductase and is induced in 
response to the respiratory burst of macrophages (Francis and Gallagher, 1993; Storz 
et al., 1989). Subsequently, Taylor et al. (1998) showed that the ahp gene of 
Salmonella typhimurium was not essential for the virulence of the organism. Given 
that this promoter is activated during macrophage interaction, it has the potential for 
controlled expression of foreign antigens during macrophage interaction in vivo. 
The pagC promoter is known to activate protein expression in response to low 
concentrations of Mg 2 (Garcia et al., 1996; Dunstan et al., 1999). PagC is a 188 
amino acid protein that is a member of a family of bacterial outer member proteins 
that are known to be involved in full virulence of Salmonella typhimurium in 
BALB/c mice. Ppag transcription is maximum within acidified macrophage 
phagosomes (Alpuche-Aranda et al., 1992). Activation may be also modulated by 
low pH conditions believed to exist within the macrophage phagolysosome (Soncini 
et al., 1996). Previously antibody production was achieved when antigens were 
under the control of the pagC promoter (Hohmann et al., 1995; Dunstan et al. 1999). 
Hohmann et at. (1995), concluded from their work that a successful antibody 
response was generated against a heterologous antigen (fragment C of tetanus toxin) 
under the control of the pagC promoter, whereas the constitutive trc promoter was 
not successful. However, in vitro a higher amount of heterologous antigen was 
produced under trc control. This is in agreement with the study of Dunstan et at. 
(1999) where higher expression was also observed in activated mouse peritoneal 
macrophages with the pagC promoter compared to the katG and nirB promoters. 
Expression from PpagC was 10 fold greater than PkatG and 100 fold greater than 
PnirB. The strain with the pagC promoter was the only strain to induce tetanus-
toxoid specific antibody. 
The virulence of Salmonella strains is highly complex and requires the expression of 
a number of genes and some of these are located on the virulence plasmid. The spy 
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genes are required for establishing systemic infection in mice (Libby et al., 1997). In 
mice the virulence plasmid is not required for the translocation of Salmonella 
through the intestinal mucosa, but is necessary for the systemic phase of the disease 
(Manning et al., 1986; Heffernan et al., 1987). The intracellular environment of 
phagocytic and non-professional phagocytic cells induces the expression of spy 
genes in vivo. The spvA promoter drives the expression of Salmonella plasmid 
virulence genes, and is located downstream of the spvR gene (Fierer et al., 1993). 
The spy coding region consists of the regulatory gene spvR and the structural genes 
spvABCD genes, which make up a region of 6Kb (Gulig et at., 1992 and Krause et 
at., 1992). Growth phase regulation of spvABCD is actioned through transcription 
from the spvA promoter, where spvA mRNA increases during stationary phase (Fang 
et at., 1991; Coynault et at., 1992; Krause et al., 1992 and 1995). The spvA promoter 
has previously been used to obtain antibody against plasmid encoded antigens 
(Dunstan et al., 1999; Marshall et at., 2000). 
4.3 Coding regions studied for heterologous expression in viva 
LLO is known to be a dominant antigen in the immune response to Listeria 
monocytogenes (Portnoy etal., 1988; Pamer et at., 1991; Safeley et al., 1991). T cell 
epitopes have been identified from Listeria components including LLO which are 
bound by MHC-I and MHC-II molecules (Safeley et at., 1991, Villanueva et al., 
1995). Verma et at., (1995) inserted an oligonucleotide encoding a MHC-II epitope 
from LLO residues 215-226 and an oligonucleotide encoding a MHC-I epitope from 
LLO residues 91-99 into the DNA encoding the hypervariable region of the 
Salmonella flagellum system. They concluded from their work, that both MHC-I and 
MHC-II T cell-restricted responses resulted. 
Glycoprotein (Gp63), is a major surface antigen of 63 kdaltons. It is a 
metalloprotease which is highly conserved among the different species of 
Leishmania (Colmer-Gould et at., 1985; Etges et at., 1986; Button et at., 1988). 
Following identification of host protective T cell antigens on Gp63 of Leishmania 
major, over 24 overlapping peptides were screened which spanned the full length of 
the 503 amino acid protein (Yang et at., 1991). Two peptides inducing a T cell 
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response were identified which corresponded to residuesl46-171 and 467-482, 
suggesting that they would induce protective immunity (Liew, 1989; Scott et al., 
1988; Henizel et al., 1989). This most N-terminal region of the peptide (146-171), 
covers a highly conserved region, believed to contain a zinc co-factor binding site, 
thought to be essential for the endopeptidase activity of gp63 (Chaudhuri et al., 1989, 
Bouvier et al., 1989 and Curry et al., 1994). 
Throughout the rest of the chapter, construction of the different plasmids used for 
immunisation and purification of proteins are explained. The first diagram shows the 
initial plasmid pBR325, into which the purA promoter and gene were cloned, 
creating pTMB2. The ahpC promoter was then cloned into pTMB2 creating pTMB3. 
A histidine tag which contained an extra cloning site and stop codon was cloned into 
pTMB3 creating pTIMB4 to aid downstream cloning and protein purification. For 
each proceeding plasmid in the series, the gene fragment was cloned into the 
previous plasmid in a sequential order, simultaneously inserting a further cloning site 
and stop codon at the 3' end of the fragment. This is explained further in the plasmid 
drawings, which follow. Also, cloning of alternative promoters to replace the ahpC 
promoter, resulting in pTMB8 and pTMB20 is described. 
Throughout this chapter, it can be seen that a number of problems were encountered 
during the cloning of the plasmids and the purification of the GST fusion proteins for 
the immunisation studies. A large volume (between 8-12 Litres) of culture was 
required to purify each of the GST fusion proteins, due to poor expression. This was 
not expected, as no problems were encountered during the expression and 
purification of GST alone. Therefore, fusion to GST affected the expression to a 
large degree. The antigens under the control of different proteins were all 
successfully expressed to an acceptable level in vitro, to enable affinity purification 
of the GST fusion proteins for the investigations on the immune responses to the 
various peptides (chapter 5). 
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Figure 4.1. Summary of the cloning purA to construct pTMB2 
The purA promoter and gene were amplified from E.coli (bases 268-2012. AC: J04199)chromosomal 
DNA by PCR, with Psil sites engineered at both the 5' and 3'ends using put -A-268 and purA-anti20l2 
respectively. This fragment was cloned into Psil site on pBR325 thereby inactivating the ampicillin 
gene. The resulting plasmid, pTMB2 was both tetracycline and chioramphenicol resistant and was 
used for constructing pTMB3. 
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Figure 4.2. Construction of pTMB3 (AhpC) and pTMB4 (AhpC-H'is) 
The ahpC promoter and part of the gene (bases 1-768, AC:J05478) was amplified from Salmonella 
tvphinurium chromosomal DNA with addition of Sal I and Sph I sites at the 5' and 3' end using 
oligos Sall-ahpC and Sphl-ahpC respectively. The amplified fragment was cloned into pTMB2 via 
these sites forming pTMB3. A poly-histidine Tag (bases 321-412. Novagen) was amplified from 
pET19b, with flanking Split and BamHI engineered sites using oligos His! and His2 and cloned into 
the same sites in pTMB3, resulting in pTMB4. A XbaI site and stop codon was engineered at the 3' 
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Figure 4.3. Summary of the cloning of pTMB5 (AhpC-His-LLO). 
The Ilo fragment. (bases 1719-2216, AC: M24199) incorporating I cell epitopes LLO 91-99 and LLO 
215-226 was amplified from Lisieria nonocytogenes chromosomal DNA by PCR, with XbaI and 
BamHI sites engineered at the 5' and 3' end, respectively using Lis] and Lis2. The i/u fragment was 
cloned into pGEM-T forming pTMB 11. to aid cloning. The LLO fragment was then excised with 
Xbal and Ba,nHl, gel purified, and cloned into the respective sites in pTMB4 to form pTMBS. A KpnI 
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Figure 4.4. Summary of the cloning of pTMB6 (AhpC-His-LLO-Gp63(1)). 
The fi rst (of two) gp63 gene fragment was amplified by PCR from Leish,nania major chromosomal 
DNA (bases 891-1080, AC:X64394) using primers Leish 3 and Leish4 with engineered Kpn I and 
Barn HI sites at the 5'and 3' ends. The fragment was cloned into pGEM-T forming pTMB12. The 
Gp63(l) fragment was then digested with Kpn I and Barn HI, gel purified and cloned into the 
corresponding sites in pTMB5 to form pTMB6. A BglII site and stop codon were engineered within 
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Figure 4.5. Summary of the cloning of pTMB7 (AhpC-His-LLO-Gp63( 1 )-Gp63(2)). 
The second gp63 fragment (bases 1608-1988, AC:X64394) was amplified from Leishmania major 
DNA by PCR, using primers Leish3 and Leish4 with Bgl 11 and Bonn HI sites engineered at their 5' 
ends, and cloned into pGEM-T forming pTMBI3. The fragment was then excised with 13g1 II and 
Barn HI, gel purified, and cloned into the corresponding sites in pTMBÔ to form pTMB7. A Nsi I site 
and stop codon were engineered with the Leish 4 oligo to enable further cloning. 
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Figure 4.6. Cloning of pTMB8 (PagC-H1s-LLO-Gp63(1)-Gp63(2)) and 
pTMB20(SpvA-His-LLO-Gp63(1 )-Gp63(2)). 
The pagC (bases 44-776, AC:M55546) and spvA (bases 961-2619, AC:X56727) promoters were 
amplified via PCR from Salmonella rs'phinuriun chromosomal DNA. The pagC primers were PagC-
xhol and PagC-rev whereas the spvA primers were Spv-xhol and Spv-sph 1. The PCR products were 
cloned into the Sal I and Spit I sites of the vector (pTMB7), forming pTMB8 and pTMB20 
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Figure 4.7. Cloning of pTMB21 (AhpC-GFP). 
The vector pTMB7 was digested with SphI and Banz H! and then gel purified to aid cloning of the 
egfp gene. The eGFP coding region (bases 304-1031, AC:U76561.1) was amplified with 5' Sph! and 
BarnHI sites using oligos Gfp-sphl and Gfp-bamHl from a plasmid maxiprep of pEGFP (Clontech) 
and cloned into the corresponding sites on the vector pTMB7, forming pTMB21. 
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Figure 4.8. Cloning of pTMB22 (PagC-GFP). 
The vector pTMB8 was digested with SphI and BarnHI and then gel purified to aid cloning of the egfp  
gene. The eGFP coding region (bases 304-1031, AC:U76561.1) was amplified with 5' Spi'il and 
BarnHI sites using oligos Gfp-sphl and Gfp-bamHl from a plasmid maxiprep of pEGFP (Clontech) 
and cloned into the corresponding sites on the vector pTMB8, forming pTMB22. 
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4.4.1 Protein expression 
After plasmid construction, protein expression was analysed to ensure that a protein 
of the correct size was expressed. The promoters were induced under different 
conditions, which are outlined under the induction profiles in the following figures. 
The ahpC promoter was induced with hydrogen peroxide whereas the pagC and spvA 
promoters were induced after entry into stationary. The pagC promoter was also 
induced after addition of EGTA (metal chelator) to the media, thereby reducing the 
concentration of Mg 2 in the media (data not shown), which has been previously 
shown for the induction of pagC (Garcia et al., 1996; Dunstan et al., 1999). 
Plasmid Promoter Fusion Protein 
Molecular weight 
(Kdaltons) 
pTMB2 None None 
pTMB3 ahpC AhpC 
pTMB4 ahpC AhpC-His 17.2 
pTMB5 ahpC AhpC-His-LLO 37 
pTMB6 ahpC AhpC-His-LLO-Gp63( 1) 44 
pTMB7 ahpC AhpC-His-LLO-Gp63(1)-Gp63(2) 60 
pTMB8 pagC PagC-His-LLO- Gp63(l)-Gp63(2) 47 
pTMB20 spvA SpvA-His-LLO- Gp63(1)-Gp63(2) 47 
pTMB21 ahpC AhpC-GFP 43 
pTMB22 pagC PagC-GFP 32 








For this purpose, Salmonella typhimurium MPG424 cells containing the plasmids 
were grown overnight in LB containing chioramphenicol. The cells were then diluted 
1 in 100 into fresh LB and grown to an OD600 I1m of 0.5. A 2m1 sample was removed 
for SDS PAGE analysis before the remainder of the culture (containing plasmid 
pTMB4, pTMB5, pTMB6, pTMB7 or pTMB21) was induced with 100tM hydrogen 
peroxide for a time period of 3 hours. 2 ml samples were removed after 30 minutes, 
45 minute, 1 hr, 1 .Shrs, 2 hrs, 2.5hrs and 3hrs. Following electrophoresis of the 
samples on parallel gels, one gel was stained using Coomassie Brilliant Blue to 
examine the protein profile of each sample (Panel A), and the other gel was 
subjected to immunoblotting using an anti-His antibody for detection (Panel B). 
Protein expression is shown for all the plasmids over the next few pages. 
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Figure 4.9 Immunoblot of MPG424 cells containing pTMB4 induced with 100.iM 
hydrogen peroxide expressing the protein Ahp-His under the control of the ahpC 
promoter. 
Lane I represents uninduced cells. Lanes 2-8 represent samples taken over the time points- 30 
minutes, 45minutes, 1 hour, 1 .5hrs. 2 hrs, 2.5hrs and 3hrs, respectively. The position of molecular size 
markers are shown as 14.2, 20.1, 24, 29, 36. 45, and 66 kdaltons. 
The expected size of AhpC-His is 17.2 kdaltons. 
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Figure 4.10. Salmonella lyphimurium cells MPG424 carrying plasmid pTMB5 
induced with hydrogen peroxide expressing the protein AhpC-His-LLO under the 
control of the ahpC promoter. 
Cells were grown and induced as described for figure 4.9. A sample was removed prior to induction 
(lane 1) or after 30 minutes, 45 minute, 1 hr, 1.5hrs, 2 hrs, 2,5hrs and 3hrs exposure to 100tM H 202 
(lanes 2-8, respectively). Following electrophoresis, one gel was stained using Coomassie Brilliant 
Blue to examine the protein profile of each sample (Panel A), and the other gel was subjected to 
immunoblotting using an anti-His antibody for detection (Panel B). The position of molecular size 
markers are shown as 20.1, 24, 29, 36. 45, and 66 kdaltons. 
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Figure 4.11. Salmonella typhimurium MPG424 cells carrying plasmid pTMB6 
induced with hydrogen peroxide expressing the protein AhpC-His-LLO-Gp63(1) 
under the control of the ahpC promoter. 
Cells were grown and induced as described for figure 4.9. A sample was removed prior to induction 
(lane 1) or after 30 minutes, 45 minute. 1 hr, 1.5hrs, 2 hrs, 2.5hrs and 3hrs exposure to 100tM H 202 
(lanes 2-8, respectively). Following electrophoresis, one gel was stained using Coomassie Brilliant 
Blue to examine the protein profile of each sample (Panel A), and the other gel was subjected to 
immunoblotting using an anti-His antibody for detection (Panel B). The position of molecular size 
markers are shown as 14.2, 20.1, 24, 29, 36. 45, and 66 kdaltons. 
The predicted size of AhpC-His-LLO-Gp63(l) is 44 kdaltons. 
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Figure 4.12. Salmonella typhimurium cells MPG424 carrying plasmid pTMB7 
induced with hydrogen peroxide expressing the protein AhpC-His-LLO-Gp63( 1)-
Gp63 (2) under the control of the ahpC promoter. 
Cells were grown and induced as described for figure 4.9. A sample was removed prior to induction 
(lane 1) or after 30 minutes, 45 minute, I hr, 1.5hrs, 2 hrs, 2.5hrs and 3hrs exposure to I00.tM H 202 
(lanes 2-8, respectively). Following electrophoresis, one gel was stained using Coomassie Brilliant 
Blue to examine the protein profile of each sample (Panel A), and the other gel was subjected to 
immunoblotting using an anti-His antibody for detection (Panel B). The position of molecular size 
markers are shown as 14.2, 20.1, 24, 29, 36. 45, and 66 kdaltons. 
The predicted size of AhpC-His-LLO-Gp63( I )-Gp63(2) was 60 kdaltons. 
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Figure 4.13. Salmonella ryphimurium cells MPG424 carrying plasmids pTMB4, 
pTMB5, pTMB6 and pTMB7 expressing the proteins under the control of the ahpC 
promoter after induction with hydrogen peroxide. 
The cells were grown as described before in figure 4.9. Samples were taken pre- and post-exposure to 
100iM hydrogen peroxide for 45 minutes. The Coomassie Brilliant Blue stained protein profile is 
shown (Panel A), with the corresponding immunoblot, using an anti-His antibody for detection (Panel 
B). Lanes 1, 3 5 and 7 represent untreated samples of pTMB4 (AhpC-His), pTMB5 (AhpC-His-LLO), 
pTMB6 (AhpC-His-LLO-Gp63(1)) and pTMB7 (AhpC-His-Llo-Gp63(l)-Gp63(2)) respectively. 
Lanes 2, 4, 6 and 8 represent protein samples of the respective plasmids induced with lOOj.tM 
hydrogen peroxide for 45 minutes (as shown by the arrows in panel A and B). The position of 
molecular size markers are shown as 14.2, 20.1, 24, 29, 36. 45, and 66 kdattons. 
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Figure 4.14. Salmonella typhimurium cells MPG424 carrying plasmid pTMB8 
induced after entry into stationery phase expressing the protein PagC-His-LLO-
Gp63( 1 )-Gp63 (2) under the control of the pagC promoter. 
Salmonella tvphimurium MPG424 cells carrying plasmid pTMB8 were grown overnight in 5m1 LB at 
37°C with shaking in the presence of chioramphenicol. The cells were then diluted 1 in 100 into fresh 
LB and grown over a period of 6 hours. A 2ml sample was removed for SDS PAGE analysis after the 
cells were diluted and this is referred to as time zero. Samples were removed after 0.5hr, lhr, 2 hrs, 
3hrs, 4hrs, 5hrs and ôhrs represented by lanes 2-8 respectively. Following electrophoresis, one gel was 
stained using Coomassie Brilliant Blue to examine the protein profile of each sample (Panel A), and 
the other gel was subjected to immunoblotting using an anti-His antibody for detection (Panel B). The 
position of molecular size markers are shown as 14.2, 20.1, 24, 29, 36. 45, and 66 kdaltons. 
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Figure 4.15. Salmonella typhimurium cells MPG424 carrying plasmid pTMB20 
induced after entry into stationery phase expressing the protein SpvA-His-LLO-
Gp63( 1 )-Gp63 (2) under the control of the spvA promoter. 
Salmonella iyphinurium MPG424 cells carrying plasmid pTMB20 were grown overnight in 5ml LB 
at 37°C with shaking in the presence of chloramphenicol. The cells were then diluted I in 100 into 
fresh LB and grown for 7 hours so that stationary phase was reached. A 2m1 sample was removed for 
SDS PAGE analysis after the cells were diluted and this is referred to as time zero. Samples were 
removed after Ihr, 2hr, 3 hrs, 4hrs, 5hrs, 6hrs and 7hrs represented by lanes 2-8 respectively. 
Following electrophoresis, one gel was stained using Coomassie Brilliant Blue to examine the protein 
profile of each sample (Panel A), and the other gel was subjected to immunoblotting using an anti-His 
antibody for detection (Panel B). The position of molecular size markers are shown as 14.2, 20.1, 24, 
29, 36. 45, and 66 kdaltons. 
The predicted size of SpvA-His-LLO-Gp63(l)-Gp63(2) is 47 kdaltons. 
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Figure 4.16. Salmonella typhimurium cells MPG424 carrying plasmid pTMB21 
expressing the protein AhpC-GFP under the control of the ahpC promoter induced 
with hydrogen peroxide. 
Cells were grown and induced as described for figure 4.9. A sample was removed prior to induction 
(lane 1) or after 30 minutes, 45 minute, 1 hr, 1.5hrs, 2 hrs, 2.5hrs and 3hrs exposure to 100l.tM H 202 
(lanes 2-8, respectively). Following electrophoresis, one gel was stained using Coomassie Brilliant 
Blue to examine the protein profile of each sample (Panel A), and the other gel was subjected to 
immunoblotting using an anti-GFP antibody for detection (Panel B). The position of molecular size 
markers are shown as 14.2, 20.1, 24, 29, 36. 45, and 66 kdaltons. 
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Figure 4.17. Salmonella typhimurium cells MPG424 carrying plasmid pTMB22 
expressing the protein PagC-GFP induced after entry into stationery phase from the 
pagC promoter. 
Salmonella lyphimurium MPG424 cells carrying plasmid pTMB22 were grown overnight in 5ml LB 
at 37°C with shaking in the presence of chioramphenicol. The cells were then diluted 1 in 100 into 
fresh LB and grown over a period of 6 hours. A 2m1 sample was removed for SDS PAGE analysis 
after the cells were diluted and this is referred to as time zero. Samples were removed after 0.5hr, lhr, 
2 hrs, Mrs, 4hrs, 5hrs and 6hrs represented by lanes 2-8 respectively. Following electrophoresis, one 
gel was stained using Coomassie Brilliant Blue to examine the protein profile of each sample (Panel 
A), and the other gel was subjected to immurioblotting using an anti-His antibody for detection (Panel 
B). The position of molecular size markers are shown as 14.2, 20.1, 24, 29, 36. 45, and 66 kdaltons. 
The predicted size of PagC-GFP is 32 kdaltons. 
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4.4.2 Construction and purification of GST fusion proteins for immunisation 
studies 
In order to study cell-mediated immunity (chapter 5), each of the antigens from the 
immunisation plasmids were constructed as in-frame glutathione S-transferase (GST) 
fusions using recombinant DNA approaches. GST fusions were constructed to ensure 
that if an immune response was detected after immunisation, this response was due 
to recognition of the antigen encoded on the immunisation plasmid. Proteins could 
not be purified by affinity purification using the Histidine tag, as the plasmids used 
for immunisation already had a histidine tag present, therefore, GST was chosen as 
an alternative tag for affinity purification. The GSTs are a family of enzymes that can 
transfer sulphur from glutathione to substances such as nitrogenated and halogenated 
compounds, leading to their detoxification (Mehler 1993). Smith and Johnson 
(1988), using GST developed a gene fusion system from the parasite helrninth 
Schistosomajaponicum. This meant that GSTs and fusion proteins could be purified 
by affinity chromatography using the immobilised cofactor glutathione, followed by 
elution with reduced glutathione (Simons and Vander 1981). 
Each of the antigens (LLO, Gp63(l), Gp63(2) and GFP) were subcloned from the 
vectors used for immunisation (pTMB6, pTMB7, pTMB8, pTMB21 and pTMB22) 
into a GST expression vector (pGEX-5X- 1). The first step was construction of a 
vector (pTMB14) with a polylinker that contained the relevant restriction sites 
(Figure 4.18) that were previously used for the cloning of the antigens into the 
immunisation plasmids (pTMB5, pTMB6, pTMB7 and pTMB21). Each antigen was 
cloned into the respective restriction sites on pTMB14 (see Figures 4.19 and 4.20). 
Plasm Id Protein Molecular Weight (kdaltons) 
pGEX-5X-1 GST 29 
pTMB15 GST-LLO 51 
pTMB16 GST-gp63(1) 38 
pTMB17 GST-GP63(2) 47 
pTMB18 GST-GFP 59 
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Figure 4.18. Cloning of a polylinker into pGEX-5X I. 
A polylinker was cloned into the Barn HI and Eco RI sites on pGEX-5X-1. creating pTMB14. The 
extra restriction sites are shown on the polylinker fragment in the diagram. The vector (pTMBI4) was 
used for subsequent cloning of all the GST fusions required for protein purification 
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The 110 fragment was 	 493 bp 
digested from pTMB11 
using Xba I and Kpn I, 
then gel purified. This 
fragment was cloned into 
Iaclq 
the corresponding sites on 
the 	polylinker 	in 
pTMB14, forming plasmid 
pTMB15. This vector was 
used for purification of 
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The gp63(l) fragment was 
digested from pTMB12 
using Kpn I and Bgl II, 
then gel purified. The 
fragment was cloned into 
the same sites on the Iaclq 
polylinker in pTMB14, 
forming pTMB16. This 
vector was used for 
purification 	of 	GST- 
gp63(1) 	for 	footpad 
assays. 
Figure 4.19. Summary of the cloning of pTMB15 (GST-LLO) and pTMB16 (GST-
Gp63(1). 
Protein expression studies from these vectors are shown in figure 4.21. 
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The gfp  fragment was 
digested from pEGFP 
using Xba I, then gel 
purified. The fragment 
was cloned into the Xba I 
site on the polylinker in 
pTMB14, forming 
pTMB18. This vector was 
used for purification of 
GST-GFP for footpad 
assays. 
Figure 4.20. Summary of the cloning of pTMBI7 (GST-Gp63(2)) and pTMBl 
(GST-GFP). 
Protein expression studies for these vectors are shown in figure 4.22. 
The gp63(2) fragment 
was digested from 
pTMB12 using Bgl II and 
Nsi 1, then gel purified. 
The fragment was cloned 
into the corresponding 
lac Iq 
sites on the polylinker in 
pTMBI4, forming 
pTMB17. This vector 
was used for purification 
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Figure 4.21. Expression of GST fusion proteins from pTMBI5 (GST-LLO) and 
pTMB 16 (GST-Gp63( 1). 
BL21 cells carrying plasmids pTMB15 (panel A) or pTMB16 (panel B) were grown in LB containing 
ampicillin overnight shaking at 37 °C. The cells were then diluted I in 100 into fresh LB containing 
ampicillin and grown to an optical density of 0.45 before being induced with 1mM IPTG for 3 hours. 
Samples were taken at time zero (Lane 1) and then every 30 minutes for the three hours (Lanes 2-7). 
The position of molecular size markers are shown as 14.2. 20.1, 24, 29, 36. 45, and 66 kdaltons. 






Figure 4.22. Expression of GST fusion proteins from pTMB17 (GST-Gp63(2) and 
pTMB18 GST-GFP). 
BL2 1 cells carrying plasmids pTMB 17 (panel A) or pTMB 18 (panel B) were grown in LB containing 
ampicillin overnight shaking at 37 °C. The cells were then diluted I in 100 into fresh LB containing 
ampicillin and grown to an optical density of 0.45 before being induced with 1mM IPTG for 3 hours. 
Samples were taken at time zero (Lane I) and then every 30 minutes for the three hours (Lanes 2-7). 
The position of molecular size markers are shown as 14.2, 20.1, 24, 29, 36. 45, and 66 kdaltons. 
The predicted size of GST-Gp63(2) is 47 kdaltons and GST-GFP is 59 kdaltons. 
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4.4.3 Affinity purification of GST-fusion proteins 
After confirming expression of the GST fusion proteins, proteins were purified by 
affinity purification as outlined in the Materials and Methods in Chapter 2, in order 
to provide material for DTH studies. For this, cultures expressing each fusion 
protein were grown in 1L volumes and used for affinity purification. Strains were 
subcultured from (1/100 dilution) after overnight growth at 37 °C in LB containing 
ampicillin and re-incubated. At an optical density of 0.4-0.5 at 600nm, IPTG was 
added to a final concentration of 1mM and incubation was continued for 3 hours. 
Samples were harvested by low speed centrifugation and the pellets were 
resuspended in lysis buffer (as outlined in Materials and Methods). Following 
sonication unbroken cells and debris were removed by centrifugation at 8,000g for 
30 minutes. The supernatant containing the GST- tagged fusion protein was 
recovered and applied to the column. The Flow-through from the Sepharose 4 Fast 
Flow column (total binding capacity of 10mg recombinant GST/rnl gel-Amersham 
Pharmacia Biotech) over a period of 40-60 minutes at 4 °C. The final flow-through 
was collected and the columns were washed 4-5 times with 5-10 volumes of buffer. 
The columns were capped and shifted to room temperature for elution of the purified 
fusion protein. The proteins were incubated with the elution buffer on the column for 
10-15 minutes prior to elution and then eluted in 4x imI volumes of elution buffer. 
Samples from each stage were analysed by SDS-PAGE. 
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Figure 4.23. Purification of GST-LLO (Panel A) and GST-Gp63(1) (Panel B) from a 
Glutathione column. 
The GST-LLO and GST- Gp63(l) fusion proteins were induced in BL21 cells from pTMB15 and 
pTMI6 as described in the text. After fractionation of the cells, samples were affinity purified on 
agarose-GST beads. Samples are shown from the supernatant containing the GST- tagged fusion 
protein applied to the column (lanel), flow-through (lane 2), washes (lanes 3-4) and the eluted fusion 
protein GST-LLO (lanes 5-9). The position of molecular size markers are shown as 14.2, 20.1, 24, 29, 
36. 45, and 66 kdaltons. 
The predicted size of GST-LLO is 51 kdaltons and GST-Gp63(l) is 38 kdaltons. 
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Figure 4.24. Purification of GST-Gp63(2) (Panel A) and GST-GFP (Panel B) from a 
Glutathione column. 
The GST- Gp63(2) and GST- GFP fusion proteins were induced in BL2I cells from pTMB17 and 
pTM 18 as described in the text. After fractionation of the cells, samples were affinity purified on 
agarose-GST beads. Samples are shown from the supernatant containing the GST- tagged fusion 
protein applied to the column (lanel), flow-through (lane 2), washes (lanes 3-4 in panel A, lanes 3-5 
in panel B) and the eluted fusion protein GST-LLO (lanes 5-9 in panel A and lanes 6-8 in panel B). 
The position of molecular size markers are shown as 14.2, 20.1, 24, 29, 36. 45, and 66 kdaltons. 
The predicted size of GST-Gp63(2) is 47 kdaltons and GST-GFP is 59 kdaltons. 
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After proteins were purified from the affinity columns, the elutions from the 
purifications were pooled together for each fusion protein. The proteins were then 
concentrated using PEG80 00, then dialysed with several changes of PBS at 4 °C. After 
dialysis the proteins were loaded on 12.5% SDS-PAGE gels as shown below. Several 
dilutions of the proteins were loaded in the following order 7.51Ai, 51il and 2.5jil 
(Figure 4.25 lanes 1-3). These proteins were then used for the DTH assays in mice. 
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Figure 4.25. GST fusion proteins used in DTH assays. 
The proteins are as follows: 
Panel A: GST (pGEX-5X-1) 
Panel B: GST-LLO (p1MB 15) 
Panel C: GST-Gp63(l)(pTMBI6) 
Panel D: GST-Gp63 (2)(pTMBI7) 
Panel E: GST-GFP (p1MB 18). 
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4.5 Discussion 
In this chapter, the details of the construction of the different plasmids used for 
immunisation (pTMB2, pTMB6, pTMB7, pTMB8, pTMB20, pTMB21 and 
pTMB22) and purification of the GST fusion proteins (pTMB15, pTMB16, pTMB17 
and pTMB 18) are outlined. The plasmids and promoters used for driving expression 
of the proteins used for the immunisation studies (chapter 5) are summarised in table 
4.1. The plasmids used for the purification of the GST fusion proteins are 
summarised in table 4.2. It can be seen that the GST fusion proteins were poorly 
expressed and were not completely stable (Figures 4.23-4.25). These points are 
discussed later. 
As can be seen from the plasmid drawing that plasmids pTMB4 to pTMB7 were 
constructed sequentially, therefore it was important to ensure that no errors occurred 
during the amplification by PCR. Thus, all the promoters and gene fragments cloned 
into the plasmids were-sequenced in both directions on an ABI prism sequencer (data 
not shown) and aligned with the reported sequences of the antigens. At each stage of 
cloning, protein expression was checked by inducing the promoter ex vivo with the 
relevant stimulus. 
In the case of the ahpC promoter, most of the proteins had maximum production 
between 30 minutes and 1 hour. However, pTMB6 showed continued protein 
accumulation up to 3 hours. Expression was also achieved from both the pagC and 
spvA promoters. The pagC promoter was induced in various different ways including 
lowering the pH of the growth media or by addition of the metal chelator EGTA to 
the growth medium as previously reported (data not shown). The promoter pagC was 
also induced, by growing the cells to stationary phase and possibly causing a 
reduction in essential elements required for growth including magnesium. The pagC 
promoter is known to activate protein expression in response to low concentrations 
of Mg2 (Garcia et al., 1996; Dunstan et at., 1999). The spy structural genes 
(spvABCD) are expressed when bacteria enter stationary phase or when cells are 
grown under carbon or nutrient starvation (Fang et al. 1991; Coynault et al. 1992; 
Fierer et al. 1993). 
In order to produce proteins for DTH assays, glutathione S-transferase (GST) fusion 
proteins were constructed. The pGEX-5X-1 plasmid was chosen as the core plasmid 
for this because of its capacity for inducible high-level expression of Schistosoma 
japonicurn GST (Baneyx, 1999). Fusion proteins are easily purified from bacterial 
lysates by affinity chromatography using glutathione sepharose. The Escherichia coli 
strain BL21 was used for the purification of GST fusion proteins, 
E.coli is an attractive choice of host for expression of heterologous proteins since it 
grows rapidly and does not require expensive substrates. It can grow to a high 
density and there are a large number of mutant host strains to aid production. The 
E.coli host strain BL21 does not express the outer membrane protein T (OmpT 
protease) (Figure 4.28), so the possibility of cleavage of the heterologous proteins 
can be reduced (Goldberg and Dunn, 1988; Sugimura et al., 1988). OmpT protease 
recognises and cleaves at dibasic amino acid (Arg-Lys) sequences (Grodberg and 
Dunn., 1988). Hellebust et al., (1989) used an ompT strain to enhance protein 
expression. The use of partially protease minus strains helps to reduce the amount of 
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Figure 4.26. Schematic distribution of E. co/i proteases in the cell (Adapted from 
Murby et al., 1996). 
Key: Black circle - ATP activated protease; Shaded circle - Membrane-associated protease; White 
circle -Serine protease; Grey circle - Metal loprotease. 
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Nevertheless, E. coli contains a number of proteases (see figure 4.28), and so an 
ompT mutation is likely to have a limited impact on protein production. The protease 
La is believed to be one of the most important proteases involved in degradation of 
recombinant proteins in E. coli. This protease is encoded by the gene ion and is 
present in the cytoplasm (Goldberg, 1992). Indeed, approximately 50% of proteases 
are located in the cytoplasm (Figure 4.28) (Murby et al., 1996). It has been shown 
that proteolysis still occurs in Ion- mutants, but at a much reduced rate (Enfors, 1992; 
Goldberg, 1992). Moreover, Ion- strains have a phenotypic disadvantage of being 
highly sensitive to DNA-damaging agents making them difficult to use (Goff and 
Goldberg 1985). Previously it was shown that deletion of the Ion and dnaK genes, 
almost completely eliminated proteolysis. It was suggested that DnaK binds to 
proteins, thereby targeting them for subsequent proteolysis (Enfors, 1992). 
Proteins become targets for proteases due to incorrect folding or the fact that the cell 
recognises them as foreign (Goff et al., 1984: Wild et al., 1993). Host strains that 
have mutations in the htpR gene, which encodes 
32,  the protein that controls the 
transcription of heat shock genes, have a reduced capacity to degrade unstable or 
abnormal proteins through protease deficiencies (Baker et al. 1984). Such strains also 
have the benefit of being defective in the heat shock response. This is an advantage 
since several chaperone proteins (DnaK, GroEL, GrpE and DnaJ) are involved in 
protein degradation. The finer details of how such chaperones influence protein 
turnover are still a matter of debate (Lee and Olins, 1991; Sherman and Goldberg 
1992: Sato et al., 1994). 
The pGEX-5X- 1 vector allows the expression of proteins in E. coli as fusion proteins 
to GST. The tac promoter present on this vector is a strong promoter and can 
produce between 15-30% of total cell protein, after induction with isopropyl--D-A-
thiogalactopyranoside (IPTG) (Baneyx 1999). Expression from strong promoters can 
increase the tendency for intracellular aggregation of recombinant proteins (Cheng et 
al., 1981) and cytoplasmic GST fusion proteins have been reported which form 
soluble proteins or inclusion bodies (Guan and Dixon, 1991; Cartwright et al., 1995; 
Pharmacia). 
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The first report of the formation of inclusion bodies came in 1982 arising from the 
over-expression of human insulin (Williams et al; 1982). Inclusion bodies are 
thought to form due to the lack of accessories required for folding proteins in their 
native forms (Kane and Hartley, 1988), or due to inappropriate intermolecular 
interactions between molecules during protein folding. Over-expression of the 
cellular chaperones GroEL and GroES during the production of human collagenase, 
has been found to result in a decrease in inclusion body formation and increase in 
yield (Lee and Olins, 1992). 
Inclusion body formation has the advantage of protecting the recombinant protein 
against proteolysis (Enfors 1992). Strong denaturants such as Guanidine 
hydrochloride and urea can be used to re-solubilise the aggregated protein but this 
has the disadvantage that it can result in chemical modifications of the recombinant 
protein (Murby et al., 1996). Also, guanidine hydrochloride is expensive, highly 
corrosive, and refolding requires to be performed at low protein concentrations. This 
extends the time of processing proteins, which is not practical if a number of proteins 
are being purified simultaneously from inclusion bodies. Also in vitro folding of 
proteins is inefficient and commonly results in recovery of only 1-10% of active 
protein from insoluble material (Rose and Craik, 1996). Nevertheless, inclusion 
bodies are resistant to shear forces compared with other cellular structures, so good 
recovery can be achieved using mechanical cell disruption methods, such as 
ultrasonication. 
In the present study large volumes of cultures expressing fusion proteins were grown 
to enable purification of sufficient quantities of recombinant protein. From the gels in 
figure 4.19, it can be seen that the recombinant proteins have undergone some 
proteolysis. This was a little surprising since protease inhibitors were utilised 
throughout the purification procedure, which was performed at 4 °C, and because the 
fusion proteins were expressed in 131,21. The protease inhibitors that are effective 
against serine and cysteine proteases (figure 4.28) included AEBSF, aprotinin and 
leupeptin. Even, pepstatin, which is effective against aspartic (acid) proteases, was 
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included. Furthermore, EDTA, that is effective against metalloproteases, was present 
in the buffers for lysis and washing (Boehringer Mannheim, 1996). Enfors (1992) 
carried out a study on the cleavage sites in the B1B2 (Binding protein G derivative) 
region of 2 fusion proteins composed of ZZ (IgG binding protein A derivative)-
proinsulin- B1B2 and ZZ-secretin- B1B2. These proteins were hydrolysed in 
Escherichia coli at several sites in the B 1B2 region. The presence of the proinsulin or 
secretin induced cleavage at other sites. From this study, it was concluded that 
proteolytic cleavage at one site maybe influenced by the structure at a remote site. It 
is possible that the tertiary structure of the proteins are radically altered due to the 
formation of fusion proteins (Enfors, 1992). There could also be a number of 
explanations for this instability. 
All the information required for the correct folding of a protein is believed to reside 
within its amino acid sequence (Anfinsen, 1973). Protein folding is not necessarily 
rapid, so partially or misfolded polypeptides can aggregate instead of proceeding to 
the native or mature state (Nilsson and Anderson, 1991; Seckler and Jaenicke, 1992). 
Molecular chaperones including GroEL and DnaK, facilitate the folding process by 
interacting with a variety of protein substrates to prevent aggregation or unfold 
misfolded structures (Van Dyk et al., 1989). 
Protein degradation is more likely to occur in the cytoplasm of E.coli than in other 
compartments because of the greater number of proteases located in the cytoplasm 
(Talmadge and Gilbert, 1982). Increasing the stability of foreign proteins may be 
achieved by directing them to the periplasm, where there is generally less protease 
activity (Figure 4.20). Indeed, the in vivo half-life of rat proinsulin was increased 10 
fold when secreted into the periplasm compared with the cytoplasm (Talmadge and 
Gilbert, 1982). Such a strategy would enhance the value of using BL21 cells since 
ompT normally functions in the periplasm of intact cells. Proteins that have a strong 
tendency to aggregate and precipitate intracellularly or contain hydrophobic 
transmembrane regions are usually hard to secrete out of the cell (Murby et al., 
1996). However, there are no general use secretion vectors that can direct the 
secretion of native proteins to the periplasm of E.coli in a single step (Jobling et al., 
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1997). Another possible solution for an increase in the production of recombinant 
protein is to increase the osmotic pressure of the media, thereby stabilising the native 
protein structure. It has been demonstrated, that by growing cells in the presence of 
sorbitol at 25°C, there was greater than 400-fold increase in the level of recombinant 
protein production (Blackwell and Horgan 1991). 
Gene fragments from Listeria monocyto genes and Leishmania major were used for 
constructing the GST fusions. This presents the possibility that codon usage could 
have an impact on protein production. The arginine codons (AGA and AGG) are 
seldom found in E. coli genes but are common in eukaryotes. There is 2 such codons 
present in LLO and 2 present in Gp63(2), along with 2 such codons in GST. The 
presence of such codons can affect protein accumulation, mRNA and plasmid 
stability (Zahn 1996). It has been implied that, rare codons primarily affect the rate 
of translation from a given gene (Andersson and Kurland 1990). Artificial 
translational pausing may well allow misfolding or transient formation of protease 
sensitive structure and thereby promote instability. The AGA codon is believed to 
cause problems in primary structure due to misincorporation of lysine for arginine 
(Forman et al., 1998). However these problems with the arginine codons can be 
overcome by making host strains that co-express the argU(dnaY) gene which 
encodes (Baneyx 1999). It is also known that G:C rich genes from 
parasites often display poor expression in E. coli (Button et at., 1991). It is 
noteworthy, that the Gp63(2) fragment of the fusion protein is encoded by a G:C rich 
region of DNA and this fusion protein had the poorest expression levels. It is also 
possible that the codon usage could be altered or improved artificially by PCR, but 
due to time constraints this was not possible. 
There is a bias towards one or two preferred codons for almost all degenerate codon 
families, e.g. CGG is the preferred triplet coding for proline as outlined in Table 4.1. 
This usually reflects the abundance of their cognate tRNAs. The table below (Table 
4.3) shows codons that are rarely used by Escherichia coli, but are present in the lb 
or gp63 fragments and may not be expressed efficiently in Escherichia coli. Such a 
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limitation may interfere with the translational capacity of the cell and promote 
protein misfolding or degradation. 
Amino acid Codons Occurrence in gene fragments 
LLO Gp63(1) Gp63 (2) 
Arg AGA, AGC, CGA, CGG 2 0 2 
Cys TGT,TGC 0 0 6 
Gly GGA,GGG 1 0 
Ile ATA 0 0 1 
Leu CTA,CTC 4 2 2 
Pro CCC, CCT, CCA 5 2 0 
Ser TCA, AGT, TCG, TCC 3 0 1 
Thr ACA 2 0 2 
Table 4.3. Low usage codons in E.coli (Makrides, 1996). 
The table also shows the occurrence of each of these codons in the gene fragments 
that were used for constructing GST fusions for the DTH assays. 
From Table 4.3, it can be seen that the gene fragments that were used to construct the 
GST fusion proteins contained a large number of amino acids with codons that were 
of low usage in Escherichia coli. It is of particular interest that the Gp63(2), which 
showed the poorest expression (Figure 4.27), contained the largest number of such 
codons (encoding 20 out of 122 amino acids in the peptide (16.3%)). In the case of 
Gp63(1) and LLO, 4 out of the total 55 codons (7.3%), and 17 out of a total of 161 
(10.5%) codons respectively, were of low usage in Escherichia co/i. GST-LLO and 
Gp63(1) were found to express to similar levels in Escherichia coli (Figure 4.27). 
However, there is one noticeable difference between these fusions compared with 
GST-Gp63(2) in that 12 out of the 20 codons in Gp63(2) are cysteine or glycine. 
Furthermore, all the glycines and 2 of the cysteines are present in the last 42 amino 
acids of the fusion protein. The other fragments, which are fused to GST, contain 
neither of these amino acid. This could be a possible explanation for the poor 
expression of the GST-Gp63(2) protein. 
Andersen et at., (1998), found that green fluorescent protein (GFP) which is known 
to be very stable, may be converted to an unstable variant through the use of natural 
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protease activity, which is apparently found in many different bacteria. They 
achieved this by minor alterations in the C-terminus, so that the protein was more 
rapidly recognised by intracellular tail-specific proteases (Tsp proteases) (Keiler et 
al., 1996). In Escherichia coli GFP is believed to have an in vivo half-life of more 
than one day. By altering the C-terminal sequence to LAA or LVA, the half-life was 
reduced to 40 minutes and, by altering to AAV or ASV the half-life was reduced to 
110 minutes. Therefore, the actual amino acid sequence present in fusion proteins is 
important in the recognition by specific proteases. 
However, the possibility remains that another fusion partner could be a possible 
solution to the problem with expression. It has been suggested that the linkage of 
thioredoxin to target proteins increases the solubility of fusion proteins expressed in 
E.coli and prevents the formation of inclusion bodies (LaVille et al., 1993). Kapust 
and Waugh (1999) found that MBP was far superior to either thioredoxin or GST as 
a solubilising partner. Therefore, a number of issues are still a matter of debate, when 
choosing an affinity tag for the purification of fusion proteins. Overall, time was 
limited for experimentation with the conditions for protein expression and 
purification. However sufficient quantities of GST fusion proteins were obtained for 
the DTH assay reported in this thesis. 
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CHAPTER 5 
.Immunisation of mice using 
attenuated Salmonella typhimurium 
as a vector for antigen delivery 
5.1. Immunisation of mice using attenuated Salmonella typhimurium as a vector 
for antigen delivery 
Salmonella enterica infects both humans and animals. Cattle, sheep, pigs, poultry 
and eggs are believed to be a major factor in the transmission of Salmonella enterica 
to humans, via the ingestion of contaminated food or water (Maurice 1994). 
Salmonellosis varies from gastroeneteritis, commonly known as food poisoning to 
the more severe typhoid fever, where the bacteria invade into deeper tissues like the 
liver and spleen (Gulig 1996). Complications of infection are often found in the 
immunosuppressed, the elderly and pregnant women. The annual incidence of 
Salmonella infections is estimated to be 0.2% per year (Wheeler et al., 1999). 
Salmonella eneterica serovar Typhi (Salmonella typhi) only infects humans and 
causes typhoid fever (Finlay and Falkow, 1989). Salmonella enterica serovar 
typhimurium causes systemic disease in mice, and acts as a model for human typhoid 
fever (Lucas and Lee 2000). 
A large amount of work has been concentrated over the past number of years, 
researching the potential use of Salmonella enterica as a live attenuated organism for 
immunisation (Chatfield et al., 1992). Live attenuated Salmonella vaccine strains 
require a balance between attenuation and persistence to induce protective immune 
responses (Chatfield et al., 1992; Ivanoff et al., 1994). Mutations that effect the 
ability of Salmonella typhimurium to cause disease have the potential to exert similar 
effects in Salmonella typhi (Tacket et al., 1992). Live attenuated Salmonella 
typhimurium produce a much greater protection in mice compared to dead cells, due 
to their potential to stimulate and develop strong cell-mediated immune responses 
(Collins, 1974; Mastroeni et al., 1993). Live bacteria can respond to the 
microenvironments of the host and produce a spectrum of antigens (Kagaya et al., 
1992). Production of these bacterial proteins within the host environment leads to 
recognition of these proteins by the immune cells, and thereby stimulation of an 
immune response. 
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Salmonella mutants that do not produce a complete lipopolysaccharide (LPS) 
molecule are attenuated in vivo and are readily lysed by complement. This suggests 
that LPS is important in the protection of bacteria against killing by the host (Gulig, 
1996). In acquired resistance, antibodies can also participate in clearance of the 
infection (Mastroeni et al., 1993). Later in infection, resistance to Salmonella is 
mediated by a T helper cell response involving mainly CD4 cells, where the immune 
response gradually clears bacteria from the organs (Nauciel, 1990; Hess et al., 
1996b). Mastroeni et al. (1993) demonstrated that naive BALBIc mice were only 
protected against challenge with virulent Salmonella typhimurium when both T cells 
and serum were donated to a susceptible mouse from an immunised mouse. 
Attenuated Salmonella typhimurium strains persist in the host for adequate time to 
induce an immune response, resulting in protection against a later challenge with a 
lethal dose of virulent Salmonella. This protective response is associated with the 
development of both humoral and cell-mediated immunity (Collins 1974; Mastroeni 
et al., 1993). 
5.2 Humoral and Cell-mediated immunity 
Humoral immunity plays an important role in the immune response to Salmonella 
enterica infection (Mastroeni et al., 1993). Antibodies have been detected against 
bacterial surface components, including LPS and flagella, and against intracellular 
proteins (Brown and Hormaeche, 1989). Proteins like GroEL and AhpC have been 
shown to be induced during interaction with macrophages, which correlates with 
their immunodominance (Buchneier and Heffron, 1990; Francis and Gallagher, 1993; 
Ahshire and Neidhart, 1993). GroEL belongs to the heat shock family of proteins 
(Hsps) and has homologues in nearly all organisms (Kaufmann, 1990). GroEL is a 
chaperone that helps to repair misfolded proteins and has been shown to be essential 
for the growth of Escherichia coli (Fayet et al., 1989). Salmonella typhimurium ahpC 
has been shown to be induced in tissue culture during interaction of the bacteria with 
macrophages (Francis and Gallagher, 1993; Francis, 1993). AhpC has also been 
shown to be immunogenic in rabbits and mice (Storz et al., 1989; Taylor et al., 
1998). 
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The T helper response mediated by CD4 cells can be divided into two subsets, Thi 
and Th2, depending on the cytokines produced. Thi cells regulate cell-mediated 
immunity and Th2 cells regulate humoral immune responses (Coffman and 
Mosmann 1991). T cell responses against intracellular pathogens and heterologous 
antigens expressed in Salmonella are generally of the Thi type (Yang et al., 1990; 
Brett et al., 1993; Xu et al., 1995; Mosmann and Sad 1996; Vancott et al., 1996). 
Thi cells induce delayed-type hypersensitivity reactions and produce 
proinflammatory cytokines such as IFN-y, IL-12 and tumour necrosis factor-beta 
(TNF-13), whereas Th2 cells produce IL-4, IL-S, IL-6, IL-10 and IL-13 (Mosmann et 
at., 1986; Nauciel and Epinasse, 1992; Mastroeni et al., 1996; Mosmann and Sad 
1996; Romagnani, 1996). IFN-y and IL-12 induce naïve and memory CD4 T cells 
and the development of Thi cells that secrete high levels of IFN-y and low levels of 
IL-2 (Bradley et al., 1996). Thi responses are accompanied with the production of 
IgG2a opsonising and complement-fixing antibodies and could be considered as 
effectors of phagocyte-dependent responses (Yang et at., 1990; Brett et at., 1993; Xu 
et at., 1995; Mosmann and Sad 1996; Romagnani, 1996; Vancott et at., 1996). 
Lipopolysaccharide (LPS) on the surface of gram negative bacteria is a T-cell 
independent antigen that induces a Thi cell response (Mattern et al., 1993). 
Th2 type T cell responses result in the production of cytokines like IL-4, IL-5, IL-6, 
IL-10 and IL-13 (Brett et at., 1993). IL-4, IL-10 and IL-13 aid production of 
antibodies from B cells, but also inhibit several macrophage functions. IL-4 is the 
most potent stimulus for Th2 differentiation and is a major inducer of B cell 
switching to IgE production (Swain et at., 1990; Romagnani, 1996). Th2 cells are 
great helpers for B lymphocytes and stimulate the production of high levels of 
antigen-specific, non-complement fixing IgGi, 1gM and IgE responses (Cofmann et 
al., 1988; Brett et al., 1993). Since, some of the cytokines produced by Th2 cells 
promote antibody production from B cells and inhibit several macrophage functions, 
they can be considered as effectors of phagocyte-independent responses (Mosmann 
and Sad 1996; Romagnani, 1996). Th2 responses are often associated with 
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gastrointestinal nematode infections and have been shown, to protective in parasitic 
infections (Else and Finkelman 1998). 
Salmonella species can induce a mixed Thl/Th2 response (Harding and Unanue, 
1990). Pascual et al., (1999) demonstrated a biphasic T cell response to mice 
immunised with Salmonella, with an early Th2 response, followed by a Thi 
response. The presence of IL-12 was detected in the early stages of infection, and 
therefore such immunisation appears to affect the Thl/Th2 balance in favour of a 
Thi response (Hseish et al., 1993; Seder et al., 1993). Production of IL-12 and IFN-
y shows biases towards a Thi response, while IL-4 production biases towards a Th2 
response (Seder et al., 1993; Constant and Bottomly 1997). IFN-y selectively inhibits 
proliferation of Th2 cells and Thi cells are inhibited by the production of IL-10 
(Mosmann and Cofmann., 1989; Fiorentino et al., 1989). The major factor that 
determines whether an immune response results in a Thi or a Th2 response is 
thought to relate to the number of antigenic epitopes available to the antigen specific 
T cell precursor for CD4 T cell priming (Constant et al., 1995; Hosken et al., 1997; 
Constant and Bottomly, 1997). 
There is conflicting evidence about whether Thi or Th2 responses result from high 
or low doses of antigen. It is generally suggested that low antigen concentrations and 
low doses induce Thi responses, whereas high doses induce the development of Th2 
responses (Bretscher et al., 1992; Hosken et al., 1995). In one study in which 
BALB/c mice were exposed to repeated low doses of ovalbumin (protein antigen), a 
Th2 response resulted with the production of IgE (Wang et al., 1996). In agreement 
with this observation, after imniunisation with 50tg of HuCiv (peptide antigen 
derived from the sequence of Human IV collagen), a Thi response developed, 
whereas when 2.tg was used a Th2 response resulted (Pfeiffer et al., 1995). In 
disagreement with these experiments, BALB/c mice immunised with low levels of 
parasites resulted in a delayed- type hypersensitivity (DTH) response (indicative of 
cell mediated immunity) accompanied by protection. However, both DTH and 
protection was gradually lost after increasing the parasite numbers from 102  to  106 
(Bretscher et al., 1992). 
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Differences in the T cell response may be a result of the difference in the type of 
antigen used in the immunisation (e.g. parasite versus protein). It is possible that at 
low antigen doses, the principal antigen presenting cells (APC) are macrophages or 
dendritic cells. Both of these cell types produce IL-12, which could skew the 
response towards a Thi response (Bretscher et al., 1992; Hosken et al., 1995). There 
could also be differences in the number and level of antigenic epitopes that are 
available to the T cell receptor, depending on the initial form of the antigen. In the 
scenario of high antigen concentration, repeated T cell stimulation may occur 
causing an increase in IL-4 production and thereby development of a Th2 response 
(Bretscher et al., 1992; Hosken et al., 1995). In the case of parasites, many are 
naturally glycosylated and this may attribute to high uptake at low antigen doses 
(Sallusto et al., 1995). 
CD4 cells recognise peptides presented by major histocompatibility complex class II 
molecules (MHC-II). Internalised bacteria reside in phagosomes and are presented to 
MHC-II molecules after the bacterial antigens have been processed (Ramachandra et 
al., 1999). MHC-II expression is found mainly on APC like macrophages, dendritic 
cells and B cells (Ramachandra et al., 1999). Class II molecules mainly present 
peptides derived from exogenous antigen (extracellular proteins including microbial 
proteins) internalised by these cells (Germain, 1994). Such antigens are 
proteolytically degraded into peptides in the endocytic pathway by vacuolar 
proteases in endocytic or phagocytic organelles (e.g. phagosomes). The peptides are 
loaded onto the MHC-II molecules and transported to the cell surface (Ramachandra 
et al., 1999). 
Previously it was thought that MHC class TI-restricted CD4 TH cells controlled 
bacterial infections, whereas MHC class I-restricted CD8 CTL cells controlled viral 
pathogens (Kaufmann, 1996). Cytolytic (CTL) responses from CD8 cells have also 
been demonstrated after immunisation with recombinant Salmonella expressing the 
listeriolysin of Listeria monocytogenes (Verma et al., 1995). It has been shown that 
an alternative MHC I pathway exists that displays phagosomal antigens to MHC- I 
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molecules using an unknown mechanism (Pfeifer et al., 1993: Wick and Pfeifer 
1994). It is thought that processing and presentation of bacteria within the 
phagosome can take place by an alternative pathway in association with MHC-I 
(Pfiefer et al., 1993). Host cells expressing endogenous antigens associated with 
class I MHC molecules are destroyed by CD8 cytolytic T cells (CTL) that recognise 
this complex (Abbas et al., 1997). CD8 cells may play a role in Salmonella enterica 
infection and have been identified in human volunteers after infection with an 
attenuated Salmonella typhi strain (Sztein et al., 1994). 
5.3 Attenuated Salmonella typhimurium aroA and purA strains 
Various strategies have been used to identify genes that can be selectively expressed 
in viva. Stocker et al., (1981) examined the effects of auxotrophy on virulence. A 
lesion was introduced into one of the genes encoding precursors of the aromatic 
amino acid (aro) pathway. These strains (aro) require the substrates para-
aminobenzoic acid and 2,3-dihydroxybenzoate, which are not readily available in 
sufficient quantity in host tissues for survival and virulence. As a consequence, they 
are generally attenuated in viva (Hoiseth et al., 1981; Roberts et al., 1994; Everest et 
al., 1995). Salmonella strains with mutations in the aromatic biosynthetic pathway 
(aro genes) have been used for immunisation of chickens, calves and sheep (Smith et 
al., 1984; Mukkur et al., 1987; Cooper et al., 1990; Jones et al., 1991; Segall et al., 
1991). 
Salmonella typhimurium strains with mutations in purine genes (pur) were also found 
to have potential as live attenuated vaccines. Strains with mutations in pur genes (e.g 
purA) block the synthesis of adenosine monophopsphate (AMP) from inosine 
monophosphate (IMP), resulting in a requirement for adenine. Mahan et al., (1993, 
1995) capitalised on this observation by using the purA gene as a means of selection. 
This was achieved using a procedure known as IVET (in viva expression technology) 
to exploit this requirement to identify genes of Salmonella typhimurium that were 
expressed during host infection. When the bacteria were injected into mice, only 
those bacteria that had developed the capacity for expressing the pur gene survived. 
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In this case, the Salmonella typhimurium strain used was a pur mutant and so, if 
modified were highly attenuated in mice because of the auxotrophic requirement for 
purines. Pashine et al., (1999), demonstrated that both aroA and purA attenuated 
strains of Salmonella typhimurium developed the same type of dominant IFN-y T cell 
response, even though they cannot proliferate in vivo. They concluded from their 
work that invasion into macrophages is necessary for effective generation of Thi-like 
immune responses. However, persistence of Salmonella beyond 48 hours is not 
required. (Pashine et al., 1999). In this thesis, the purA gene was utilised as a means 
of in vivo selection of bacteria that were able to maintain their plasmids. This was 
achieved by using a Salmonella lyphimurium strain with a chromosomal purA 
mutation and supplying the purA promoter and gene on a plasmid as a means of in 
vivo selection. 
5.4 In vivo activated promoters 
Stable expression of the guest antigen in vivo is necessary for presentation of the 
antigen, thereby inducing a protective immune response. The unregulated expression 
of foreign antigens within Salmonella can lead to plasmid instability. One way to 
promote the stable expression of guest antigens is by chromosomal integration of the 
guest antigen. However, one possible disadvantage is that the foreign gene will be 
present as a single copy per bacterial cell, which may result in lower antigen 
expression (Cardenas et al., 1993; Covone et al. 1998). A range of antigens have 
been expressed under the control of such in vivo expressed promoters (Roberts et al. 
1998; Chatfield et al. 1992; Hohmann et al. 1995; Mc Sorley et al. 1997; Dunstan et 
al., 1999; Marshall et al. 2000) 
Francis and Gallagher (1993) identified a hydrogen peroxide inducible locus ahpCF 
(Alkyl hydroperoxide reductase), induced upon interaction of Salmonella 
typhimurium cells with macrophages. This gene is part of the OxyR regulon and may 
act to minimise damage to Salmonella typhimurium during the course of infection by 
protecting the cell membrane from lipid peroxidation (Christman et al., 1985; 
Tartaglia et al., 1990). It has been shown previously that AhpC is not required for 
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full virulence of Salmonella zyphimurium in mice (Taylor et al., 1998). Moreover, 
because of its mode of activation, the ahpC promoter has the potential to express 
foreign antigens in vivo, in response to interaction with macrophage cells which play 
a central role in microbial destruction and stimulation of the immune response via 
antigen presentation (Francis et al., 1993; Taylor et al., 1998). 
The Salmonella typhimurium two-component transcriptional regulatory system 
PhoP-PhoQ responds to signals within the environment of the acidified macrophage 
phagosome by inducing PhoP activated gene (pag) transcription (Alpuche-Aranda et 
al. 1992). PhoP activated (pag) genes promote survival within macrophages in mice 
(Miller et al. 1989,1990; Miller 1991). The pagC gene encodes an outer member 
protein of 188 amino acid (PagC), which is essential for the full virulence of 
Salmonella typhimurium in BALB/c mice. (Pulkkinen et al. 1991; Hohmann et al. 
1995). The pagC promoter is known to activate protein expression in response to low 
concentrations of Mg 2 (Garcia et al., 1996; Dunstan et al., 1999). Attenuated 
Salmonella typhimurium has been shown to provide stable high level expression of a 
heterologous antigen encoded on a plasmid under the control of the in vivo induced 
pagC promoter (Dunstan et al. 1999). 
The spy genes play a role in the establishment of systemic Salmonella infection in 
mice (Libby et al. 1997). The spy structural genes (spvABCD) are expressed when 
bacteria enter stationary phase or when cells are grown under carbon or nutrient 
starvation (Fang et al. 1991; Coynault et al. 1992; Fierer et al. 1993). The spy locus 
consists of the regulatory gene spvR and the structural genes spvABCD genes (Gulig 
et al., 1992 and Krause et al., 1992). The regulatory protein SpvR binds to regions 
upstream of both spvR and spvA promoters, in order to induce expression of the 
spvABCD operon (Fang etal.1991; Krause et al., 1992; Grob et al., 1996). It has 
been shown that mice inoculated with Salmonella typhimurium (SL3261) containing 
a plasmid expressing the C fragment of Tetanus toxin (TetC) under the control of the 
spy promoter, resulted in good antibody responses to TetC (Marshall et al 2000). 
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Therefore, these three promoters (ahpC, pagC and spvA) were selected to investigate 
expression of the guest antigens from Leishmania major and Listeria monocyto genes 
on a plasmid carried by live attenuated Salmonella typhimurium. The ahpC promoter 
was selected because of its possible potential to express foreign antigens in vivo, in 
response to interaction with macrophage cells. Both the pagC and spvA promoter 
have been previously used for the expression of foreign antigens in Salmonella 
typhimurium (Dunstan et al., 1999; Marshall et al 2000). There is conflicting 
evidence about the expression in vivo from the pagC and spvA promoters in vivo, 
whereas both promoters expressed antigens to a high level in vitro. In the case of 
pagC, a good antibody response was obtained when this promoter was used to 
express the antigen TetC. However, bacteria recovered for the spleen had lost the 
plasmid over the 15 day period (Hohmann et al. 1995; Dunstan et al. 1999). The spy 
promoter was also included in this study, because although the expression of the spy 
promoter in vitro was successful in comparison with the promoter dps, the level of 
antibody against the guest antigen differed. The level of antibody detected was lower 
in the mice immunised with the plasmid expressing the antigen from the spy 
promoter, as opposed to the dps promoter (Marshall et al., 2000). However, in vitro 
analyses suggested that the expression of the spy promoter was more strongly 
induced than the dps promoter in macrophage-like cell lines and that the spy 
promoter could induce higher levels of TetC in culture (Marshall et al., 2000). Thus, 
the pagC and spvA promoters were included in the present study, to investigate if 
sufficient expression of the heterologous antigens occurred from the plasmid 
constructs to result in a measurable immune response. 
5.5 Antigens of interest 
Leishmaniasis is caused by a protozoan parasite Leishmania major and is transmitted 
to mammals by the bite of a sandfly. It is a tropical disease whose symptoms range 
from simple self-healing cutaneous lesions, destructive mucosal disease and 
subclinical visceral infection to fatal visceral leishmaniasis (Russo et al. 1991). The 
major surface glycoprotein (gp63) is a protease that is highly conserved among 
Leishmania species, and has been implicated in virulence (Chang et al., 1986; Etges 
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et al., 1989). This protein is of major interest since it is expressed in both the 
promastigote and amastigote stages of the life cycle (Boudier 1987; Chaudhuri et at. 
1989). Yang et at., (1991) carried out an analysis of T cell epitopes present in gp63 
of Leishmania major and concluded that gp63 is a dominant T cell inducer in vivo. 
They concluded from their study that peptides p146-171 and p467-482 were able to 
induce significant host resistance against Leishmania major infection. Therefore, in 
this study these regions were included in the plasmid constructs used for 
immunisation of BALB/c mice. 
Listeria monocyto genes is a gram positive, facultative intracellular bacterium that 
causes listeriosis in animals and humans, especially in immunocompromised 
individuals (Kaufmann 1988; Schuchat et at., 1991). Class I (LLO 91-99) and class 
II (LLO 215-226) MHC-restricted T cell epitopes have both been shown to be 
important in protection (Safeley et at., 1991; Harty et at. 1992; Safeley et at., 1995). 
However, unpublished results from Ziegler and Safeley, found that synthetic peptides 
corresponding to these epitopes failed to confer protection, suggesting that an 
efficient delivery system is required to achieve full potential efficacy from these 
epitopes (Verma et at., 1995). In the study in this thesis, both peptides were included 
in the plasmid constructs to investigate if protection was obtained by delivery using 
live attenuated Salmonella typhimurium. 
This chapter describes the use of a variation on the IVET system, where the 
Salmonella typhimurium strain contained both a purA and an aroA mutation, leaving 
the strain hyper-attenuated. However, a complementing purA promoter and gene 
were supplied in trans on plasmids used to express the heterologous guest antigens. 
Complementation of a lethal mutation by a plasmid is a method of ensuring plasmid 
maintenance (Nakayama et at. 1988; Curtis et at. 1990). 
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The aim of this study was to investigate whether successful immunisation against 
Listeria monocyto genes and Leishmania major could be achieved using Salmonella 
typhimurium as a vector for immunisation. As stated above, the antigens of interest 
were gene fragments cloned from listeriolysin (LLO) of Listeria monocyto genes and 
glycoprotein 63 (gp63) of Leishmania major under the control of three different in 
vivo promoters (ahpC, pagC or spvA). Both humoral and cell-mediated immunity 
were investigated to ascertain if there was any difference in the response to the 
antigens encoded on the plasmids, depending on the promoter used for expression. 
5.6 RESULTS 
5.6.1 Construction of an attenuated Salmonella lyphimurium strain for 
immunisation 
The first part of this study involved constructing a Salmonella typhimurium strain 
that contained both a purA and an aroA mutation. A purA::TnlO was moved by 
transduction with phage P22 HTint4 (Roth 1970) from Salmonella lyphimurium 
CH23 into SL3261 (aroA mutant) to generate MPG424 for use in the present study 
(Chapter 2; section 2.2.2). The purA mutation on the Salmonella typhimurium strain 
was complemented by the presence of both the purA promoter and gene on a 
plasmid. This provided a means of selection for maintenance of the plasmids in vivo 
without the use of antibiotics. This also provided the basis for construction of further 
plasmids whereby a heterologous (guest) antigen was placed under the control of 
three different in vivo-activated promoters. These constructs were designed to allow 
investigation of the antibody response to the individual peptides depending on the 
promoter used. 
5.6.2 Construction of plasmids for immunisation studies 
The first plasmid (pTMB2) in the series was constructed with the purA promoter and 
gene, which formed the basis for construction of the other plasmids in the series. The 
final plasmids (pTMB6, pTMB7, pTMB8 and pTMB20) had the gene fragments of 
interest (llo from Listeria monocyto genes and gp63 from Leishmania major) cloned 
downstream of either the ahpC, pagC or spvA promoter. A region encoding a 
Polyhistidine Tag was also cloned downstream of the promoters to aid verification of 
protein production at each stage of construction by immunoblots. Two additional 
plasmids were constructed which contained the stable enhanced green fluorescent 
protein (GFP) fused to either the ahpC (pTMB2 1) or pagC (pTMB22) promoter. 
Construction of the plasmids is outlined in Chapter 4 and a summary of the plasmids 
is shown in Table 5.1. The plasmid constructs were subsequently transformed into 
the strain MPG424 (aroA, purA) for immunisation studies. BALB/c mice (H-2") 
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were chosen for this study because of their proven responsiveness to Salmonella 
vaccines and because the epitopes under study had been shown to be recognised by T 
cells in other studies (Fayolle et al., 1994). 
Plasmid Promoter Fusion Protein 
pTMB2 None None 
pTMB6 ahpC His-LLO-Gp63 
pTMB7 ahpC His-LLO-Gp63 (1 )-Gp63 (2) 
pTMB8 pagC His-LLO- Gp63(1)-Gp63(2) 
pTMB20 spvA His-LLO- Gp63(1)-Gp63(2) 
pTMB21 ahpC GFP 
pTMB22 pagC GFP 
Table 5.1. Plasmids used for immunisation. 
All the plasmids contained the purA promoter and gene to complement the chromosomal purA 
mutation in MPG424. This strain contained both a purA and an aroA mutation. Details of the 
construction of the plasmids are outlined in Chapter 4. 
5.6.3 Analysis of humoral and cell-mediated immunity 
In order to determine whether humoral or cell mediated immunity was generated, 
groups of BALB/c female mice, aged 8-10 weeks (15-20g) were injected 
intraperitoneally (i.p.) with MPG424 carrying one of the different plasmids. In 
summary, cultures containing the plasmids were grown overnight in the presence of 
10tg/p1 of chioramphenicol then washed and diluted in PBS. The number of 
organisms injected was determined by serial dilution on solid LB media containing 
chioramphenicol on the day of immunisation. Therefore, if there was a slight 
difference in the bacterial dose used for immunisation in experimental groups, this 
was determined by plating on solid media on the day of immunisation. The dose of 
Salmonella typhimurium was chosen because a similar bacterial inoculum had 
resulted in no visible signs of illness in the mice. However, protection against 
challenge by a virulent Salmonella typhimurium (SL1344) was obtained, thus 
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indicating that a suitable immune response had been generated (Hoiseth and Stocker 
1981). 
After infection, mice were caged in groups of no more than three, and supplied with 
a commercial pellet diet and water ad libitum. Antibody responses to proteins during 
the course of infection were determined by examining the serum from mice at day 0, 
14 and 28 post-infection. On one occasion serum was taken at day 21 and analysed 
(section 5.2.4). Humoral immunity was assessed by ELISA plates coated with 
GroEL, AhpC-His, GST-LLO, GST-Gp63(1), GST-Gp63(2) or GST. The presence 
of antibody against GroEL and AhpC (Salmonella proteins) provided an internal 
control to check for persistence of Salmonella typhimurium within the mice. 
Purification of the antigens is described in Chapter 2. Serum samples were pooled on 
each day from mice within an experimental group and analysis was determined on 
pooled sera. The secondary antibody was HRP anti-mouse IgG (sheep), used at a 
dilution of 1 in 3000 (SAPU). Antibody titres were analysed at 490nm. The lower 
cut-off for the antibody titres was calculated as an absorbance reading of 0.25. Any 
absorbance recorded about this threshold was considered as a positive result and the 
titres were calculated accordingly. 
Cell-mediated immunity (CMI) was investigated by analysing the delayed type 
hypersensitivity (DTH) response to proteins injected into the footpad. A DTH 
response occurs when a mouse is challenged with an antigen that has been previously 
recognised by the immune system (Abbas et al., 1991; Mitov et al., 1992). The 
injection of antigen into the footpad produces a swelling at the injection site, due to 
recognition of the antigen by memory T cells and activation of an inflammatory 
response. The DTH test requires careful preparation of antigen for injection and 
accurate measurement of the degree of swelling. DTH reactions to individual 
proteins were investigated 35 days after infection, by subcutaneously (s.c.) injecting 
the right hind footpad (RHFP) of each mouse with 50jtl of PBS containing 20j.tg of 
heat aggregated protein. As a control the left hind footpad (LHFP) of each mouse in 
all groups was injected with 50p.l of PBS only. Unchallenged mice (Not injected with 
Salmonella at day zero), treated in a similar way acted as controls. At 24 hours and 
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48 hours after challenge the thickness of the RHFPs and LHFPs were measured in 
thousandths of an inch, taking three measurements of each footpad in three different 
planes using dial-type callipers. The thickness of the RHFP (protein injected) was 
divided by the thickness of the LHFP (saline injected) to give a footpad thickness 
ratio. The ability of a particular protein to elicit a DTH response was determined by 
comparison of the mean increase in footpad ratio per group between infected and 
uninfected control mice. The statistical significance of the results was calculated by 
the student's t-test. 
5.6.4 Immunisation of mice with a multipeptide fusion protein expressed under 
the control of the ahpC promoter. 
Studies in this laboratory have shown that genes, which are activated by oxidative 
stress, such as exposure to hydrogen peroxide, may also be activated during 
macrophage interaction. The ahp locus, which encodes the heterodimeric enzyme 
alkyl hydroperoxide reductase, represents such an operon and this locus is induced 
by activation of the respiratory burst in macrophages (Francis and Gallagher, 1993; 
Storz et al., 1989). Given that this promoter is induced during macrophage 
interaction, it may have the potential for controlled expression of foreign antigens. 
Taylor etal. (1997) demonstrated that the ahp gene of Salmonella typhimurium was 
not essential for the virulence of the organism, and could be a potential site for the 
chromosomal insertion of genes encoding heterologous antigens (Taylor et al., 
1998). 
In this study the ahpC promoter was selected to drive the expression of the guest 
antigens from Listeria monocyto genes and Leishmania major as outlined in Table 
5.1. BALB/c mice were immunised with either 8 x 
104  Salmonella typhimurium 
carrying the plasmid pTMB2 (control) or 2 x 104  MPG424 cells (determined by plate 
counts) carrying plasmid pTMB7 in I OOtl of phosphate buffered saline (PBS). 
PTMB2 contains only the purA promoter and gene on a plasmid, which acts as an 
internal control for the experiment, whilst plasmid pTMB7 contains the ahpC 
promoter to drive the expression of the chimeric antigens. 
lV1 
Serum samples were pooled within a group and were analysed for the presence of 
antibodies against GroEL, AhpC, GST, LLO, Gp63(l) and Gp63(2). Surprisingly, 
antibody titres of <16 were recorded for all proteins (GroEL, AhpC, LLO, Gp63(1), 
Gp63(2) and GST) at day 0, 14 and 28, regardless of whether the mice were 
immunised with pTMB2, pTMB7 or injected with PBS at day zero. Previously in this 
laboratory, antibodies against GroEL and AhpC were observed in serum from mice 
immunised with aroA Salmonella typhimurium by Western blots using a 1 in 200 
dilution of the sera at day 28 (Taylor etal., 1998). However in this instance there was 
no production of antibodies, irrespective of the plasmid used for immunisation. At 
day 35, cell-mediated immunity was investigated by measuring footpad enlargement 
after the experimental protein was injected into the RHFP. The data for the footpad 
thickness for 24 and 48 hours are recorded in Tables 5.2 and 5.3, respectively. The 
ratios of the RHFP to the LHFP were calculated as a percentage in order to eliminate 
the level of different responses (Table 5.2 and Table 5.3a and 5.3b). 
All proteins except GST were found to cause a significant footpad enlargement at 24 
hours in mice immunised with MPG424 cells containing pTMB7, pTMB2 and the 
PBS control mice. The largest footpad response at 24 hours was recorded in both 
groups of mice immunised with cells containing pTMB7 and pTMB2 when 
challenged with His-AhpC with ratios of 127.1% and 124.3%. The p values were 
highly significant with values of <0.001 and <0.01 respectively. After 48 hours the 
ratios decreased to 120.1% and 111.4% respectively. This was as expected, since 
previous work in the laboratory has recorded similar footpad enlargements after 
immunisation with Salmonella lyphimurium and challenge with His-AhpC (Taylor 
1997). Also, a significant response with a  value at <0.01 was observed in the PBS 
controls (injected at day0 with PBS) after His-AhpC challenge, with a footpad ratio 
of 110.2% at 24 hours, decreasing to 103.9% at 48 hours. This was not overly 
surprising, as the mouse would have been exposed to its own gut flora, which would 
contain Escherichia coil. Salmonella typhimurium AhpC shares 92% identity to 
Escherichia coil AhpC (Smillie, 1994; Armstrong-Buisseret, 1995). 
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Immunised 
At day 0 
Protein 
Mean Footpad thickness 
(inches x10 3 ) ± SEM P value 
Footpad ratio 
(RHFP/LHFP) 
 x 10 (%)  R1-IFP LHFP 
pTMB7 AhpC 73.4± 1.85 59.1 ± 0.97 <0.001 124.1 
AhpC-LLO- Gp63(1) 67.7± 1.19 60.1 ± 0.36 <0.01 112.7 
LLO 66.7 ± 2.00 59.2 ± 0.42 <0.01 112.6 
GST 62.2 ± 0.61 60.4+0.46 <0.05 103.0 
pTMB2 
None 
AhpC 73.0±2.23 58.7 ±0.31 <0.01 124.3 
Gp63(1) 65.2 ± 0.76 59.7 ± 0.76 <0.01 109.3 
LLO 70.0± 1.53 61.0 ±0.17 <0.05 114.8 
GST 62.4 ± 1.07 60.2 ± 1.22 NS 103.7 
PBS AhpC 68.4±0.64 62.0±0.85 <0.01 110.2 
Gp63(1) 65.7±0.70 62.1 ± 0.96 <0.05 105.8 
LLO 65.1 ± 0.44 60.6 ± 0.94 <0.05 107.6 
GST 63.1 ±0.70 60.0 ±0.54 <0.01 105.1 
Table 5.2. Footpad thickness recorded 24 hours after challenge in the right hind 
footpad (RHFP) with the experimental protein. 
Mice were challenged in the RHFP by injecting 20ig of heat aggregated AhpC, GST, GST-LLO or 
Gp63(1) in 50jil of PBS, the LHFP was injected with PBS as a control. Thickness was recorded in 
thousandths of an inch. P values were obtained using the students t test by comparing the RHFP and 
LHFP. PBS controls were injected at day 0 with PBS. NS= non-significant p value 
Immunised 
At day 0 
Protein 
Mean Footpad thickness 
(inches x10 3) ± SEM P value 
Footpad ratio 
(RHFP/LHFP) 
 xlOO (%)  RHFP LHFP 
pTMB7 AhpC 67.9 ± 1.5 61.0± 0.5 <0.01 111.4 
AhpC-LLO- Gp63(1) 65.8 ± 1.3 59.6 ±0.3 <0.01 110.6 
LLO 63.9 ± 0.9 59.3 ± 1.0 <0.05 107.8 
GST 61.5 ± 1.0 59.7 ± 0.5 NS 103.0 
pTMB2 AhpC 71.0±1.7 59.1 ± 0.1 <0.01 120.1 
None Gp63(1) 63.5 ± 0.7 60.3 ± 0.4 <0.01 107.0 
LLO 67.7 ± 1.0 61.6 ± 0.1 <0.05 109.9 
GST 61.0 ± 0.6 59.9 ± 0.8 <0.01 101.9 
PBS AhpC 62.0±0.6 59.7±0.7 <0.01 103.9 
Gp63(Il) 64.0 ± 0.8 62.3 ± 1.3 NS 102.7 
LLO 63.2 ± 0.3 60.9 ± 0.4 NS 103.8 
GST 60.8 ±0 .5 59.9 ± 0.5 NS 101.5 
Table 5.3a. Footpad thickness recorded 48 hours after challenge in the right hind 
footpad (RHFP) with the experimental protein. 
192 
Footpad enlargements were also recorded against GST-Gp63(1) and GST-LLO in 
mice immunised with cells containing pTMB7 and pTMB2. At 24 and 48 hours post-
challenge the mean footpad ratios of 112.7% and 110.6% were recorded for pTMB7 
immunised mice, inoculated with GST-Gp63(1) in the RHFP. In the case of mice 
immunised with cells containing pTMB2, the response was surprising since there 
was no presence of Gp63 (1) or LLO on the plasmid used for immunisation. There 
was no footpad enlargements observed in the pTMB7 or PBS control mice (PBS 
injected at day 0) challenged with GST, but an enlargement was noted in the mice 
infected with Salmonella containing pTMB2. No response against GST-Gp63(1) or 
GST-LLO was observed in the PBS control mice, as calculated by the students t-test 
(i.e. NS). 
Immunised p values (Experimental compared with PBS controls) 
At day 24 Hours 48 hours 
zero AhpC Gp63(1) LLO GST AhpC Gp63(1) LLO GST 
pTMB7 <0.01 <0.05 NS NS <0.05 <0.05 NS NS 
pTMB2 0.01 NS NS NS <0.01 NS <0.05 NS 
Table 5.3b. P values recorded after footpad ratios of the immunised mice were 
compared with the footpad ratios for the PBS controls injected with the same 
experimental protein. 
NS= non-significant p value. PBS controls were injected at day 0 with PBS. 
When the footpad ratios of the immunised mice challenged with particular proteins 	- 
were compared after subtraction of the values for animals immunised at day zero 
with PBS, a number of differences were recorded (Table 5.3b). When mice, 
immunised with cells containing pTMB7 or pTMB2 challenged with AhpC, were 
compared, significant footpad enlargement ratios were recorded with p values 
ranging from <0.01 to < 0.05 at both 24 and 48 hours. A significant response was 
also recorded at 24 and 48 hours for pTMB7 immunised mice challenged with 
Gp63(1), when compared with the PBS controls. P values of <0.05 were recorded at 
both times, which indicates that the response to this protein is significant. Therefore, 
mice immunised with pTMB7, although showing no stimulation of B cells as 
recorded via antibody production, showed some stimulation of T cells, which 
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resulted in a footpad response after injection of the protein. However, no significant 
response was recorded against GST-LLO in the mice immunised with cells 
containing pTMB7, even though LLO was encoded on the plasmid with Leish-1. 
One response that was not expected, was the significant response recorded at 48 
hours with a p value of <0.05 to GST-LLO in mice immunised with cells containing 
pTMB2. This could be explained by the possibility that the immune response was 
directed against a small portion of the protein that is homologous to another protein 
that the mice have already encountered. It can be concluded from this study that the 
footpad responses, which were statistically significant, were not due to GST. All of 
the immunised mice recorded a non-significant response against GST when 
compared with the PBS control mice injected with the same protein (Table 5.3b). 
Overall, this study showed that although pTMB7 immunised mice failed to induce 
measurable antibody against Salmonella proteins (Gr0EL or AhpC) or the proteins 
encoded on the plasmids, relevant footpad responses were observed against certain 
proteins. The possible reasons for poor antibody responses were therefore, 
investigated further. The possibility existed that the fusion protein (His-LLO-
Gp63(1)-Gp63(2)) was not optimally expressed from the ahpC promoter and so 
resulted in poor antibody induction. 
5.6.5 Immunisation of mice with fusion proteins, expressed under the control of 
alternative promoters 
Since there was no antibody observed from mice immunised with cells containing 
pTMB7 in the above experiment, the next part of the study was to determine whether 
poor expression from the ahpC promoter was the main reason for inadequate 
stimulation of humoral immunity. To address this possibility, plasmids where 
constructed that contained alternative in vivo-inducible promoters (spvA and pagC). 
Plasmids pTMB8 (PpagC) and pTMB20 (PspvA) were constructed with promoters 
upstream of the encoded polyvalent polypeptide to facilitate expression in vivo. Two 
other plasmids with the ahpC promoter (pTMB6 and pTMB7) were included in the 
study for comparisons (refer to Table 5.1). Each of these plasmids were derived from 
pTMB2 (refer to Chapter 4). Groups of BALB/c mice were immunised i.p. with 
between Ix iO 4 and 6x105 Salmonella lyphimurium (determined by plate counts) 
carrying the plasmids prepared as above (Table 5.4). Serum was pooled from each 
group of 5 mice and analysed for the presence of antibodies at day 0, 14 and 28. 
Plasmid Promoter Fusion Protein 
Bacterial dose 
(c.f.0 in 100d PBS) 
pTMB2 None None 6x105 
pTMB6 ahpC His-LLO- Gp63(1) 6x104 
pTMB7 ahpC His-LLO- Gp63(1)-Gp63(2) 1x104 
pTMB8 pagC His-LLO- Gp63(1)-Gp63(2) 8.5x104 
pTMB20 spvA His-LLO- Gp63(1)-Gp63(2) 6.2x104 
Table 5.4. Bacterial doses used for immunisation with Salmonella lyphimurium 
carrying different plasmid constructs. 
Construction of the plasm ids is outlined in Chapter 4 
As before, antibody was analysed against GroEL and AhpC to check for sufficient 
persistence of Salmonella typhimurium within the mice to stimulate humoral 
immunity. Pooled sera was analysed at day 0, 14 and day 28 for the presence of 
antibody against these proteins. A positive antibody titre against GroEL was 
observed in mice immunised with MPG424 carrying pTMB6, resulting in an 
antibody titre of 64 at day 28. All other antibody titres against AhpC and GroEL 
were <16 at each of day 0, 14 and 28. Antibody titres against LLO, Gp63(1)and GST 
remained at <16 for each of day 0, 14 and day 28. Overall, no antibody was detected 
against any of the peptides encoded on the plasmid, irrespective of the promoter used 
to drive the expression of the fusion proteins. 
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5.6.6 Stability of the polypeptide constructs and immunisation of mice 
Since negligible antibody responses resulted from mice immunised with Salmonella 
typhimurium carrying the plasmid constructs, stability of the fusion protein could 
have been a factor in the lack of detectable antibody. To address the possibility of 
whether the polyvalent polypeptides were unstable, an enhanced green fluorescent 
protein (eGFP) was cloned downstream of the promoters (ahpC and spvA) replacing 
the previous polyvalent fusion protein (His-LLO- Gp63(1)-Gp63(2)). Plasmids were 
constructed, where GFP expression was under the control of either the ahpC 
promoter (pTMB2I) orpagC promoter (pTMB22). 
The GFP protein from the jellyfish Aequorea victoria is a stable protein with a half-
life greater than 24 hours (Clontech 1998, www.clontech.com ). GFP is a cytoplasmic 
protein with low toxicity, and the presence of GFP does not normally interfere with 
the growth of the host (Chalfie etal., 1994; Andersen et al., 1998). Previously, GFP 
has been used as a selectable marker in conjunction with fluorescence-activated cell 
sorting (FACS), to identify genes in Salmonella typhimurium induced upon 
association with host cells (Valdiva et al., 1997). GFP has also been used as a tool to 
monitor gene expression in Mycobacterium smegmatis and Mycobacterium bovis 
BCG using signal transduction and stress-response systems. Dhandayuthapani et al., 
(1995) also used GFP to track mycobacterial cells within macrophages. GFP was 
also used to visualise plasma membrane ruffling when Salmonella typhimurium 
invades human Hep-2 cells (Francis et al., 1992; 1993). In this thesis, the fact that the 
GFP protein is stable for >24hours, was advantageous to investigate if protein 
stability was an issue in the immune response obtained after immunisation. 
Groups of female BALB/c mice were immunised essentially as before, with 8.8x 10 5 
Salmonella typhimurium (MPG424) carrying pTMB2I and 6.5x10 4 Salmonella 
typhimurium (MPG424) carrying pTMB22. To check for the persistence of 
Salmonella typhimurium in the mice during the course of infection, pooled sera from 
each group were analysed by ELISA at day 0, 14 and 28 for the presence of antibody 
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against GroEL and AhpC. In each case, antibody titres against these proteins were 
<16 at day 0,14 and 28. A positive control was included in each plate coated with 
GroEL. The pooled sera used, as the primary antibody for the positive control was 
serum obtained from mice that had been previously immunised with GroEL. The 
titres in the control samples had an end-point of 1 in 32,000. This acted as a control 
for the ELISA, as the same protein and same secondary antibody was used in each 
case. Antibody titres against both eGFP and GST at day 0,14 and 28 were also <16 
when pooled sera from the groups of mice immunised with cells containing pTMB21 
and pTMB22 were analysed. Thus, it has been observed that none of the constructs, 
irrespective of promoter or fusion protein used, increased the antibody titres against 
the Salmonella typhimurium proteins (Gr0EL or AhpC) or the GFP present on the 
plasmid. It could be suggested therefore, that the bacteria were not surviving in vivo 
long enough to induce an immune response. 
5.6.7 Effect of increasing the bacterial dose used for immunisation 
The above experiments indicated that there was no increase in antibody titres after 
mice were immunised with either pTMB21 or pTMB22. However, the reason for the 
absence of humoral immunity against the Salmonella proteins and plasmid peptides 
was still an issue. It could be suggested that the poor antibody induction could have 
been due to the inadequate survival of Salmonella typhimurium in vivo, since no 
antibody was detected against the salmonella proteins GroEL or AhpC expressed 
from the chromosome. To address this question, three groups of 5 BALB/c female 
mice were immunised with higher infection doses (5x10 6, 5x10 7 or 5x108) of 
Salmonella typhimurium MPG424 in 100[d of PBS carrying the plasmid construct 
pTMB22 (pagC-GFP). 
Large doses of Salmonella typhimurium were used to immunise mice, because the 
possibility exists that this strain with mutations in aroA and purA requires larger 
doses for infection. Larger doses may be required for the strain to persist in the host 
long enough to induce an immune response. The construct pTMB22 was chosen 
because it had been previously shown in the literature that a good antibody response 
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was obtained to guest antigens encoded on a plasmid under the control of the pagC 
promoter (Dunstan et al., 1999). 
All mice immunised with 5x 108  Salmonella lyphimurium did not survive. In the other 
groups (5x10 6, 5x10 7), serum was removed at day 0, 14, 21 and 28 to ensure that no 
antibody production was missed during the schedule. Antibody induction was 
analysed from pooled sera within each group by ELISA as before. Antibody titres 
against GroEL, AhpC, GFP and GST were all found to be <16 at day zero. Antibody 
titres against GFP and GST also remained at <16 over the 28 day period for mice 
immunised with Salmonella typhimurium carrying pTMB22 in both groups. 
However, antibody against GroEL was observed in mice immunised with 5x10 7 
Salmonella typhimurium carrying plasmid pTMB22 (Table 5.5). 
Day 0 14 21 28 
Titre <16 64 32/64 32 
Table 5.5 Antibody titres recorded against GroEL after immunisation with 5x10 7 
Salmonella lyphimurium (MPG424) carrying the plasmid construct pTMB22. 
Over the 28 day period, the antibody titre against GroEL peaked between day 14 and 
21 at a titre of 64 and then decreased slightly at day 28 to a titre of 32 (Table 5.5). 
However, no antibody against GroEL was detected in mice immunised with 5x10 6 
Salmonella lyphimurium (pTMB22). This suggests that there was a better antibody 
response to GroEL when the bacterial numbers used for immunisation were 
increased to 5x10 7 Salmonella typhimurium carrying the plasmids. The absence of 
responses to the prominent bacterial protein GroEL in the other group (5x10 6) lends 
support to this hypothesis. These results would suggest that the lack of antibody 
expression was partially solved by increasing the bacterial numbers. Since there was 
an increase in the antibody titre recorded after increasing bacterial dose, it was 
suggested that this approach could be applied for all the plasmids used for 
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immunisation. It is possible that if fewer bacteria were present in the host, than fewer 
bacteria would persist long enough to stimulate humoral immunity. If this were the 
case, then a lower antibody response would be expected. In agreement with this 
statement, results from section 5.2.2 and 5.2.3, where BALB/c mice were immunised 
with between 6.5x I 0 to 8.8x 105  Salmonella typhimurium carrying different plasmids 
(determined by plate counts), an antibody response of <16 was recorded in all cases. 
Increasing the bacterial load by approximately 100-fold, resulted in an increased 
antibody response. 
To investigate this suggestion, six groups of five mice, were immunised with 
between 1 .5x 106  and 5 .2x 107  Salmonella typhimurium carrying the complete range 
of plasmids, in each case in 100 jil of PBS (Table 5.6). Pooled sera at day 0, 14 and 
28 was analysed for antibody production against the various proteins. Results for 
antibody titres against Salmonella GroEL are shown in Table 5.6. 




Antibody Titres against 
GroEL 
Day 0 Day 14 Day 28 
PTM132 None None 5.2 x107 <16 <16 64 
PTM136 ahpC His-LLO-Gp63(1) 3.7x106 <16 32 <16 
PTM137 ahpC His-LLO-Gp63(1)-Gp63(2) 1.5 x106 <16 <16 64 
PTM138 pagC His-LLO- Gp63(1)-Gp63(2) 4.6 x107 <16 <16 16 
PTMB20 spvA His-LLO- Gp63(1)-Gp63(2) 3.6 x107 <16 <16 <16 
PTMB21 ahpC GFP 4.4x10' <16 <16 128 
Table 5.6. Analysis of antibody titres against GroEL from mice immunised with 
Salmonella typhimurium carrying different plasmids. 
The promoter and the fusion protein are shown for each plasmid construct. The bacterial dose used for 
immunisation i.p. is shown in c.f.u. 
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The antibody titres against AhpC, LLO, Gp63(1), Gp63(2), and GST were all <16 
regardless of the plasmid carried within MPG424. The antibody titre against GFP in 
those mice immunised with pTMB2I was still <16, regardless of the fact that the 
bacterial numbers had been increased in comparison with the previous study (section 
5.2.3). However, there was an increase in antibody production against the Salmonella 
heat shock protein GroEL. Indeed, an antibody response against GroEL was detected 
in all immunised mice, except in mice immunised with Salmonella typhimurium 
carrying pTMB20, where the antibody titre remained at <16 over the 28 day period. 
The best antibody response was detected in pTMB2 1 immunised mice, where an 
antibody titre of 128 against GroEL was recorded. It was observed that mice 
immunised with 4.6 x10 7 Salmonella typhimurium carrying pTMB8 (which expresses 
the large peptide from the pagC promoter) produced an antibody titre of 16 against 
GroEL. However, when mice were immunised with similar numbers (5x10 7) 
Salmonella carrying pTMB22 (pagC-GFP), antibody titres between 32 and 64 was 
recorded at days 14 and 21, decreasing to titre of 32 by day 28. Thus, there is slight 
variation in the antibody production against Salmonella protein (GroEL) depending 
on the plasmid carried by the Salmonella strain. GroEL is not present on any of the 
plasmids, but the antibody titre seemed to differ depending on the plasmid construct. 
While no antibodies were recorded against the peptides present on the plasmids 
(LLO, Gp63(1), Gp63(2)or GFP), the possibility remained that T cells were 
stimulated by the immunisation regimes. In a preliminary experiment to investigate 
specific memory in the TH I cell population after immunisation, groups of BALB/c 
mice were subdivided into groups of one to three mice. The mice were challenged in 
the right hind footpad with 20tg of either GroEL or the other specific proteins. They 
were injected in the left hind footpad with PBS, as a control for specific enlargement 
induced by the experimental protein. A group of mice left untreated at day zero, were 








Mean footpad thickness (thousandths of an inch) 
24 Hours 48 Hours 
RHFP 
(insx 1 0) 
LHFP 




(insx 1 03) 
LHFP 
(insx I 0) 
Ratio 
(%) 
PTMB2 2 73.7 62.0 118.9 69.0 64.7 106.7 
PTMB6 1 76.7 59.7 128.5 7 3. 7 61.7 119.4 
PTMB7 2 82.2 62.5 131.1 79.8 63.8 125.1 
PTMB8 2 73.7 62.7 117.6 75.7 67.3 112.4 
PTMB20 2 73.8 63.2 116.9 69.7 65.5 105.8 
PTMB21 1 74.7 59.0 126.7 75.0 62.0 121.0 
Uninjected 3 70.3 65.2 107.8 64.9 64.6 100.5 
Table 5.7. Footpad enlargements induced by inoculation with GroEL, measured at 24 
and 48 hours post challenge. 
Uninjected controls were left untreated at day 0 and infected in the RHFP with the specific protein at 
day 35. Mice were injected in the LHFP with PBS as a control. 
The footpad ratio is (RHFP/LHFP) xlOO is shown as a percentage. 
This was a preliminarily experiment with small numbers of mice in each group, so 
statistics are inappropriate but various trends can be tentatively inferred from the 
data. For example, there was an increase in footpad thickness in all groups of mice 
following challenge with GroEL at all time points. The greatest increase in footpad 
thickness was visible in pTMB7 immunised mice, where the RHFP was 82.17 units 
at 24 hours, but then decreased to 79.83 at 48 hours (compared with the LHFP which 
was 62.5 and 63.83 respectively). The footpad ratio for this group of mice was 
131.1% at 24 hours decreasing to 125.1% at 48 hours. Mice immunised with cells 
containing pTMB6 (which contained the ahpC promoter and the peptide His-LLO-
Gp63(1)) produced a significant footpad enlargement against GroEL with a footpad 
ratio of 128.5% at 24 hours and 119.4% at 48 hours. This can be compared with mice 
immunised with cells containing pTMB2 1 (which contained the ahpC promoter and 
GFP) having a footpad ratio of 126.7% and 121.1% at 24 and 48 hours, respectively. 
Both groups of mice had detectable antibody against GroEL with mice immunised 
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with cells containing pTMB6 recording an antibody titre of 32 at day 14 and 
pTMB21 immunised mice with a titre of 128 at day 28. 
Mice immunised with pTMB8 (pagC-His-LLO-Gp63(1)-Gp63(2)) had the highest 
footpad ratio of 125.4% at 48 hours after challenge with GroEL. However, this group 
had a low antibody titre of 16. The lowest footpad response after challenge with 
GroEL (24 hours was 116.9% and 48 hours of 105.8%) was observed in mice 
immunised with cells containing pTMB20. This was also in agreement with the 
lowest antibody titre of <16, which was recorded for mice immunised with pTMB20. 
In all cases, there was a trend suggesting that footpad enlargements continued after 
challenge with GroEL over the 48 hour period. This suggests that the bacteria in this 
experiment persisted for an adequate length of time, to induce at least a small TH 1 
response to GoEL. This is in agreement with previous work in the laboratory, which 
showed TH1 responses to GroEL after immunisation with an aroA mutant of 
Salmonella typhimurium (Taylor et al., 1998). In the current study, it was noted that 
the uninjected controls (untreated at day 0) had an initial footpad enlargement with a 
ratio of 107.8% at 24 hours, which then decreased to background levels of 100.5% at 
48 hours. This re-enforced the view that the mice had not seen GroEL previously, 
and is also in agreement with the lack of antibody detected in pre-immune sera with 
titres <16. 
Since there was a positive footpad response to GroEL in the group immunised with 
cells containing pTMB2 1, a further experiment was undertaken to investigate if there 
was any footpad response to GST-GFP, since GFP was encoded on the plasmid. 
Previously, mice were immunised with cells containing pTMB6 (AhpC-His-LLO-
Gp63(1)) or pTMB7 (AhpC-His-LLO-Gp63(1)-Gp63(2)) and were analysed for the 
presence of a cell mediated immune response against the peptides encoded on the 
plasmids (Section 5.2.1). Therefore, for completeness, it was decided to investigate if 
there was any footpad enlargements detected after challenge with GST-GFP in mice 
immunised with cells containing pTMB21 and to determine if these responses were 
more pronounced since GFP was known to be a stable protein. GST responses were 
also examined because the challenge protein GFP was a fusion protein to GST. Thus, 
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it was determined if there was a background response to GST. The results of the 
footpad challenge with GFP and GST at 24 hours and 48 hours are shown in Table 
5.8 
Footpad thickness at 24 hours 
(thousandths of an inch) 
Footpad thickness at 48 hours 
(thousandths of an inch) 
GFP GST GFP GST 
RHFP 








(x10 3 ) 
LHFP 





PTMB21 81.8 61.8 73.3 61.8 77.0 65.2 73.7 65.5 
Uninjected 74.0 63.0 69.7 63.7 
PBS 66.4 60.7 76.2 60.2 63.3 59.1 65.7 60.0 
Table 5.8. Footpad enlargement recorded at 24 hours and 48 hours after challenge 
with GFP or GST. 
Groups of female mice, 8-10 weeks old were injected i.p. with 4.4x10 7 c.f.u. of an aroA purA 
Salmonella lyphimurium mutant (MPG424) carrying plasmid pTMB2 1, in I 00tl of PBS or left 
uninjected or were injected with I00l.tl of PBS only. Thirty-five days after immunisation, mice were 
challenged in the RHFP by injecting 20ig of heat aggregated GroEL, GFP or GST in 50il of PBS. 
The mice were injected in the left hind footpad (LHFP) with PBS (50p1) as a control. At 24 hours 
after challenge, the thickness of the LHFP and RHFP were measured and recorded in thousandths of 
an inch and averaged as indicted previously. 
From the footpad analysis of the pTMB2 1 immunised mice, footpad thickness were 
observed against GST-GFP at both 24 and 48 hours after challenge with values of 
81.8 and 77.0 respectively in the RHFP. The LHFP, which was injected, with PBS 
had a thickness value of 61.8 and 65.2 respectively. This was slightly higher than 
expected, as the LHFP was injected with PBS and so was anticipated to fall to 
background levels equivalent to those seen from treatment with PBS. In comparison 
with the PBS controls (injected at day zero with PBS instead of Salmonella 
lyphimurium), the footpad response to GST-GFP gave a value of 66.4 and 63.3 at 24 
and 48 hours, respectively. This was still slightly higher than the LHFP which was 
injected with PBS and had a thickness value of 60.7 and 59.1 at 24 and 48 hours 
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respectively. Therefore by 48 hours the response to GST-GFP in the PBS controls 
had decreased to relatively low levels. This was encouraging and suggested that the 
response to GST-GFP was significant. 
Furthermore, there was also a response to GST at both 24 and 48 hours after 
challenge in all the mice. The RHFP measurement in mice immunised with cells 
containing pTMB21 was 73.3 and 73.7 at 24 and 48 hours respectively. This was 
also the case for the uninjected control mice that had RHFP thickness of 74.0 and 
69.7 at 24 and 48 hours respectively. The PBS control mice, also had footpad 
responses against GST where the RHFP was 76.2 and 65.7 at 24 and 48 hours 
respectively. The footpad enlargements detected against GST are unexpected, as 






Footpad ratio (%) No of 
mice 
Footpad ratio (%) 
GFP GST 
24 hours 48 hours 24 hours 48 hours 
PTMB21 2 132.4 118.2 2 118.6 112.5 
Uninjected 1 117.5 109.4 
PBS 3 109.5 107.1 2 126.6 109.5 
Table 5.9. Mean footpad thickness expressed as a ratio (%) after protein challenge 
recorded at 24 and 48 hours. 
Ratio was calculated as (R1-IFPILHFP)x 100 
Analysis of the footpad ratios (Table 5.9) shows that there was a large immune 
response to GST-GFP in mice immunised with pTMB21 (AhpC-GFP) with a 
response at 24 hours of 132.4% decreasing to 118.2% after 48 hours. In comparison, 
the PBS control mice had a footpad enlargement of 109.5% at 24 hours, which 
decreased to 107.1% after 48 hours. This could suggest that GFP was expressed to 
sufficient levels during the immunisation regime and stimulation of CMI had 
occurred because the ratio remained relatively high, 48 hours after challenge into the 
footpad. However, it was noted that there was a high background response to GST in 
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the mice immunised with Salmonella containing pTMB21, of 118.6% with an even 
higher response in the PBS control mice of 126.6% at 24 hours. By 48 hours, the 
ratios had decreased to 112.5% and 109.5% respectively. Also one mouse was 
included as an uninjected control and had a footpad thickness ratio of 117.5% at 24 
hours, which reduced to background levels of 109.4% after 48 hours. This 
background enlargement in the controls (uninjected and PBS) could be explained by 
the presence of some contaminating material in the purified proteins (GST and GST-
GFP). Weak bands were identified on SDS PAGE gels (Chapter 4) and may 
represent Escherichia coil homologues of Salmonella lyphimurium proteins, as the 
GST and GST fusion proteins were isolated from E.coli BL21. The footpad 
enlargement to GST is relevant because a GST-GFP fusion protein was used for 
challenge. Overall, the response to GST-GFP is still higher at 48 hours in the mice 
immunised with cells containing pTMB21, compared with the pTMB21 immunised 
mice (challenged with GST) with ratios of 118.2% and 112.5% respectively. This 
may indicate a response to GFP that was encoded on the plasmid, and that the GFP 
was induced from the plasmid for sufficient time to induce T cells. However, it is 
worth remembering that this was a preliminarily experiment and no more than three 
mice were used to analyse the DTH response. Therefore, because of the small 
numbers in each group, it was not possible to perform statistical tests to verify if any 
of the responses were statistically significant. 
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5.7. Discussion 
Throughout this study, cell-mediated immune responses were recorded against the 
Salmonella proteins GroEL and AhpC, in mice immunised with Salmonella 
typhimurium (MPG424) carrying various plasmids. Both AhpC and GroEL have 
been shown to be expressed during interaction with macrophages (Buchmeier and 
Heffron 1990; Francis and Gallagher 1993). AhpC is a protein normally expressed 
during oxidative stress within Salmonella lyphimurium. The difference in the 
immune responses to AhpC and GroEL, may reflect the relative abundance of both 
these proteins in the bacterial cell. In the E.coli cells, the normal concentration of 
GroEL in unstressed cells is approximately 1%, increasing to nearly 10% under 
stress conditions (Hemmingsen et al., 1988). However, AhpC appears to be a minor 
component even under optimal conditions (Taylor, 1997). 
From the study carried out in Section 5.2.1, it was concluded that there was a 
significant response after challenge with AhpC with p values of <0.01 in mice 
immunised with cells containing pTMB2 or pTMB7 at 24 and 48 hours. These 
pTMB2 immunised mice acted as controls, since they did not have the ahpC 
promoter present on the plasmid. There was also a significant response in the PBS 
control mice after challenge with AhpC with a relatively low footpad ratio of 103.9% 
and a p value of <0.01. This is not surprising, as AhpC is present as a chromosomal 
copy in a number of different bacteria. Previous immunological recognition of both 
GroEL and AhpC is possible, since both proteins are thought to be conserved in a 
number of species, since Salmonella AhpC shows 92% identity to that of Escherichia 
coli (Smillie, 1994, Armstrong-Buisseret et al., 1995). Therefore, normal commensal 
organisms that colonise the mouse would seem a likely source of cross- reacting 
antigens that may be encountered by the immune system. Escherichia coli is part of 
the normal gut flora, so it is possible that these proteins provided the mouse with 
some immunological memory to AhpC and GroEL, prior to infection with 
Salmonella typhimurium. Overall, this suggests that Salmonella lyphimurium 
survived long enough in vivo to stimulate T cells in both pTMB2 and pTMB7 
immunised mice. The immune response in the pTMB7 immunised mice cannot be 
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concluded to be via protection from the plasmid construct alone, due to the presence 
of a chromosomal copy of ahpC. Also, since the complete ahpC gene was not 
present on the plasmid construct, the part of the AhpC protein encoded is relatively 
small (110 amino acids), so probably did not contain a T cell or B cell epitope. 
However, there was significant presentation of the protein AhpC to cause stimulation 
of TH 1 cells, but due to the absence of antibody it suggests no detectable stimulation 
of B cells. 
A significant response was recorded after challenge with Gp63(1) in pTMB7 
immunised mice, compared with the PBS controls at 24 and 48 hours. This would 
suggest that sufficient expression of the polyvalent protein occurred under the control 
of the ahpC promoter (Table 5.3b). As expected there was no response to Leish-1 in 
the control pTMB2 immunised mice, since the plasmid did not contain Leish-1 in the 
construct. This response to Gp63(1) was a true response to this protein since the 
response to GST was not significant in the PBS controls. A significant immune 
response was observed after challenge with LLO in those mice immunised with 
pTMB2 when the footpad ratios were compared with the PBS controls at 48 hours 
(Table 5.3b). This would suggest that there was a component that is causing a cross-
reaction from the protein preparations, or that there were contaminating proteins 
homologous to proteins that are present in Salmonella lyphimurium. This latter 
option seems plausible, as there were contaminating protein bands visible in the 
protein preparations on SDS PAGE, which could explain why a reaction was 
observed in the pTMB2 immunised mice, but not in the PBS control mice. Since the 
Gp63(1) and LLO protein preparations were prepared as GST fusions, it was 
important to test for an immune response against GST. Following footpad challenge 
the largest enlargement due to GST was a ratio of 103% in the mice immunised with 
pTMB7. When the footpad ratios of the pTMB7 and pTMB2 immunised mice were 
compared with the PBS controls after challenge with GST in the RHFP, a non 
significant response was recorded at 24 and 48 hours. This suggests that the immune 
response observed against Gp63(1) was a true response against this protein and not 
due to GST. 
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It was suggested that poor antibody responses could be due to poor expression from 
the ahpC promoter, but there was no difference in the response, even when the 
promoter was changed. From the results of immunisation of BALB/c mice with the 
various constructs, no antibody was detected against any of the peptides (LLO, 
Gp63(1) or Gp63(2)) over the 28 day period. The lack of antibody response 
suggested there was another reason for the low antibody titres. One possibility is that 
the protein that was expressed from these promoters was unstable and is degraded 
before adequate expression for stimulation of antibody production. 
The antibody titres against GroEL seemed to vary amongst the different groups of 
experimental mice, even though GroEL is a heat shock protein, rather than a protein 
expressed from the plasmid. Antibody was analysed against GroEL after 
immunisation of mice with various different plasmids under the control of different 
promoters (section 5.6.5). There was no antibody detected in the pooled sera 
analysed from any of these mice, except an antibody titre of 64 was detected against 
GroEL in pTMB6 immunised mice. 
Both the AhpC and GroEL proteins were used as internal markers for survival of 
Salmonella typhimurium in vivo. No antibody titres of higher than 64 were recorded 
against either of these proteins in the experiments performed in Section 5.6.4 to 
section 5.6.6. Nevertheless, in section 5.6.7 antibody responses were recorded 
against GroEL with titres ranging from <16 to 128 on one occasion, but remained at 
<16 against AhpC. The difference in the, antibody responses against both proteins 
could be explained by the different concentrations of the proteins in the cell. 
When bacterial cells become stressed, the concentration of GroEL increase from 1% 
to 10%, compared with AhpC, which remains a minor component (Hemmingsen et 
al., 1988; Taylor, 1997). This demonstrates that the B cell response to GroEL and 
AhpC were different, and suggested that GroEL was more immunogenic than AhpC. 
It is noted from section 5.2.1 that, although there was no antibody response to AhpC, 
there was a T cell response recorded from the footpad responses when challenged 
with AhpC. Throughout this thesis, T cell responses against both GroEL and AhpC 
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were recorded at different points of the investigation. Antibody responses against all 
the proteins were expected because T cells were stimulated according to the results 
from the various footpad analysis. Therefore, since T cells stimulate B cells to 
produce antibody, greater antibody responses were expected to both the Salmonella 
proteins and the proteins encoded on the plasmids (Nauciel, 1990). This difference 
could be explained by the fact that the epitopes recognised by T cells and B cells are 
different. B cells, are stimulated by conformational epitopes, whereas Thi cells are 
stimulated by linear epitopes (Townsend et al., 1986; Rothbard and Taylor, 1988; 
Abbas et al., 1991). 
The peptides encoded on the plasmids in this thesis were not in their native 
configuration, but were instead present as fusion proteins, efficient stimulation of B 
cells could have been a challenge. The topology of the expressed antigen can also 
influence the overall efficacy of the immune response. It has been shown previously 
that antigen secretion and its attachment to the bacterial surface is more efficient than 
antigens retained in the cytoplasm to generate an immune response (Langermann et 
al., 1994; Hess et al., 1996). Immune response to Salmonella infections are usually 
controlled by T helper responses via CD4 cells, since the bacterial antigens are 
processed via the endocytic pathway in APCs and presented in the context of MHC-
II (Abbas et al., 1991). Thi cells produce INF-y and activates macrophages to kill 
intracellular facultative parasites, whereas Th2 cells produce IL-4 which is central to 
the maturation of antibodies and helps in the clearance of extracellular pathogens 
(Scott and Kaufmann, 1991). Therefore, since Salmonella enterica can survive 
within host cells like macrophages it is plausible that a Thi response would result 
with the presence of cell-mediated responses, to aid the killing of Salmonella. The 
results obtained in this thesis support this suggestion. 
Overall, when the bacterial dose was increased to between 1x10 6 and 5x10 7 there was 
a variation in the antibody detected against the Salmonella heat shock protein GroEL 
(Section 5.2.4). The antibody titres varied from 16 in pTMB8 immunised mice to the 
highest titre of 128 in pTMB22 immunised mice (Table 5.4). However, no antibody 
response against GroEL was recorded for pTMB20 (spvA promoter construct) 
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immunised mice. This result was rather surprising, as the mice were immunised with 
3.6 x107  Salmonella lyphimurium. It has been observed that mice immunised with 
plasmid pTMB20 carrying the spvA promoter had consistently produced no antibody 
regardless of bacterial numbers used for immunisation. Therefore, increasing the 
bacterial numbers does not seem to be the complete solution to increasing antibody 
production against Salmonella proteins or the peptides present on the plasmids 
After immunisation with increased numbers of Salmonella typhimurium carrying the 
different plasmids, the mice were analysed for cell-mediated immune responses 
against Salmonella GroEL. When mice were challenged in the R}IFP with GroEL, 
there was a larger footpad ratio at both 24 and 48 hours for all the experimental 
groups, compared to the enlargement seen in the PBS controls after challenge with 
GroEL (Table 5.5). It was found that pTMB20 immunised mice had a small footpad 
enlargement after challenge with GroEL. Although no antibody was detectable 
against GroEL in these immunised mice, footpad ratios of 116.9% and 105.8% were 
recorded at 24 and 48 hours respectively. Since GroEL was not expressed by this 
plasmid, the possibility was raised that the stability of its product or some other 
property of a particular plasmid may have affected bacterial survival and/or 
expression of bacterial proteins. 
Mice immunised with pTMB2 produced a footpad ratio of 106.7% 48 hours after 
challenge with GroEL, slightly larger than the pTMB20 immunised mice. However, 
the pTMB2 immunised mice had a detectable antibody titre of 64 at day 28. In 
comparison, the footpad ratios for the PBS controls were 107.8% and 100.5% at 24 
and 48 hours respectively. There were large footpad ratios recorded 48 hours after 
challenge with GroEL in TMB6, pTMB7, pTMB8 and pTMB21 immunised mice of 
119.4%, 125.1%, 112.4% and 121.0% respectively (Table 5.5). These footpad 
enlargements corresponded with detection of antibodies against GroEL over a 28 day 
period (Table 5.4). The highest antibody titre at day 28 of 128 was detected in the 
pTMB2I immunised mice. These mice had a footpad ratio against challenge with 
GroEL of 121.0%. This construct (pTMB21) comprised the stable GFP under the 
control of the ahpC promoter. However, it is important to remember that the GroEL 
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protein is a Salmonella heat shock protein and is not present on the plasmid. Mice 
immunised with pTMB7 received I .5x10 6 Salmonella lyphimurium, resulting in an 
antibody titre of 64, with the highest footpad ratio against GroEL of 125.1%. This 
was a log lower than the bacterial dose used to immunise the mice with pTMB20 
(3.6x107c.f.u). Also, antibody was detected in mice immunised with 3.7x10 6 
Salmonella typhimurium carrying pTMB6 at a titre of 32 at day 14 and a footpad 
ratio of 119.4% 48 hours after challenge. 
Mice immunised with pTMB2 I demonstrated footpad responses against GFP and 
GST including a response to GroEL. There was a strong footpad response of 132.4% 
and 118.6% at 24 and 48 hours respectively recorded after challenge in the RHFP 
with GFP. However, there were footpad responses recorded after challenge with GST 
in all mice including the PBS and uninjected controls. Footpad ratios of 109.4% and 
109.5% were recorded at 24 hours in the uninjected and PBS controls respectively. 
Therefore, in order to interpret the true response to GFP, the response to GST has to 
be taken into consideration. It could be suggested that the response to GFP in the 
pTMB2 1 immunised mice was larger in magnitude when compared with GST at 48 
hours (118.6% versus 112.5%). Since this was a preliminary experiment using small 
numbers of mice, it was not possible to carry out statistical tests to conclude if any of 
the responses to the proteins were significant. 
There is controversy as to whether the initial amount of antigen that primes the gut 
associated lymphoid tissue (GALT), longer persistence of Salmonella in the Peyers 
patches, genetic background or attenuation has the greatest effect on the immune 
response (Cardenas et al., 1994; Tacket et al., 1997; Covone et al., 1998; Dunstan et 
al., 1998; Valentine et al., 1998; VanCott et al., 1998; Pashine et al., 1999). 
Cardenas et al. (1994) concluded that the initial amount of antigen delivered by the 
Salmonella vector is more important than the persistence of the organism in the host. 
They demonstrated that organisms, which deliver large amounts of antigen to the 
Peyers patches and do not persist, are more effective at inducing mucosal antibody 
than Salmonella that persist and express low amounts of antigen. Hess et al., (1996), 
found that better protection was achieved against the p60 protein of Listeria 
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monocytogenes when it was secreted into the phagocytic vacuole containing the 
Salmonella host vector, than when the protein was located intracellularly. 
A consistent finding throughout all the immunisation studies in this thesis was that 
no antibody was recorded against any of the peptides, regardless of the promoter 
used for expression of the peptides. Chatfield et al. (1992), found that expression of 
the antigen toxC from the nirB promoter was superior to the response obtained from 
expressing the same antigen from the tac promoter in an aroA aroD strain of 
Salmonella lyphimurium. This suggests that the expression system is an important 
factor for immunogenicity . It has been suggested that high expression of the antigen 
is crucial during the early phase of the induction of the immune response (Covone et 
al., 1998). Although antibody was detected against the Salmonella protein GroEL, 
the titres were low, which could be indicative of a problem with maintenance of the 
plasmids in vivo. It has been previously shown that bacteria that do not contain 
plasmids grow more efficiently than bacteria that contain plasmids (Boe et al., 1987; 
Mc Dermott et al., 1993; Summers, 1998). The immune response to an antigen and 
the carrier of the antigen, are related to the ability of the carrier (Salmonella) to 
invade, replicate and persist in host cells. 
Galan and Curtiss (1989) showed that a phoP mutant was able to induce protective 
immunity against challenge with Salmonella lyphimurium, even though there was no 
evidence of colonisation of the spleen. It has been suggested that colonisation of the 
Peyers patches is more important than colonisation of the spleen (O'Callaghan et al., 
1988). The immune response also relates to the level of expression and the stability 
of the antigen (Hopkins et al., 1995). This in part will depend on the stability of the 
plasmid on which the antigens are encoded (Galen etal., 1999). Dogett etal. (1993), 
found no detectable humoral responses after a single immunisation with recombinant 
Salmonella lyphimurium (cya crp) expressing a surface protein antigen from 
Streptococcus sobrinus. However, after a booster dose containing three tandem 
repeats of the antigen, a significant antibody response was detected. This suggests 
that the level of antigen expressed in vivo is important for successful immunisation 
using Salmonella vectors. 
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Heterologous antigens encoded on plasmids affect the growth of the bacterial strain 
and as the expression of the heterologous antigen increases the growth rate of the 
strain decreases (Pecota et al., 1997). Therefore, the possibility of plasmid loss exists 
in such a situation, resulting in an increase in growth of the bacteria that do not 
contain the plasmid. This would result in fewer bacteria surviving that contain the 
plasmid. This would cause a reduction in the expression of the heterologous antigen 
and thereby a reduction in the efficiency of the immune response directed against the 
heterologous antigen (Galen et al., 1999). Vaccine dose may be another important 
factor to consider when designing a vaccine. Fayolle et al., (1994), cloned the E.coli 
MalE protein into different plasmids for expression in Salmonella typhimurium, and 
investigated the immune responses. They found that the bacteria expressing the 
highest level of MalE protein produced the greatest immune response. 
The original work by Stocker used 5x10 5 organisms for immunisation, as did a more 
recent study using an aroA Salmonella typhimurium strain for immunisation by the 
i.p. route (Stocker 1988; Gentschev et al., 2001). Throughout this study, an aroA 
purA Salmonella lyphimurium strain (MPG424) was utilised, with complementation 
of the purA mutation with the presence of the purA promoter and gene on a plasmid. 
The double mutation rendered the Salmonella lyphimurium strain hyper-attenuated. 
Complementation of purA eased the hyper-attenuation slightly, but was not sufficient 
for successful immunisation. In agreement with the study carried out in this thesis, 
Dunstan et al., (1998) suggested that the mutation used to attenuate Salmonella 
strains, affect the immunogenicity of the vaccine. They concluded from their work 
that the Salmonella lyphimurium mutants (i\aroAD, AompR and i\htrA) expressing 
fragment C of tetanus toxin, induced high levels of anti-tetanus toxin antibody, 
whereas the ApurA mutant induced a significantly lower antibody titre. O'Callaghan 
et al., (1988) had shown previously that, after intravenous immunisation with the 
purA mutant, no protection against challenge with virulent Salmonella was recorded. 
Sigwart et al., (1989) concluded from their work that purA decreases the virulence of 
the organism, but so attenuates the Salmonella that makes them unsuitable for use in 
live vaccines. In their study, only the Salmonella strain SL7163 with an aroA 
mutation was able to significantly colonise, invade and persist in tissues and evoke 
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an antibody response, especially at the mucosal surfaces. Neither, the purA or the 
aroA purA strains demonstrated any of these properties. O'Callaghan et al. (1988), 
demonstrated that mice were not protected from challenge with virulent Salmonella 
after immunisation with a purA mutant of Salmonella by the intravenous route. 
However, in this thesis a Salmonella typhimurium strain (MPG424) was utilised that 
contained both a purA and an aroA mutation. The purA mutation was complemented 
by the presence of an Escherichia coli purA promoter and gene on the plasmid used 
for immunisation (chapter 4). Therefore, during the planning of the experiments in 
this chapter, the presence of the purA mutation on the Salmonella typhimurium strain 
was thought not to be an issue since the purA promoter was being complemented. 
This complementation of the purA gene, also provided an alternative to antibiotics 
for maintenance of Salmonella typhimurium in vivo, as only those cells that 
maintained the plasmids survived within the host. 
Mutations used to attenuate bacteria have the potential to affect the way that the host 
responds to the attenuated bacteria. For example, aro mutation affects the physiology 
of the bacterial cell (Cardenas et al., 1992). The type of mutation used to attenuate 
the strain (e.g. aroA, purA, htrA, ompR) affects the immunogenicity, including the 
antibody response to both Salmonella and the response to the heterologous antigens. 
Fragment C expressed from AaroAD, AompR, and MtrA produced high levels of 
anti-tetanus antibody after oral immunisation, whereas the ipurA induced 
significantly lower levels of anti tetanus toxoid antibody. All of these Salmonella 
mutants produced sufficient antibody to protect against 100 LD50 of tetanus toxoid 
except the t\purA mutant. Cytokine assays suggested that all strains including the 
ApurA, induced a Thl type response indicated by the presence of !TN-y in 
splenocytes and proliferative T cell responses. It was concluded that the inability of 
the ApurA to protect mice from tetanus toxoid challenge was due to quantitative 
rather than qualitative differences in the immune responses (Dunstan et al., 1998). 
The Salmonella strain and the type of attenuation can jointly influence the level of 
attenuation and immunogenicity of the resultant Salmonella typhimurium strain 
(Dunstan et al., 1998). 
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Future Work 
Due to the low antibody response under the various immunisation regimes, it could 
be suggested that it would be worth repeating the immunisations again using at least 
106  Salmonella lyphimurium cells (MPG424) carrying the plasmids and then re-
immunising the mice with at least two boosts at two intervals. ELISA could be used 
to check for the presence of antibody in the serum at various intervals after boosting 
by removing a sample and testing against various antigens. If the antibody titre was 
still low, boosting could be continued until there was an adequate increase in the 
antibody response. Also, other antigens including LPS, porins or a whole cell 
sonicate of Salmonella as well as GroEL and AhpC could be used as internal controls 
for the ELISA's to check for the presence of antibodies against the Salmonella strain. 
The plamids could also be transferred into other Salmonella strains containing only 
one mutation (e.g.aroA), and checking to see if the antibody and cell mediated 
immune responses where increased if the Salmonella strain did not contain a double 
mutation (aroA and purA). Therefore, the purA complementation would not be used 
for maintenance of the plasmid, but instead plasmid maintenance would be via the 
use of antibiotics. I would also suggest that other plasmids expressing the full length 
Gp63 and LLO, instead of fusion proteins should be constructed to ascertain if the 
fusion proteins were the reason for the low antibody response obtained in the 
immunisation experiments. The fact that the plasmids used in the immunisation 
studies carried out in this thesis used gene fragments, there is no guarantee that the 
proteins folded corrected or got processed adequately to result in an optimum 
immune response. 
I would also suggest that other assays should be used for looking at cell mediated 
immunity instead of the DTH assay that was performed in this thesis. I would 
suggest that T cell proliferation assays and cytokine assays would produce more 
informative results about the immune response. However, these assays always have 
disadvantages, which include the use of relatively pure protein, free of contaminating 
proteins for example LPS. Also contaminating B cells could be a problem, but these 




6.1 Concluding Discussion 
6.1.1 Regulation of Ahp expression 
Salmonella are considered to cause approximately 1.3 billion cases of gastroenteritis per 
year in the world (Ivanoff et al., 1994). A small subset of approximately ten serotypes 
including Salmonella typhimurium, Salmonella enteriditis and Salmonella heidelberg, 
account for the majority of infections (Darwin and Miller 1999). Salmonella 
typhimurium is ubiquitous and can infect a wide variety of animal hosts. The widespread 
distribution of salmonellae in the environment, their increasing prevalence in the global 
food chain, and their virulence and adaptability in the host, result in an enormous public 
health and economic impact. 
Invasive Salmonellae are capable of passing through the epithelial barrier of the intestine 
to proliferate in the Peyer's patches and the draining mesenteric lymph nodes. 
Salmonella enterica is an intracellular pathogen, which can survive within macrophages, 
whereby protection against the action of antibody and complement occurs to a certain 
degree (Moulder 1985; Finlay and Falkow 1989b). Ingestion by macrophages may also 
serve as a vehicle for transmitting these bacteria to the lymph nodes, liver and spleen 
and facilitate a systemic infection. Salmonella are capable of surviving and multiplying 
within macrophages and they can use these cells as a vehicle for transmission to other 
parts of the body such as the liver and spleen. In macrophages and polymorphonuclear 
monocytes (PNMs), the oxidative or respiratory burst is one of the primary antibacterial 
functions. These include reactive oxygen intermediates, superoxide, peroxide, hydroxyl 
radicals, hypochiorous acid and nitric oxide (Hasett and Cohen 1989). 
In Salmonella typhimurium and Escherichia coli, the AhpCF system is required for the 
elimination of alkyl hydroperoxides by reduction of them to their corresponding alcohol 
(Calzi and Poole, 1997). Experiments previously carried out using the pathogenic 
Salmonella typhimurium strains SL1344 and a derivative MPG203 which carries a 
Mudlux insertion in ahpC indicated that expression of ahp by MPG203 did not 
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accurately mimic that of the wild type locus (Taylor, 1997). When the ahp gene was 
tagged with Mudlux, it was found to be relatively unresponsive to hydrogen peroxide in 
a low osmotic environment (Taylor, 1997), whereas the ahp locus in Salmonella 
typhimurium SL1344 was activated by hydrogen peroxide as expected. The lux element 
therefore appeared to cause ahp to be predominately osmoregulated and luminescent 
studies indicated that a combination of high osmolarity (03M) and hydrogen peroxide 
(100tM) resulted in enhanced expression of ahp (Taylor, 1997). Initially a plasmid 
pTMB 1 was constructed that contained the ahpC promoter and part of the gene and 
luxAB, and it can be seen from Figure3.2, that light production from cells carrying 
pTMB1 was only induced with hydrogen peroxide. This result suggests that the 
curiosity of the sodium chloride induction in MPG203, relates to the presence of the 
more extensive Mudlux unit (containing luxI'CDABE) or relates to chromosomal 
location of the Mudlux element or the fact that it is present in single copy. 
RT-PCR studies using ahpC specific primers was carried out to see if the response at the 
level of RNA was similar to the results obtained from the luminometer studies. After 
growth in LSLB (Table 3. 1), ahpC expression in MPG203 was induced to a degree with 
either salt (2 fold) or hydrogen peroxide (3.3 fold) separately. Maximum expression of 
ahpC was noted in cells induced with both salt and hydrogen peroxide in combination 
(5.9 fold). In SL1344 cells the highest induction of ahpC was recorded in cells induced 
with hydrogen peroxide (8.1 fold) as expected (Table 3.1). In minimal media, ahpC 
expression was maximum in MPG203 (37 fold) and SL1344 (2.4 fold) cells induced 
with both stimuli in combination. Michan et al. (1999), found that induction of gene 
expression from ahpC, katG, gorA and dps in Escherichia coli K-12 was higher in M9 
minimal medium than in LB. The lowest induction for MPG203 cells grown in LSLB or 
minimal media was recorded in cells treated with salt (Table3.1). In comparison, 
MPG203 showed maximum induction after treatment with salt and hydrogen peroxide 
in the luminometer data (Figures3.1 and 3.11). Therefore, this suggests that in some 
way, sodium chloride had a synergistic effect on ahpC expression when tagged with 
Mudlux. Using micro-array technology, it was shown that ahpC was highly expressed in 
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Escherichia coli cells in minimal medium, but this was not the case in cells grown in LB 
(Wei et al., 2001). This expression of ahpC in MPG203 cannot be explained solely by 
either transcriptional or post-transcriptional regulation. If this expression was under 
transcriptional control, an increase in expression of ahpC when MPG203 cells were 
induced with salt would be expected. Nevertheless, it could be argued that since there 
was a large increase in expression of ahpC in MPG203 induced with a combination of 
salt and hydrogen peroxide, in both the RT-PCR and luminometer experiments, an 
increase in ahpC transcript level correlates with the increase in light production. 
However, RT-PCR for MPG203, showed that ahpC was induced to a larger degree in 
cells induced with hydrogen peroxide as opposed to salt for both LSLB and minimal 
media. In contrast to this, ahpC expression in MPG203 was not induced with hydrogen 
peroxide when grown in LSLB or minimal media as determined by luminometery. 
Therefore, this anomaly of ahpC expression, remains a mystery. A full understanding of 
the regulation of this locus requires further analysis. Care should be taken in particular 
when trying to interpret results using the lux reporter system. 
6.1.2 In vivo regulation of antigens 
The outcome of a Salmonella infection depends on a number of factors including the 
size of the bacterial inoculum, the virulence of the infecting Salmonella strain and the 
ability of the host to mobilise immune defences to respond to the infection. Humans and 
animals deal with Salmonella infections by activating both humoral and cell mediated 
immunity (CMI) against bacterial proteins and in vivo expressed antigens are thought to 
be important immunological targets for protection. In BALB/c mice immunity to 
Salmonella enterica infection, involves a T helper cell (THI) response. T cells mediate 
their effect by producing cytokines which modulate B cells and macrophages, while also 
enhancing the activity of other T cells (Kelso, 1995; Nauciel et al., 1992). During a TH1 
response, macrophage activation and a delayed-type hypersensitivity (DTH) reaction 
result, which is usually associated with the development of T-cell mediated immunity 
(Collins, 1974). A TO type response is highly protective against Salmonella and usually 
causes elimination of the infection in mice. 
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Most research has focused on S. typhimurium because it is easy to genetically 
manipulate genetically and also, because it produces a typhoid-like disease in 
susceptible mice. Attenuated vaccine strains have been prepared by inactivating genes 
encoding various biochemical pathways, global regulatory systems, stress proteins, 
putative virulence properties, other regulatory genes. The discovery that aroA mutants 
were attenuated in vivo but able to persist in the host long enough to produce protective 
immunity was a major development in terms of rational vaccine design (Hosieth and 
Stocker, 1981). With relevance to this thesis, an aroA strain of Salmonella typhimurium 
SL3261 was used to construct MPG424, where a purA::TnlO was introduced by 
transduction, producing a Salmonella typhimurium strain that had two attenuating 
lesions (aroA and purA). Salmonella typhimurium purA mutants administered by the i.p. 
route, were found to be highly attenuated in mice (McFarland and Stocker 1987). 
Salmonella enterica strains are useful vehicles for displaying foreign microbial antigens, 
simultaneously eliciting protection against Salmonella and other pathogens (Chatfield et 
al., 1992; Gonzalez et al., 1994; Verma et al., 1995; Chabalagoity et al., 1996; Karem et 
al., 1997). The efficiency of such a system is partially dependent on the level of antigen 
expression and its regulation. Firstly, successful expression of the antigens and proteins 
in Salmonella is required, followed by delivery of the constructs to the immune system. 
Both the carrier and the promoter used to drive the antigen expression can affect the 
immune response to an antigen and the T cell pattern can be biased towards a TH1 or a 
TH2  response depending on the construct (Medina et al. 2000). 
The present study was designed to investigate expression of guest antigens from 
Leishmania major and Listeria monocyto genes on a plasm id carried by live attenuated 
Salmonella typhimurium under the control of these three promoters (ahpC, pagC and 
spvA). The ahpC promoter was selected, because of its possible potential to express 
foreign antigens in vivo, particularly in response to interaction with macrophage cells. 
Moreover, since the ahpC gene was found not to be important for virulence of the 
organism, it has great potential for the expression of foreign antigens in vivo. From the 
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study carried out in Section 5.2.1, it was concluded that there was a significant DTH 
response after challenge with AhpC (p values of <0.01) in mice infected with cells 
containing pTMB2 or pTMB7 containing the ahpC promoter (at 24 and 48 hours). There 
was also a small but significant response in the PBS control mice after challenge with 
AhpC with a relatively low footpad ratio of 103.9% and a p value of <0.01. This is not 
surprising, as AhpC is present as a chromosomal copy in a number of different bacteria, 
which inhabit the intestine. Overall, this suggests that Salmonella typhimurium survived 
long enough in vivo to stimulate T cells in both pTMB2 and pTMB7 immunised mice. 
The immune response in the pTMB7 immunised mice cannot be concluded to have 
arisen from the plasmid construct alone, due to the presence of a chromosomal copy of 
ahpC. Both the AhpC and GroEL proteins were used as internal markers for survival of 
Salmonella typhimurium in vivo. No antibody titres of higher than 16 were recorded 
against either of these proteins in these instances (Section 5.2.1 and 5.2.3). Nevertheless, 
in sections 5.2.2 and 5.2.4 antibody responses were recorded against GroEL with a titre 
of 128 on one occasion (pTMB21), but remained at <16 against AhpC. This 
demonstrates that the B cell responses to GroEL and AhpC were different, and 
suggested that GroEL was more immunogenic than AhpC. The difference in the 
antibody responses against both proteins could also relate to the different concentrations 
of the proteins in the cell. When bacterial cells become appropriately stressed, the 
concentration of GroEL can increase from 1% to 10%, compared with AhpC, which 
remains lowly abundant (Henimingsen et al., 1988; Taylor, 1997). 
Both the pagC and spvA promoter have been used previously for the expression of 
foreign antigens in Salmonella typhimurium (Dunstan et al., 1999; Marshall et al 2000). 
There is conflicting evidence about the expression in vivo from the pagC and spvA 
promoters, whereas both promoters expressed antigens to a high level in vitro. In the 
case of pagC, a good antibody response was obtained when, this promoter was used to 
express the antigen TetC (Hohmann et al. 1995; Dunstan et al. 1999). The level of 
antibody detected, was lower in the mice immunised with the plasmid expressing the 
antigen from the spvA promoter, as opposed to the dps promoter expressing the same 
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antigen (Marshall et al., 2000). However, since the spy promoter expressed antigen 
efficiently in vitro and was found to be reasonably successful in the other study 
(Dunstan et al., 1999), thus, the pagC and spvA promoters were included in the present 
study. These promoters were used to investigate if sufficient expression of the 
heterologous antigens occurred from the plasmid constructs to result in a measurable 
immune response. Both humoral and cell-mediated immunity were investigated to 
ascertain if there was any difference in the response to the antigens encoded on the 
plasmids, depending on the promoter used for expression. From the results of 
immunisation of BALB/c mice with the various constructs, no antibody was detected 
against any of the peptides (LLO, Gp63(1) or Gp63(2)) expressed from either the ahpC, 
pagC or spvA promoter over the 28 day period. One possibility is that the protein that 
was expressed from these promoters was unstable and is degraded before adequate 
expression for stimulation of antibody production. 
Antibody responses against all the proteins were expected because T cells were 
stimulated according to the results from the various footpad analysis (Table 5.7). 
Therefore, since T cells stimulate B cells to produce antibody, greater antibody 
responses were expected (but not found) to both the Salmonella proteins and the proteins 
encoded on the plasmids (Kelso, 1995; Nauciel et al., 1992). This paradox could be 
explained by the fact that the epitopes recognised by T cells and B cells are different. B 
cells, are stimulated by conformational epitopes, whereas TH-1 cells are stimulated by 
linear epitopes (Townsend et al., 1986; Rothbard and Taylor, 1988; Abbas et al., 1991). 
Since the peptides encoded on the plasmids in this thesis were not in their native 
configuration, but were instead present as fusion proteins, efficient stimulation of B cells 
was uncertain. The immune response also relates to the level of expression and the 
stability of the antigen (Hopkins et al., 1995). This in part will depend on the stability of 
the plasmid on which the antigens are encoded (Galen et al., 1999). The cellular 
topology location of the expressed antigen can also influence the overall efficacy of the 
immune response. It has been shown previously that antigen secretion and its 
attachment to the bacterial surface is more efficient than antigens retained in the 
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cytoplasm as a means to generate an immune response (Langermann et al., 1994; Hess 
et al., 1996). Dogett et al. (1993), found no detectable humoral responses after a single 
immunisation with recombinant Salmonella typhimurium (cya crp) expressing a surface 
protein antigen from Streptococcus sobrinus. However, after a booster dose containing 
three tandem repeats of the antigen, a significant antibody response was detected. This 
suggests that the level of antigen expressed in vivo is important for successful 
immunisation using Salmonella vectors. 
Vaccine dose may be another important factor to consider when designing a vaccine. 
Fayolle et at., (1994) cloned the E. coli MalE protein into different plasmids for 
expression in Salmonella typhimurium, and investigated the immune responses. They 
found that the bacteria expressing the highest level of MalE protein produced the 
greatest immune response. In the present study, when the bacterial dose was increased to 
between lx 106  and 5x107  cells (Table 5.6), there was a variation in the antibody detected 
against the Salmonella heat shock protein GroEL (Section 5.2.4). Although antibody 
was detected against the Salmonella protein GroEL, the titres were low, which could be 
indicative of a problem with maintenance of the plasmids or strains in vivo. It has been 
observed that mice immunised with plasmid pTMB20 carrying the spvA promoter 
consistently produced no antibody regardless of bacterial numbers used for 
immunisation. Therefore, increasing the bacterial numbers does not seem to be the 
complete solution to increasing antibody production against Salmonella proteins or the 
peptides present on the different plasmids. Heterologous antigens encoded on plasmids 
affect the growth of the bacterial strain and as the expression of the heterologous antigen 
increases the growth rate of the strain may decrease (Wu et al., 1994; Pecota et al., 
1997). Therefore, the possibility of plasmid loss exists in such a situation, resulting in an 
increase in growth of the bacteria that do not contain the plasmid. This would result in 
fewer bacteria surviving that contain the plasmid. This would cause a reduction in the 
total production of the heterologous antigen and thereby a reduction in the efficiency of 
the immune response directed against the heterologous antigen (Galen et at., 1999). 
Chatfield et al. (1992), found that expression of the antigen toxC from the nirB promoter 
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was superior to the response obtained from expressing the same antigen from the tac 
promoter in an aroA aroD strain of Salmonella typhimurium. This suggests that the 
expression system is an important factor, which may influence immunity. It has been 
suggested that high expression of the antigen is crucial during the early phase of 
induction of an immune response (Covone et al., 1998). 
The immune response to an antigen and the carrier of the antigen, are related to the 
ability of the carrier (Salmonella) to invade, replicate and persist in host cells. Galan and 
Curtiss (1989) showed that a phoP mutant was able to induce protective immunity 
against challenge with Salmonella typhimurium, even though there was no evidence of 
colonisation of the spleen. It has also been suggested that colonisation of the Peyers 
patches is more important than colonisation of the spleen (O'Callaghan et al., 1988). 
Throughout the study described in this thesis, an aroA purA Salmonella typhimurium 
strain (MPG424) was utilised, with plasmid complementation of the purA mutation by 
presence of the purA promoter and gene. The double mutation is known to render the 
Salmonella typhimurium strain hyper-attenuated. Complementation of purA eased the 
hyper-attenuation slightly, but in the current study was not sufficient for successful 
immunisation. In agreement with the study carried out in this thesis, Dunstan et at., 
(1998) suggested that the mutations used to attenuate Salmonella strains, affect the 
immunogenicity of the vaccine. O'Callaghan et al., (1988) had shown previously that, 
after intravenous immunisation with the purA mutant, no protection against challenge 
with virulent Salmonella was recorded. Sigwart et al., (1989) concluded from their work 
that purA decreases the virulence of the organism, but may attenuate so greatly that the 
Salmonella become unsuitable for use in live vaccines. In their study, only the 
Salmonella strain SL7 163 with an aroA mutation was able to significantly colonise, 
invade and persist in tissues and evoke an antibody response, especially at the mucosal 
surfaces. Neither, the purA nor the aroA purA strains demonstrated any of these 
properties. The Salmonella strain, the type of attenuation and the mode of mutant 
complementation can jointly influence the level of attenuation and immunogenicity of a 
Salmonella typhimurium strain (Dunstan et at., 1998). 
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